ANNUAL
REPORT ON FORM 10-K
For
the fiscal year ended December 31, 2008
TABLE
OF CONTENTS
|
|||
PAGE
|
|||
PART
I
|
|||
Business.
|
3
|
||
Risk
Factors.
|
10
|
||
Unresolved
Staff Comments.
|
13
|
||
Properties.
|
14
|
||
Legal
Proceedings.
|
15
|
||
Submission
of Matters to a Vote of Security Holders.
|
20
|
||
PART
II
|
|||
Market
for Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities.
|
23
|
||
Selected
Financial Data.
|
24
|
||
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations.
|
26
|
||
Quantitative
and Qualitative Disclosures About Market Risk.
|
62
|
||
Financial
Statements and Supplementary Data.
|
63
|
||
Changes
in and Disagreements With Accountants on Accounting and Financial
Disclosure.
|
126
|
||
Controls
and Procedures.
|
126
|
||
Other
Information.
|
128
|
||
PART
III
|
|||
Directors,
Executive Officers and Corporate Governance.
|
129
|
||
Executive
Compensation.
|
129
|
||
Security
Ownership of Certain Beneficial Owners and Management and Related
Stockholders Matters.
|
129
|
||
Certain
Relationships and Related Transactions, and Director
Independence.
|
129
|
||
Principal
Accounting Fees and Services.
|
129
|
||
PART
IV
|
|||
Exhibits,
Financial Statement Schedules.
|
130
|
||
133
|
|||
|
·
|
Products
: BETAFOAM™ NVH
and structural foams; BETAMATE™ structural adhesives; BETASEAL™ glass
bonding systems; DOW™ polyethylene resins; IMPAXX™ energy management foam;
INSPIRE™
performance
polymers; INTEGRAL™ adhesive films; ISONATE™ pure and modified methylene
diphenyl diisocyanate (MDI) products; MAGNUM™ ABS resins; PELLETHANE™
thermoplastic polyurethane elastomers; Premium brake fluids and
lubricants; PULSE™ engineering resins; SPECFLEX™ semi-flexible
polyurethane foam systems; VORACTIV™ polyether and copolymer
polyols
|
|
·
|
Products
: FROTH-PAK™
polyurethane spray foam; GREAT STUFF™ polyurethane foam sealant;
INSTA-STIK™ roof insulation adhesive; SARAN™ vapor retarder film and tape;
STYROFOAM™ brand insulation products (including XPS and polyisocyanurate
rigid foam sheathing products); THERMAX™ brand insulation; TILE BOND™ roof
tile adhesive; WEATHERMATE™ weather barrier solutions (housewraps, sill
pans, flashings and tapes)
|
|
·
|
Products
: AIRSTONE™
epoxy systems; D.E.H.™ epoxy curing agents or hardeners; D.E.N.™ epoxy
novolac resins; D.E.R.™ epoxy resins (liquids, solids and solutions);
Epoxy resin waterborne emulsions and dispersions; Epoxy intermediates
(acetone, allyl chloride, bisphenol A, epichlorohydrin, and phenol);
FORTEGRA™ epoxy tougheners; Glycidyl methacrylate (GMA); UCAR™ solution
vinyl resins
|
|
·
|
Products
: ECHELON™
polyurethane prepolymer; ENFORCER™ and ENHANCER™ for polyurethane carpet
and turf backing; HYPOL™ prepolymers; ISONATE™ MDI; MONOTHANE™ single
component polyurethane elastomers; PAPI™ polymeric MDI; Propylene glycol;
Propylene oxide; RENUVA™ Renewable Resource Technology; SPECFLEX™
copolymer
polyols; TRAFFIDECK™ and VERDISEAL™ waterproofing systems; VORACOR™ and
VORALAST™ polyurethane systems and VORALAST™ R renewable content
system; VORALUX™ and VORAMER™ MR series; VORANATE™ isocyanate; VORANOL™
VORACTIV™ polyether and copolymer polyols; VORASTAR™ polyurethane systems;
XITRACK™ polyurethane rail ballast stabilization
systems
|
|
·
|
Products
: AFFINITY™
polyolefin plastomers (POPs); AMPLIFY™
functional
polymers; CALIBRE™ polycarbonate resins; DOW XLA™ elastic fiber; EMERGE™
advanced resins; ENGAGE™ polyolefin elastomers; FLEXOMER™ very low density
polyethylene (VLDPE) resins; INTEGRAL™ adhesive films; ISOPLAST™
engineering thermoplastic polyurethane resins; MAGNUM™ ABS resins; NORDEL™
hydrocarbon rubber; PELLETHANE™ thermoplastic
polyurethane elastomers; PRIMACOR™ copolymers; PROCITE™ window
envelope films; PULSE™ engineering resins; REDI-LINK™ polyethylene-based
wire & cable insulation compounds; SARAN™ PVDC resin and SARAN™ PVDC
film; SARANEX™ barrier films; SI-LINK™ polyethylene-based low voltage
insulation compounds; TRENCHCOAT™ protective films; TYRIL™ SAN
resins; TYRIN™ chlorinated polyethylene; UNIGARD™ HP high-performance
flame-retardant compounds; UNIGARD™ RE reduced emissions flame-retardant
compounds; UNIPURGE™ purging compound; VERSIFY™ plastomers and
elastomers
|
|
·
|
Products
:
LP OXO™ SELECTOR™
technology and NORMAX™ catalysts; METEOR™ EO/EG process technology and
catalysts; PTA process technology; UNIPOL™ PP process technology and SHAC™
and SHAC™ ADT catalyst systems
|
|
·
|
Products and Services
:
Acrolein derivatives; Basic nitroparaffins and nitroparaffin-based
specialty chemicals; CANGUARD™ BIT preservatives; CELLOSIZE™ hydroxyethyl
cellulose; Chiral compounds and biocatalysts; CLEAR+STABLE™ carboxymethyl
cellulose; CYCLOTENE™ advanced electronics resins; DOW™
electrodeionization; DOW™ latex powders; DOW™ ultrafiltration; DOWEX™ ion
exchange resins; DOWICIDE™ antimicrobial bactericides and fungicides;
FILMTEC™ elements; FORTEFIBER™ soluble dietary fiber; Hydrocarbon resins;
Industrial biocides; METHOCEL™ cellulose ethers; POLYOX™ water-soluble
resins; Quaternaries; Reverse osmosis, electrodeionization and
ultrafiltration modules; SATINFX™ delivery system; SATISFIT™ Weight Care
Technology; SILK™ semiconductor dielectric resins; SOLTERRA™ boost; UCARE™
polymers; WALOCEL™ cellulose polymers; WALSRODER™
nitrocellulose
|
|
·
|
Products
: EVOCAR™ vinyl
acetate ethylene; FOUNDATIONS™ latex; NEOCAR™ branched vinyl ester
latexes; Styrene-acrylic latex; Styrene-butadiene latex; UCAR™
all-acrylic, styrene-acrylic and vinyl-acrylic latexes;
UCAR™ POLYPHOBE™
rheology modifiers; UCARHIDE™
opacifier
|
|
·
|
Products
: Acrylic
acid/Acrylic esters; AMBITROL™ and NORKOOL™ industrial coolants; Butyl
CARBITOL™ and Butyl CELLOSOLVE™ solvents; CARBOWAX™ and CARBOWAX™ SENTRY™
polyethylene glycols and methoxypolyethylene glycols; DOW™ polypropylene
glycols; DOWANOL™ glycol ethers; DOWCAL™, DOWFROST™ and DOWTHERM™ heat
transfer fluids; DOWFAX™, TERGITOL™ and TRITON™ surfactants; Dow
Haltermann Custom Processing and Haltermann Products; Ethanolamines;
Ethyleneamines; SAFE-TAINER™ closed-loop delivery system; SYNALOX™
lubricants; UCAR™ deicing fluids; UCARSOL™ formulated solvents; UCON™
fluids and VERSENE™ chelating
agents
|
|
·
|
Products
: AGROMEN™
seeds; BRODBECK™ seed; CLINCHER™ herbicide; DAIRYLAND™ seed; DELEGATE™
insecticide; DITHANE™ fungicide; EXZACT™ precision traits; FORTRESS™
fungicide; GARLON™ herbicide; GLYPHOMAX™ herbicide; GRANITE™ herbicide;
HERCULEX™ I, HERCULEX™ RW and HERCULEX™ XTRA insect protection;
KEYSTONE™ herbicides; LAREDO™ fungicide; LONTREL™
herbicide;
LORSBAN™ insecticides; MILESTONE™ herbicide; MUSTANG™ herbicide; MYCOGEN™
seeds; NEXERA™ canola and sunflower seeds; PHYTOGEN™ brand cottonseeds;
PROFUME™ gas fumigant; RENZE™ seed; SENTRICON™ termite colony elimination
system; SIMPLICITY™ herbicide; STARANE™ herbicide; TELONE™ soil fumigant;
TORDON™ herbicide; TRACER™ NATURALYTE™ insect control; TRIUMPH™ seed;
VIKANE™ structural fumigant; WIDESTRIKE™ insect
protection
|
|
·
|
Products
: ASPUN™ fiber
grade resins; ATTANE™ ultra low density polyethylene (ULDPE) resins;
CONTINUUM™ bimodal polyethylene resins; DOW™ high density polyethylene
(HDPE) resins; DOW™ low density polyethylene (LDPE) resins; DOWLEX™
polyethylene resins; ELITE™ enhanced polyethylene (EPE) resins; TUFLIN™
linear low density polyethylene (LLDPE) resins; UNIVAL™ HDPE
resins
|
|
·
|
Products
: DOW™
homopolymer polypropylene resins; DOW™ impact copolymer polypropylene
resins; DOW™ random copolymer polypropylene resins; INSPIRE™ performance
polymers
|
|
·
|
Products
: STYRON A-TECH™
and C-TECH™ advanced technology polystyrene resins and a full line of
STYRON™ general purpose polystyrene resins; STYRON™ high-impact
polystyrene resins
|
|
·
|
Products
: Ethylene
glycol (EG); Ethylene oxide (EO)
|
|
·
|
Products
: Benzene;
Butadiene; Butylene; Cumene; Ethylene; Propylene; Styrene; Power, steam
and other utilities
|
Patents
Owned at December 31, 2008
|
||
U.S.
|
Foreign
|
|
Performance
Plastics
|
1,029
|
5,286
|
Performance
Chemicals
|
349
|
1,406
|
Agricultural
Sciences
|
508
|
1,604
|
Basic
Plastics
|
247
|
757
|
Basic
Chemicals
|
38
|
78
|
Hydrocarbons
and Energy
|
27
|
185
|
Unallocated
and Other
|
68
|
162
|
Total
|
2,266
|
9,478
|
|
·
|
Americas
Styrenics LLC – 50 percent – a U.S. limited liability company that
manufactures polystyrene and styrene monomer.
|
|
·
|
Compañía
Mega S.A. – 28 percent – an Argentine company that owns a natural gas
separation and fractionation plant, which provides feedstocks to the
Company’s petrochemical plant located in Bahia Blanca,
Argentina.
|
|
·
|
Dow
Corning Corporation – 50 percent – a U.S. company that manufactures
silicone and silicone products. See Note K to the Consolidated
Financial Statements.
|
|
·
|
EQUATE
Petrochemical Company K.S.C. – 42.5 percent – a Kuwait-based company that
manufactures ethylene, polyethylene and ethylene glycol.
|
|
·
|
Equipolymers
– 50 percent – a company, headquartered in Horgen, Switzerland, that
manufactures purified terephthalic acid, and manufactures and markets
polyethylene terephthalate resins.
|
|
·
|
MEGlobal
– 50 percent – a company, headquartered in Dubai, United Arab Emirates,
that manufactures and markets monoethylene glycol and diethylene
glycol.
|
|
·
|
The
OPTIMAL Group of Companies [consisting of OPTIMAL Olefins (Malaysia) Sdn.
Bhd. – 23.75 percent; OPTIMAL Glycols (Malaysia) Sdn. Bhd. –
50 percent; OPTIMAL Chemicals (Malaysia) Sdn. Bhd. – 50 percent]
– Malaysian companies that operate an ethane/propane cracker, an ethylene
glycol facility and a production facility for ethylene and propylene
derivatives within a world-scale, integrated chemical complex located in
Kertih, Terengganu, Malaysia.
|
|
·
|
The
SCG-Dow Group [consisting of Siam Polyethylene Company Limited –
49 percent; Siam Polystyrene Company Limited – 50 percent; Siam
Styrene Monomer Co., Ltd. – 50 percent; Siam Synthetic Latex Company
Limited – 50 percent] – Thailand-based companies that manufacture
polyurethanes, polyethylene, polystyrene, styrene and latex.
|
|
·
|
Univation
Technologies, LLC – 50 percent – a U.S. limited liability company
that develops, markets and licenses polyethylene process technology and
related catalysts.
|
United
States
:
|
Plaquemine
and Hahnville, Louisiana; Midland, Michigan; Freeport, Seadrift and Texas
City, Texas; South Charleston, West Virginia.
|
Canada
:
|
Fort
Saskatchewan and Prentiss, Alberta.
|
Germany
:
|
Boehlen;
Leuna; Rheinmuenster; Schkopau; Stade.
|
France
:
|
Drusenheim.
|
The
Netherlands
:
|
Terneuzen.
|
Spain
:
|
Tarragona.
|
Argentina
:
|
Bahia
Blanca.
|
Brazil
:
|
Aratu.
|
United
States
:
|
42
manufacturing locations in 16 states.
|
Canada
:
|
6
manufacturing locations in 3 provinces.
|
Europe
:
|
48
manufacturing locations in 16 countries.
|
Latin
America
:
|
26
manufacturing locations in 5 countries.
|
Asia
Pacific
:
|
23
manufacturing locations in 8 countries.
|
India,
Middle East and Africa:
|
5
manufacturing locations in 4
countries.
|
2008
|
2007
|
2006
|
||||||||||
Claims
unresolved at January 1
|
90,322 | 111,887 | 146,325 | |||||||||
Claims
filed
|
10,922 | 10,157 | 16,386 | |||||||||
Claims
settled, dismissed or otherwise resolved
|
(25,538 | ) | (31,722 | ) | (50,824 | ) | ||||||
Claims
unresolved at December 31
|
75,706 | 90,322 | 111,887 | |||||||||
Claimants
with claims against both UCC and Amchem
|
24,213 | 28,937 | 38,529 | |||||||||
Individual
claimants at December 31
|
51,493 | 61,385 | 73,358 |
Defense
and Resolution Costs
|
Aggregate
Costs
|
||||
In
millions
|
2008
|
2007
|
2006
|
to
Date as of
Dec.
31, 2008
|
|
Defense
costs
|
$60
|
$84
|
$62
|
$625
|
|
Resolution
costs
|
$116
|
$88
|
$117
|
$1,386
|
(1)
|
Shares
received from employees and non-employee directors to pay taxes owed to
the Company as a result of the exercise of stock options or the delivery
of deferred stock. For information regarding the Company’s stock option
plans, see Note O to the Consolidated Financial
Statements.
|
(2)
|
On
October 26, 2006, the Company announced that the Board of Directors
had approved a share buy-back program, authorizing up to $2 billion
to be spent on the repurchase of the Company’s common stock. Purchases
under this program began in March 2007 and were completed in the third
quarter of 2008.
|
The
Dow Chemical Company and Subsidiaries
|
||||||||||||||||||||
In
millions, except as noted
(Unaudited)
|
2008
|
2007
|
2006
|
2005
|
2004
|
|||||||||||||||
Summary
of Operations
|
||||||||||||||||||||
Net sales
(1)
|
$ | 57,514 | $ | 53,513 | $ | 49,124 | $ | 46,307 | $ | 40,161 | ||||||||||
Cost of sales
(1)
|
52,019 | 46,400 | 41,526 | 38,276 | 34,244 | |||||||||||||||
Research
and development expenses
|
1,310 | 1,305 | 1,164 | 1,073 | 1,022 | |||||||||||||||
Selling,
general and administrative expenses
|
1,969 | 1,864 | 1,663 | 1,545 | 1,436 | |||||||||||||||
Amortization
of intangibles
|
92 | 72 | 50 | 55 | 81 | |||||||||||||||
Purchased
in-process research and development charges
|
44 | 57 | - | - | - | |||||||||||||||
Special
charges, merger-related expenses, and restructuring
charges
|
1,127 | 578 | 591 | 114 | 543 | |||||||||||||||
Asbestos-related
charge (credit)
|
(54 | ) | - | (177 | ) | - | - | |||||||||||||
Equity
in earnings of nonconsolidated affiliates
|
787 | 1,122 | 959 | 964 | 923 | |||||||||||||||
Other
income
|
89 | 324 | 137 | 755 | 699 | |||||||||||||||
Interest
expense - net
|
562 | 454 | 431 | 564 | 661 | |||||||||||||||
Income
(Loss) before income taxes and minority interests
|
1,321 | 4,229 | 4,972 | 6,399 | 3,796 | |||||||||||||||
Provision
(Credit) for income taxes
|
667 | 1,244 | 1,155 | 1,782 | 877 | |||||||||||||||
Minority
interests' share in income
|
75 | 98 | 93 | 82 | 122 | |||||||||||||||
Preferred
stock dividends
|
- | - | - | - | - | |||||||||||||||
Income
(Loss) before cumulative effect of changes in
|
||||||||||||||||||||
accounting
principles
|
579 | 2,887 | 3,724 | 4,535 | 2,797 | |||||||||||||||
Cumulative
effect of changes in accounting principles
|
- | - | - | (20 | ) | - | ||||||||||||||
Net
income (loss) available for common stockholders
|
$ | 579 | $ | 2,887 | $ | 3,724 | $ | 4,515 | $ | 2,797 | ||||||||||
Per share of common stock (in
dollars):
(2)
|
||||||||||||||||||||
Earnings
(Loss) before cumulative effect of changes in
|
||||||||||||||||||||
accounting
principles per common share - basic
|
$ | 0.62 | $ | 3.03 | $ | 3.87 | $ | 4.71 | $ | 2.98 | ||||||||||
Earnings
(Loss) per common share - basic
|
0.62 | 3.03 | 3.87 | 4.69 | 2.98 | |||||||||||||||
Earnings
(Loss) before cumulative effect of changes in
|
||||||||||||||||||||
accounting
principles per common share - diluted
|
0.62 | 2.99 | 3.82 | 4.64 | 2.93 | |||||||||||||||
Earnings
(Loss) per common share - diluted
|
0.62 | 2.99 | 3.82 | 4.62 | 2.93 | |||||||||||||||
Cash
dividends declared per share of common stock
|
1.68 | 1.635 | 1.50 | 1.34 | 1.34 | |||||||||||||||
Cash
dividends paid per share of common stock
|
1.68 | 1.59 | 1.46 | 1.34 | 1.34 | |||||||||||||||
Book
value per share of common stock
|
14.62 | 20.62 | 17.81 | 15.84 | 12.88 | |||||||||||||||
Weighted-average common shares
outstanding - basic
(2)
|
930.4 | 953.1 | 962.3 | 963.2 | 940.1 | |||||||||||||||
Weighted-average common shares
outstanding - diluted
(2)
|
939.0 | 965.6 | 974.4 | 976.8 | 953.8 | |||||||||||||||
Convertible
preferred shares outstanding
|
- | - | - | - | - | |||||||||||||||
Year-end
Financial Position
|
||||||||||||||||||||
Total
assets
|
$ | 45,474 | $ | 48,801 | $ | 45,581 | $ | 45,934 | $ | 45,885 | ||||||||||
Working
capital
|
2,952 | 6,209 | 6,608 | 6,741 | 5,384 | |||||||||||||||
Property
- gross
|
48,391 | 47,708 | 44,381 | 41,934 | 41,898 | |||||||||||||||
Property
- net
|
14,294 | 14,388 | 13,722 | 13,537 | 13,828 | |||||||||||||||
Long-term
debt and redeemable preferred stock
|
8,042 | 7,581 | 8,036 | 9,186 | 11,629 | |||||||||||||||
Total
debt
|
11,856 | 9,715 | 9,546 | 10,706 | 12,594 | |||||||||||||||
Net
stockholders' equity
|
13,511 | 19,389 | 17,065 | 15,324 | 12,270 | |||||||||||||||
Financial
Ratios
|
||||||||||||||||||||
Research and development expenses
as percent of net sales
(1)
|
2.3 | % | 2.4 | % | 2.4 | % | 2.3 | % | 2.5 | % | ||||||||||
Income
(Loss) before income taxes and minority interests
|
||||||||||||||||||||
as percent of
net sales
(1)
|
2.3 | % | 7.9 | % | 10.1 | % | 13.8 | % | 9.5 | % | ||||||||||
Return on stockholders' equity
(3)
|
4.3 | % | 14.9 | % | 21.8 | % | 29.5 | % | 22.8 | % | ||||||||||
Debt
as a percent of total capitalization
|
45.7 | % | 31.8 | % | 34.1 | % | 39.1 | % | 47.9 | % | ||||||||||
General
|
||||||||||||||||||||
Capital
expenditures
|
$ | 2,276 | $ | 2,075 | $ | 1,775 | $ | 1,597 | $ | 1,333 | ||||||||||
Depreciation
|
2,016 | 1,959 | 1,904 | 1,904 | 1,904 | |||||||||||||||
Salaries
and wages paid
|
4,681 | 4,404 | 3,935 | 4,309 | 3,993 | |||||||||||||||
Cost
of employee benefits
|
981 | 1,130 | 1,125 | 988 | 885 | |||||||||||||||
Number
of employees at year-end (thousands)
|
46.1 | 45.9 | 42.6 | 42.4 | 43.2 | |||||||||||||||
Number of Dow stockholders of
record at year-end (thousands)
(4)
|
94.6 | 98.7 | 103.1 | 105.6 | 108.3 |
(1)
Adjusted for reclassification of freight on sales in 2000 and
reclassification
|
(4)
Stockholders of record as reported by the transfer agent.
The
|
|||||
of
insurance operations in 2002.
|
Company
estimates that there were an additional 587,000
|
|||||
(2)
Adjusted for 3-for-1 stock split in 2000.
|
stockholders
whose shares were held in nominee names at
|
|||||
(3)
Included Temporary Equity in 1997-1999.
|
December
31, 2008.
|
The
Dow Chemical Company and Subsidiaries
|
||||||||||||||||||||||||
PART
II, Item 6. Selected Financial Data.
|
||||||||||||||||||||||||
In
millions, except as noted
(Unaudited)
|
2003
|
2002
|
2001
|
2000
|
1999
|
1998
|
||||||||||||||||||
Summary
of Operations
|
||||||||||||||||||||||||
Net sales
(1)
|
$ | 32,632 | $ | 27,609 | $ | 28,075 | $ | 29,798 | $ | 26,131 | $ | 25,396 | ||||||||||||
Cost of sales
(1)
|
28,177 | 23,780 | 23,892 | 24,310 | 20,422 | 19,566 | ||||||||||||||||||
Research
and development expenses
|
981 | 1,066 | 1,072 | 1,119 | 1,075 | 1,026 | ||||||||||||||||||
Selling,
general and administrative expenses
|
1,392 | 1,598 | 1,765 | 1,825 | 1,776 | 1,964 | ||||||||||||||||||
Amortization
of intangibles
|
63 | 65 | 178 | 139 | 160 | 106 | ||||||||||||||||||
Purchased
in-process research and development charges
|
- | - | 69 | 6 | 6 | 349 | ||||||||||||||||||
Special
charges, merger-related expenses, and restructuring
charges
|
- | 280 | 1,487 | - | 94 | 458 | ||||||||||||||||||
Asbestos-related
charge (credit)
|
- | 828 | - | - | - | - | ||||||||||||||||||
Equity
in earnings of nonconsolidated affiliates
|
322 | 40 | 29 | 354 | 95 | 31 | ||||||||||||||||||
Other
income
|
146 | 54 | 394 | 352 | 329 | 1,135 | ||||||||||||||||||
Interest
expense - net
|
736 | 708 | 648 | 519 | 432 | 458 | ||||||||||||||||||
Income
(Loss) before income taxes and minority interests
|
1,751 | (622 | ) | (613 | ) | 2,586 | 2,590 | 2,635 | ||||||||||||||||
Provision
(Credit) for income taxes
|
(82 | ) | (280 | ) | (228 | ) | 839 | 874 | 902 | |||||||||||||||
Minority
interests' share in income
|
94 | 63 | 32 | 72 | 74 | 20 | ||||||||||||||||||
Preferred
stock dividends
|
- | - | - | - | 5 | 6 | ||||||||||||||||||
Income
(Loss) before cumulative effect of changes in
|
||||||||||||||||||||||||
accounting
principles
|
1,739 | (405 | ) | (417 | ) | 1,675 | 1,637 | 1,707 | ||||||||||||||||
Cumulative
effect of changes in accounting principles
|
(9 | ) | 67 | 32 | - | (20 | ) | - | ||||||||||||||||
Net
income (loss) available for common stockholders
|
$ | 1,730 | $ | (338 | ) | $ | (385 | ) | $ | 1,675 | $ | 1,617 | $ | 1,707 | ||||||||||
Per share of common stock (in
dollars):
(2)
|
||||||||||||||||||||||||
Earnings
(Loss) before cumulative effect of changes in
|
||||||||||||||||||||||||
accounting
principles per common share - basic
|
$ | 1.89 | $ | (0.44 | ) | $ | (0.46 | ) | $ | 1.88 | $ | 1.87 | $ | 1.92 | ||||||||||
Earnings
(Loss) per common share - basic
|
1.88 | (0.37 | ) | (0.43 | ) | 1.88 | 1.85 | 1.92 | ||||||||||||||||
Earnings
(Loss) before cumulative effect of changes in
|
||||||||||||||||||||||||
accounting
principles per common share - diluted
|
1.88 | (0.44 | ) | (0.46 | ) | 1.85 | 1.84 | 1.89 | ||||||||||||||||
Earnings
(Loss) per common share - diluted
|
1.87 | (0.37 | ) | (0.43 | ) | 1.85 | 1.82 | 1.89 | ||||||||||||||||
Cash
dividends declared per share of common stock
|
1.34 | 1.34 | 1.295 | 1.16 | 1.16 | 1.16 | ||||||||||||||||||
Cash
dividends paid per share of common stock
|
1.34 | 1.34 | 1.25 | 1.16 | 1.16 | 1.16 | ||||||||||||||||||
Book
value per share of common stock
|
9.89 | 8.36 | 11.04 | 13.22 | 12.40 | 11.34 | ||||||||||||||||||
Weighted-average common shares
outstanding - basic
(2)
|
918.8 | 910.5 | 901.8 | 893.2 | 874.9 | 888.1 | ||||||||||||||||||
Weighted-average common shares
outstanding - diluted
(2)
|
926.1 | 910.5 | 901.8 | 904.5 | 893.5 | 904.8 | ||||||||||||||||||
Convertible
preferred shares outstanding
|
- | - | - | - | 1.3 | 1.4 | ||||||||||||||||||
Year-end
Financial Position
|
||||||||||||||||||||||||
Total
assets
|
$ | 41,891 | $ | 39,562 | $ | 35,515 | $ | 35,991 | $ | 33,456 | $ | 31,121 | ||||||||||||
Working
capital
|
3,578 | 2,519 | 2,183 | 1,150 | 2,848 | 1,570 | ||||||||||||||||||
Property
- gross
|
40,812 | 37,934 | 35,890 | 34,852 | 33,333 | 32,844 | ||||||||||||||||||
Property
- net
|
14,217 | 13,797 | 13,579 | 13,711 | 13,011 | 12,628 | ||||||||||||||||||
Long-term
debt and redeemable preferred stock
|
11,763 | 11,659 | 9,266 | 6,613 | 6,941 | 5,890 | ||||||||||||||||||
Total
debt
|
13,109 | 13,036 | 10,883 | 9,450 | 8,708 | 8,099 | ||||||||||||||||||
Net
stockholders' equity
|
9,175 | 7,626 | 9,993 | 11,840 | 10,940 | 9,878 | ||||||||||||||||||
Financial
Ratios
|
||||||||||||||||||||||||
Research and development expenses
as percent of net sales
(1)
|
3.0 | % | 3.9 | % | 3.8 | % | 3.8 | % | 4.1 | % | 4.0 | % | ||||||||||||
Income
(Loss) before income taxes and minority interests
|
||||||||||||||||||||||||
as percent of
net sales
(1)
|
5.4 | % | (2.3 | )% | (2.2 | )% | 8.7 | % | 9.9 | % | 10.4 | % | ||||||||||||
Return on stockholders' equity
(3)
|
18.9 | % | (4.4 | )% | (3.9 | )% | 14.1 | % | 14.7 | % | 17.2 | % | ||||||||||||
Debt
as a percent of total capitalization
|
55.4 | % | 59.2 | % | 48.9 | % | 42.5 | % | 42.2 | % | 43.6 | % | ||||||||||||
General
|
||||||||||||||||||||||||
Capital
expenditures
|
$ | 1,100 | $ | 1,623 | $ | 1,587 | $ | 1,808 | $ | 2,176 | $ | 2,328 | ||||||||||||
Depreciation
|
1,753 | 1,680 | 1,595 | 1,554 | 1,516 | 1,559 | ||||||||||||||||||
Salaries
and wages paid
|
3,608 | 3,202 | 3,215 | 3,395 | 3,536 | 3,579 | ||||||||||||||||||
Cost
of employee benefits
|
783 | 611 | 540 | 486 | 653 | 798 | ||||||||||||||||||
Number
of employees at year-end (thousands)
|
46.4 | 50.0 | 52.7 | 53.3 | 51.0 | 50.7 | ||||||||||||||||||
Number of Dow stockholders of
record at year-end (thousands)
(4)
|
113.1 | 122.5 | 125.1 | 87.9 | 87.7 | 93.0 |
(1)
Adjusted for reclassification of freight on sales in 2000 and
reclassification
|
(4)
Stockholders of record as reported by the transfer agent.
The
|
|||||
of
insurance operations in 2002.
|
Company
estimates that there were an additional 587,000
|
|||||
(2)
Adjusted for 3-for-1 stock split in 2000.
|
stockholders
whose shares were held in nominee names at
|
|||||
(3)
Included Temporary Equity in 1997-1999.
|
December
31, 2008.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
Page
|
2008
Overview
|
27
|
Results
of Operations
|
29
|
Segment
Results
|
34
|
Performance
Plastics
|
34
|
Performance
Chemicals
|
37
|
Agricultural
Sciences
|
38
|
Basic
Plastics
|
39
|
Basic
Chemicals
|
41
|
Hydrocarbons
and Energy
|
42
|
Sales
Price and Volume Chart (Percent change from prior year)
|
44
|
Liquidity
and Capital Resources
|
44
|
Cash
Flow
|
44
|
Working
Capital
|
45
|
Debt
|
45
|
Capital
Expenditures
|
47
|
Contractual
Obligations
|
48
|
Off-Balance
Sheet Arrangements
|
48
|
Fair
Value Measurements
|
48
|
Dividends
|
49
|
Outlook
for 2009
|
49
|
Critical
Accounting Policies
|
50
|
Environmental
Matters
|
53
|
Asbestos-Related
Matters of Union Carbide Corporation
|
57
|
Matters
Involving the Formation of K-Dow Petrochemicals
|
60
|
Matters
Involving the Acquisition of Rohm and Haas Company
|
61
|
|
·
|
Dow
announced plans to invest in a state-of-the-art membrane chlor-alkali
production facility at its Freeport, Texas site. The new facility will
replace several facilities that are nearing the end of their economic
life.
|
|
·
|
Dow
Agrosciences broadened its product portfolio and geographic reach with the
announcements of six bolt-on acquisitions: Triumph Seed Co., Inc.;
Dairyland Seed Co., Inc.; Bio-Plant Research Ltd.; assets of Renze Hybrids
Inc.; assets of Südwestsaat GbR; and assets of Brodbeck Seed
Inc.
|
|
·
|
Dow
Polyurethanes broke ground on a major capacity expansion at its polyols
plant in Terneuzen, The
Netherlands.
|
|
·
|
Dow
Epoxy Systems introduced AIRSTONE™ epoxy systems, a family of products
with performance characteristics that are well-suited for use in the
fabrication of wind blades.
|
·
|
Americas
Styrenics LLC, a joint venture between Dow and Chevron Phillips Chemical
Company LP, began operations.
|
·
|
The
Company announced two broad-based pricing initiatives to combat surging
feedstock and energy costs. The first announcement, in May, called for an
increase of up to 20 percent on all products. The second initiative,
announced in June, called for an additional price increase of up to
25 percent as well as freight
surcharges.
|
·
|
The
SCG-Dow Group, a joint venture between Dow and The Siam Cement Group,
broke ground on a world-scale propylene oxide facility in Thailand that
will use innovative hydrogen peroxide to propylene oxide technology
jointly developed by Dow and BASF. In 2008, the SCG-Dow Group announced a
50:50 joint venture to construct a specialty elastomers train, also in
Thailand.
|
·
|
Dow
Water Solutions announced plans to expand its Edina, Minnesota
manufacturing facility to produce additional products for advanced water
solutions. It will be the third expansion at this location in the past
eight years.
|
·
|
Dow
Izolan, a joint venture between Dow and Russia-based Scientific
Manufacturing Company Izolan Ltd., broke ground on a state-of-the-art
polyurethane systems manufacturing facility in Vladimir,
Russia.
|
·
|
The
Kuwait Olefins Company, a joint venture between Dow and Petrochemical
Industries Company (K.S.C.) (“PIC”), announced the launch of commercial
operations of its Olefins II Kuwait Program Ethylene Unit and its Ethylene
Glycol Unit.
|
·
|
On
November 28, 2008, the Company and PIC signed a Joint Venture
Formation Agreement (“JVFA”) to form a 50:50 global petrochemicals joint
venture, K-Dow Petrochemicals (“K-Dow”). However, PIC failed to close the
K-Dow transaction on January 2, 2009, as required by the JVFA. As a
result, the Company is pursuing all legal options available to it relating
to PIC’s failure to close the proposed K-Dow joint venture. In addition,
the Company is in the process of seeking an alternative joint venture
partner. See Matters Involving the Formation of K-Dow Petrochemicals at
the end of Management’s Discussion and Analysis of Financial Condition and
Results of Operations for additional information regarding these
matters.
|
·
|
As
economic conditions worsened toward the end of the year, Dow announced a
restructuring plan as part of a series of actions to advance the Company’s
strategy and respond to the recent, severe economic downturn. The
restructuring plan included the elimination of approximately 5,000 jobs
(including planned divestitures) and the closure of facilities in
high-cost locations. Related to this plan, the Company recorded a pretax
restructuring charge of $785 million in the fourth quarter. In
addition, the Company announced the temporary idling of nearly 200
plants.
|
·
|
On
July 10, 2008, the Company and Rohm and Haas Company (“Rohm and
Haas”) announced a definitive agreement, under which the Company would
acquire all outstanding shares of Rohm and Haas common stock for
$78 per share in cash. The acquisition of Rohm and Haas would make
the Company the world’s leading specialty chemicals and advanced materials
company, combining the two organizations’ best-in-class technologies,
broad geographic reach and strong industry channels to create a business
portfolio with significant growth opportunities. The Rohm and Haas
transaction did not close in January 2009 in light of the Company’s
determination that recent material developments created unacceptable
uncertainties related to the funding and economics of the combined Dow and
Rohm and Haas enterprise. This assessment was based on several
macro-economic factors such as the continued crisis in global financial
and credit markets, combined with the failure of PIC to fulfill its
obligation to complete the formation of the proposed K-Dow joint venture.
See Matters Involving the Acquisition of Rohm and Haas Company at the end
of Management’s Discussion and Analysis of Financial Condition and Results
of Operations and Part I, Item 3. Legal Proceedings for additional
information regarding these
matters.
|
Production
Costs and Operating Expenses
|
||||||||||||
Cost
components as a percent of total
|
2008
|
2007
|
2006
|
|||||||||
Hydrocarbon
feedstocks and energy
|
48 | % | 49 | % | 49 | % | ||||||
Salaries,
wages and employee benefits
|
10 | 11 | 11 | |||||||||
Maintenance
|
3 | 3 | 3 | |||||||||
Depreciation
|
4 | 4 | 4 | |||||||||
Restructuring
charges
|
1 | 1 | 1 | |||||||||
Supplies,
services and other raw materials
|
34 | 32 | 32 | |||||||||
Total
|
100 | % | 100 | % | 100 | % |
Pretax
Impact
(1)
|
Impact
on
Net Income
(2)
|
Impact
on
EPS
(3)
|
||||||||||||||||||||||||||||||||||
In
millions, except per share amounts
|
2008
|
2007
|
2006
|
2008
|
2007
|
2006
|
2008
|
2007
|
2006
|
|||||||||||||||||||||||||||
Cost
of sales:
|
||||||||||||||||||||||||||||||||||||
Impact
of Hurricanes Gustav and Ike
|
$ | (181 | ) | - | - | $ | (115 | ) | - | - | $ | (0.12 | ) | - | - | |||||||||||||||||||||
K-Dow
related expenses
|
(69 | ) | - | - | (44 | ) | - | - | (0.05 | ) | - | - | ||||||||||||||||||||||||
Goodwill
impairment losses
|
(239 | ) | - | - | (230 | ) | - | - | (0.25 | ) | - | - | ||||||||||||||||||||||||
Restructuring
charges
|
(839 | ) | $ | (578 | ) | $ | (591 | ) | (628 | ) | $ | (436 | ) | $ | (445 | ) | (0.68 | ) | $ | (0.46 | ) | $ | (0.46 | ) | ||||||||||||
Purchased
in-process research and development charges
|
(44 | ) | (57 | ) | - | (44 | ) | (50 | ) | - | (0.05 | ) | (0.05 | ) | - | |||||||||||||||||||||
Acquisition-related
expenses
|
(49 | ) | - | - | (43 | ) | - | - | (0.05 | ) | - | - | ||||||||||||||||||||||||
Asbestos-related
credit
|
- | - | 177 | - | - | 112 | - | - | 0.12 | |||||||||||||||||||||||||||
Sundry
income - net:
|
||||||||||||||||||||||||||||||||||||
Loss
contingency related to EC fine
|
- | - | (85 | ) | - | - | (84 | ) | - | - | (0.09 | ) | ||||||||||||||||||||||||
Provision
for income taxes:
|
||||||||||||||||||||||||||||||||||||
German
tax law change
|
- | - | - | - | (362 | ) | - | - | (0.38 | ) | - | |||||||||||||||||||||||||
Change
in EQUATE legal ownership structure
|
- | - | - | - | 113 | - | - | 0.12 | - | |||||||||||||||||||||||||||
Total
|
$ | (1,421 | ) | $ | (635 | ) | $ | (499 | ) | $ | (1,104 | ) | $ | (735 | ) | $ | (417 | ) | $ | (1.20 | ) | $ | (0.77 | ) | $ | (0.43 | ) |
(1)
|
Impact
on “Income before Income Taxes and Minority
Interests”
|
(2)
|
Impact
on “Net Income Available for Common
Stockholders”
|
(3)
|
Impact
on “Earnings per common share -
diluted”
|
|
·
|
results
of insurance company operations,
|
|
·
|
gains
and losses on sales of financial assets,
|
|
·
|
stock-based
compensation expense and severance costs,
|
|
·
|
changes
in the allowance for doubtful receivables,
|
|
·
|
expenses
related to New Ventures,
|
|
·
|
asbestos-related
defense and resolution costs,
|
|
·
|
foreign
exchange hedging results, and
|
|
·
|
certain
overhead and other cost recovery variances not allocated to the operating
segments
|
Cash
Flow Summary
In
millions
|
2008
|
2007
|
2006
|
|||||||||
Cash
provided by (used in):
|
||||||||||||
Operating
activities
|
$ | 4,711 | $ | 4,484 | $ | 4,154 | ||||||
Investing
activities
|
(2,737 | ) | (2,858 | ) | (1,907 | ) | ||||||
Financing
activities
|
(978 | ) | (2,728 | ) | (3,302 | ) | ||||||
Effect
of exchange rate changes on cash
|
68 | 81 | 6 | |||||||||
Net
increase (decrease) in cash and cash equivalents
|
$ | 1,064 | $ | (1,021 | ) | $ | (1,049 | ) |
Total
Debt at December 31
In
millions
|
2008
|
2007
|
||||||
Notes
payable
|
$ | 2,360 | $ | 1,548 | ||||
Long-term
debt due within one year
|
1,454 | 586 | ||||||
Long-term
debt
|
8,042 | 7,581 | ||||||
Total
debt
|
$ | 11,856 | $ | 9,715 | ||||
Debt
as a percent of total capitalization
|
45.7 | % | 31.8 | % |
Contractual
Obligations at December 31, 2008
|
Payments Due by Year | |||||||||||||||||||||||||||
In
millions
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
and
beyond
|
Total
|
|||||||||||||||||||||
Long-term
debt – current and noncurrent
|
$ | 1,454 | $ | 1,060 | $ | 1,523 | $ | 1,004 | $ | 601 | $ | 3,854 | $ | 9,496 | ||||||||||||||
Deferred
income tax liabilities – noncurrent
(1)
|
- | - | - | - | - | 746 | 746 | |||||||||||||||||||||
Pension
and other postretirement benefits
|
487 | 521 | 796 | 723 | 788 | 2,151 | 5,466 | |||||||||||||||||||||
Other
noncurrent obligations
(2)
|
253 | 306 | 168 | 90 | 63 | 3,152 | 4,032 | |||||||||||||||||||||
FIN
No. 48 obligations, including interest and penalties
(3)
|
254 | - | - | - | - | 573 | 827 | |||||||||||||||||||||
Other
contractual obligations:
|
||||||||||||||||||||||||||||
Minimum
operating lease commitments
|
204 | 157 | 103 | 75 | 64 | 340 | 943 | |||||||||||||||||||||
Purchase
commitments – take-or-pay and throughput obligations
|
2,023 | 1,708 | 1,798 | 1,392 | 895 | 5,969 | 13,785 | |||||||||||||||||||||
Purchase
commitments – other
(4)
|
178 | 136 | 5 | 3 | - | 5 | 327 | |||||||||||||||||||||
Expected
cash requirements for interest
|
552 | 501 | 438 | 356 | 298 | 4,096 | 6,241 | |||||||||||||||||||||
Total
|
$ | 5,405 | $ | 4,389 | $ | 4,831 | $ | 3,643 | $ | 2,709 | $ | 20,886 | $ | 41,863 | ||||||||||||||
(1)
Deferred income tax liabilities may vary according to changes in tax laws,
tax rates and the operating results of the Company. As a result, it is
impractical to determine whether there will be a cash impact to an
individual year. All noncurrent deferred income tax liabilities have
been reflected in “2014 and beyond.”
|
||||||||||||||||||||||||||||
(2)
Annual payments to resolve asbestos litigation will vary based on changes
in defense strategies, changes in state and national law, and claims
filing and resolution rates. As a result, it is impractical to determine
the anticipated payments in any given year. Therefore, the majority of the
noncurrent asbestos-related liability of $824 million has been reflected
in “2014 and beyond.”
|
||||||||||||||||||||||||||||
(3)
Due to uncertainties in the timing of the effective settlement of tax
positions with the respective taxing authorities, the Company is unable to
determine the timing of payments related to its FIN No. 48 noncurrent
obligations, including interest and penalties. These amounts are therefore
reflected in “2014 and beyond.”
|
||||||||||||||||||||||||||||
(4)
Includes outstanding purchase orders and other commitments greater than $1
million, obtained through a survey of the Company.
|
Net
Decrease in Market-Related Asset Value Due to Recognition of Prior Asset
Gains and Losses
In
millions
|
||||
2009
|
$ | 728 | ||
2010
|
738 | |||
2011
|
827 | |||
2012
|
891 | |||
Total
|
$ | 3,184 |
2008
|
2007
|
2006
|
||||||||||
Claims
unresolved at January 1
|
90,322 | 111,887 | 146,325 | |||||||||
Claims
filed
|
10,922 | 10,157 | 16,386 | |||||||||
Claims
settled, dismissed or otherwise resolved
|
(25,538 | ) | (31,722 | ) | (50,824 | ) | ||||||
Claims
unresolved at December 31
|
75,706 | 90,322 | 111,887 | |||||||||
Claimants
with claims against both UCC and Amchem
|
24,213 | 28,937 | 38,529 | |||||||||
Individual
claimants at December 31
|
51,493 | 61,385 | 73,358 |
Defense
and Resolution Costs
|
Aggregate
Costs
|
||||
In
millions
|
2008
|
2007
|
2006
|
to
Date as of
Dec.
31, 2008
|
|
Defense
costs
|
$60
|
$84
|
$62
|
$625
|
|
Resolution
costs
|
$116
|
$88
|
$117
|
$1,386
|
Total Daily VAR at December
31
(1)
|
2008
|
2007
|
||
In
millions
|
Year-end
|
Average
|
Year-end
|
Average
|
Foreign
exchange
|
$1
|
$4
|
$7
|
$5
|
Interest
rate
|
$121
|
$93
|
$57
|
$44
|
Equity
exposures, net of hedges
|
$24
|
$17
|
$15
|
$16
|
Commodities
|
$8
|
$17
|
$17
|
$11
|
(1)
Using a 95 percent confidence level
|
|
·
|
pertain
to the maintenance of records that, in reasonable detail, accurately and
fairly reflect the transactions and dispositions of the assets of the
Company;
|
|
·
|
provide
reasonable assurance that transactions are recorded properly to allow for
the preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the
Company are being made only in accordance with authorizations of
management and Directors of the Company;
|
|
·
|
provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the Company’s assets that
could have a material effect on the consolidated financial statements;
and
|
|
·
|
provide
reasonable assurance as to the detection of
fraud.
|
/s/
ANDREW N. LIVERIS
|
/s/
GEOFFERY E. MERSZEI
|
|
Andrew
N. Liveris
President,
Chief Executive Officer and
Chairman
of the Board
|
Geoffery
E. Merszei
Executive
Vice President and Chief Financial Officer
|
|
/s/
WILLIAM H. WEIDEMAN
|
||
William
H. Weideman
Vice
President and Controller
|
||
February
11, 2009
|
Note
|
Page
|
||
A
|
Summary
of Significant Accounting Policies and Recent Accounting
Pronouncements
|
70
|
|
B
|
Restructuring
|
75
|
|
C
|
Acquisitions
|
82
|
|
D
|
Inventories
|
83
|
|
E
|
Property
|
83
|
|
F
|
Nonconsolidated
Affiliates and Related Company Transactions
|
84
|
|
G
|
Goodwill
and Other Intangible Assets
|
86
|
|
H
|
Financial
Instruments
|
88
|
|
I
|
Fair
Value Measurements
|
94
|
|
J
|
Supplementary
Information
|
95
|
|
K
|
Commitments
and Contingent Liabilities
|
96
|
|
L
|
Notes
Payable, Long-Term Debt and Available Credit Facilities
|
103
|
|
M
|
Pension
Plans and Other Postretirement Benefits
|
105
|
|
N
|
Leased
Property and Variable Interest Entities
|
109
|
|
O
|
Stock-Based
Compensation
|
109
|
|
P
|
Limited
Partnership
|
113
|
|
Q
|
Preferred
Securities of Subsidiaries
|
113
|
|
R
|
Stockholders’
Equity
|
114
|
|
S
|
Income
Taxes
|
114
|
|
T
|
Operating
Segments and Geographic Areas
|
117
|
|
U
|
Subsequent
Events
|
124
|
|
·
|
Due
to the recent, severe economic downturn, the Company decided in the fourth
quarter of 2008 to shut down a number of facilities, including the
following:
|
|
·
|
Chlor-alkali
manufacturing facility in Oyster Creek, Texas. A $31 million
write-off of the net book value of the related buildings, machinery and
equipment against the Basic Chemicals segment was recorded in the fourth
quarter of 2008. This facility will be shut down in the first quarter of
2009.
|
|
·
|
Styrene
and styrene derivatives manufacturing facilities principally in Freeport,
Texas; Pittsburg, California; Terneuzen, The Netherlands; King’s Lynn,
England, and Varennes, Canada. A $37 million write-off of the net
book value of the related buildings, machinery and equipment against the
Hydrocarbons and Energy ($14 million), Basic Plastics
($6 million), Performance Chemicals ($10 million) and
Performance Plastics ($2 million) segments, as well as Unallocated
and Other ($5 million) was recorded in the fourth quarter of 2008.
The facilities will be shut down by the end of 2009.
|
|
·
|
Facilities
that manufacture NORDEL™ hydrocarbon rubber in Seadrift, Texas, and TYRIN™
chlorinated polyethylene in Plaquemine, Louisiana. A $36 million
write-down of the net book value of the related buildings, machinery and
equipment against the Performance Plastics segment was recorded in the
fourth quarter of 2008. Both facilities will close in the first quarter of
2009.
|
|
·
|
Solution
vinyl resin manufacturing facilities in Texas City, Texas. A
$26 million write-down of the net book value of the related
buildings, machinery and equipment against the Performance Plastics
segment was recorded in the fourth quarter of 2008. This plant will be
shut down in the third quarter of 2009.
|
|
·
|
Perchloroethylene/carbon
tetrachloride manufacturing facility in Aratu, Brazil. An $11 million
write-off of the net book value of the related buildings, machinery and
equipment against the Basic Chemicals segment was recorded in the fourth
quarter of 2008. This facility will be shut down by the end of
2009.
|
|
·
|
In
addition to the locations described above, the restructuring charges for
plant closures included $26 million related to the shutdown of
several small production facilities.
|
|
·
|
The
Company decided in the fourth quarter to pursue strategic alternatives
regarding its Wilton, England, ethylene oxide/ethylene glycol (“EO/EG”)
plant. Based on the results of asset impairment testing, an impairment
charge of $30 million against the Basic Chemicals segment was
recorded in the fourth quarter of 2008.
|
|
·
|
Due
to an expected loss on the pending sale of the automotive sealants
business in Europe, an impairment charge of $8 million against the
Performance Plastics segment was recorded in the fourth quarter of
2008.
|
|
·
|
Due
to a change in scope, the Company’s investment (primarily engineering
costs) in a project to form a joint venture to design, build and operate a
petrochemical complex in Oman was written down. An $83 million
write-down of the project-related spending against the Basic Plastics
segment was recorded in the fourth quarter of 2008.
|
2008
Restructuring Activities
In
millions
|
Impairment
of
Long-Lived
Assets and Other Assets
|
Costs
associated with Exit or Disposal Activities
|
Severance
Costs
|
Total
|
||||||||||||
Restructuring
charges recognized in the fourth quarter of 2008
|
$ | 336 | $ | 128 | $ | 321 | $ | 785 | ||||||||
Cash
payments
|
- | - | (2 | ) | (2 | ) | ||||||||||
Charges
against reserve
|
(336 | ) | - | - | (336 | ) | ||||||||||
Reserve
balance at December 31, 2008
|
- | $ | 128 | $ | 319 | $ | 447 |
|
·
|
Due
to overcapacity within the industry, a disadvantaged cost position, and
increasing pressure from generic suppliers, the Company launched an
information/consultation process with local employee representatives on a
closure project in the fourth quarter of 2007 and recorded an asset
impairment charge related to its agricultural products manufacturing site
located in Lauterbourg, France; upon completion of the
information/consultation process, the plant was shut down in the fourth
quarter of 2008. A $44 million write-down of the net book value of
the related buildings, machinery and equipment against the Agricultural
Sciences segment was recorded in the fourth quarter of 2007.
|
|
·
|
The
Company evaluated the economic and financial feasibility of its styrene
plant in Camaçari, Brazil, and due to raw material competitiveness, the
age of the facility, as well as the ready availability of styrene within
the global marketplace, the Company idled the facility in the fourth
quarter of 2007 and recorded a $14 million write-down of the net book
value of the related buildings, machinery and equipment against the
Hydrocarbons and Energy segment.
|
|
·
|
The
Company closed its hydroxyethyl cellulose manufacturing facility located
in Aratu, Brazil, in the first quarter of 2008, due to a number of
factors, including capacity limitations, high structural and raw material
costs, and older technology. A $12 million write-down of the net book
value of the related buildings, machinery and equipment was recorded
against the Performance Chemicals segment in the fourth quarter of
2007.
|
|
·
|
The
Company determined that the operating costs of its fiber solution
manufacturing plant in Tarragona, Spain, cannot be sustained. The Company
is evaluating more economically viable alternative manufacturing options.
As a result, the Company recorded a $29 million impairment write-down
of the net book value of the related buildings, machinery and equipment
against the Performance Plastics segment in the fourth quarter of
2007.
|
|
·
|
Due
to a number of factors, including the inability to secure an economically
sustainable source of propylene and the use of older technologies at the
plant, Union Carbide decided in the fourth quarter of 2007 to shut down
its polypropylene facility at St. Charles Operations in Hahnville,
Louisiana. As a result of the shutdown, a $23 million write-down of
the net book value of the related buildings, machinery and equipment was
recorded against the Basic Plastics segment in the fourth quarter of 2007.
The plant was shut down in the first quarter of 2008.
|
|
·
|
The
Company determined that it would not be possible to renegotiate an
economically viable contract manufacturing agreement to continue the
operations of the rubber plant located in Berre, France. A
$27 million impairment write-down of the net book value of the
related buildings, machinery and equipment was recorded against the
Performance Plastics segment in the fourth quarter of 2007. The plant was
shut down in the second quarter of 2008.
|
|
·
|
The
Company assessed the long-term profitability of its participation in the
automotive sealants business and determined that the projected results are
inconsistent with the financial performance expected of a market-facing
business. As a result, in the fourth quarter of 2007, the Company made the
decision to exit the automotive sealants business in North America, Asia
Pacific and Latin America by mid-2009; the business explored strategic
options within Europe and decided in the fourth quarter of 2008 to divest
the automotive sealants business within Europe. A $58 million
write-down of the net book value of the related buildings, machinery and
equipment against the Performance Plastics segment was recorded in the
fourth quarter of 2007.
|
|
·
|
Due
to an unfavorable financial outlook, reflecting significant long-term
economic challenges, the Company determined in the fourth quarter of 2007
that its equity investment in Pétromont, a 50 percent owned company,
was other-than-temporarily impaired and recorded a $46 million
write-down of its interest in Pétromont against the Basic Plastics
segment. In the fourth quarter of 2008, the joint venture announced the
permanent shutdown of its operations. As a result of this announcement,
the Company recorded an additional charge of $50 million in the
fourth quarter of 2008.
|
·
|
Due
to the loss of a significant portion of business and the lack of
replacement business opportunities, the Company determined its equity
investment in Dow Reichold Specialty Latex LLC, a 50:50 joint venture to
be other-than-temporarily impaired and recorded a $42 million
write-down of its interest in Dow Reichhold Specialty Latex LLC against
the Performance Chemicals segment in the fourth quarter of 2007. An
agreement was reached in the third quarter of 2008 to end the Company’s
involvement in the joint venture.
|
2007
Restructuring Activities
In
millions
|
Impairment
of
Long-Lived
Assets, Other Intangible Assets and Equity Investments
|
Costs
associated with Exit or Disposal Activities
|
Severance
Costs
|
Total
|
||||||||||||
Restructuring
charges recognized in the fourth quarter of 2007
|
$ | 422 | $ | 82 | $ | 86 | $ | 590 | ||||||||
Cash
payments
|
- | - | (1 | ) | (1 | ) | ||||||||||
Charges
against reserve
|
(422 | ) | (3 | ) | - | (425 | ) | |||||||||
Reserve
balance at December 31, 2007
|
- | $ | 79 | $ | 85 | $ | 164 | |||||||||
Adjustments
to reserve
|
$ | 30 | 30 | - | 60 | |||||||||||
Cash
payments
|
- | (7 | ) | (47 | ) | (54 | ) | |||||||||
Charges
against reserve
|
(30 | ) | - | - | (30 | ) | ||||||||||
Foreign
currency impact
|
- | (9 | ) | (1 | ) | (10 | ) | |||||||||
Reserve
balance at December 31, 2008
|
- | $ | 93 | $ | 37 | $ | 130 |
|
·
|
In
Porto Marghera, Italy, the Company’s toluene diisocyanate (“TDI”) plant
was shut down for planned maintenance in early August 2006. Business
fundamentals in the TDI business were weak due to excess global capacity.
As a result, the Company decided to permanently close the facility at the
end of August, resulting in a $115 million write-down of the net book
value of the related buildings, machinery and equipment against the
Performance Plastics segment in the third quarter of 2006.
|
|
·
|
Substantial
capital costs would be required to address efficiency issues at the
Company’s chlor-alkali and direct chlorination ethylene dichloride plants
in Fort Saskatchewan, Canada. Based on an analysis of the discounted
future cash flows, management determined that an investment in these
facilities could not be justified. As a result, the Company shut down the
facilities at the end of October 2006, resulting in a $74 million
write-down of the net book value of the related buildings, machinery and
equipment against the Basic Chemicals segment in the third quarter of
2006.
|
|
·
|
Assessments
by the businesses located in Sarnia, Canada, were triggered by the
suspension of ethylene shipments through the Cochin Pipeline, a subsidiary
of BP Canada Energy Resources Company, due to safety concerns. The
assessments highlighted a variety of issues related to the effectiveness,
efficiency and long-term sustainability of the Sarnia-based assets. Based
on these assessments, the Company decided to cease all production activity
at the Sarnia site by the end of the first quarter of 2009 as
follows:
|
|
·
|
The
low density polyethylene plant was shut down in the third quarter of
2006.
|
|
·
|
The
polystyrene plant ceased production in December 2006.
|
|
·
|
Latex
production from the UCAR Emulsion Systems facility was shut down in the
fourth quarter of 2007.
|
|
·
|
The
polyols plant is expected to be shut down in the first quarter of
2009.
|
2006
Restructuring Activities
In
millions
|
Impairment
of
Long-Lived
Assets and Other
Intangible
Assets
|
Costs
associated with Exit or Disposal Activities
|
Severance
Costs
|
Total
|
||||||||||||
Restructuring
charges recognized in 2006
|
$ | 346 | $ | 172 | $ | 73 | $ | 591 | ||||||||
Cash
payments
|
- | (1 | ) | (4 | ) | (5 | ) | |||||||||
Charges
against reserve
|
(346 | ) | - | - | (346 | ) | ||||||||||
Reserve
balance at December 31, 2006
|
- | $ | 171 | $ | 69 | $ | 240 | |||||||||
Adjustments
to reserve
|
- | (4 | ) | (8 | ) | (12 | ) | |||||||||
Cash
payments
|
- | (53 | ) | (25 | ) | (78 | ) | |||||||||
Foreign
currency impact
|
- | 21 | 3 | 24 | ||||||||||||
Reserve
balance at December 31, 2007
|
- | $ | 135 | $ | 39 | $ | 174 | |||||||||
Adjustments
to reserve
|
- | (8 | ) | (3 | ) | (11 | ) | |||||||||
Cash
payments
|
- | (15 | ) | (17 | ) | (32 | ) | |||||||||
Foreign
currency impact
|
- | (20 | ) | (5 | ) | (25 | ) | |||||||||
Reserve
balance at December 31, 2008
|
- | $ | 92 | $ | 14 | $ | 106 |
Assets
Acquired and Liabilities Assumed
In
millions
|
At
June 30,
2007
|
Purchase Price Adjustments
(1)
|
At
Dec. 31,
2007
|
Purchase
Price Adjustments
|
At
Dec. 31,
2008
|
|||||||||||||||
Current
assets
|
$ | 188 | $ | 15 | $ | 203 | - | $ | 203 | |||||||||||
Property
|
233 | 89 | 322 | $ | (3 | ) | 319 | |||||||||||||
Goodwill
(2)
|
364 | (163 | ) | 201 | 6 | 207 | ||||||||||||||
Other
intangible assets
(2)
|
8 | 148 | 156 | - | 156 | |||||||||||||||
Other
assets
|
11 | (5 | ) | 6 | - | 6 | ||||||||||||||
Total
assets acquired
|
$ | 804 | $ | 84 | $ | 888 | $ | 3 | $ | 891 | ||||||||||
Accounts
payable
|
$ | 27 | - | $ | 27 | - | $ | 27 | ||||||||||||
Long-term
debt
|
10 | - | 10 | - | 10 | |||||||||||||||
Accrued
and other liabilities
|
47 | $ | (5 | ) | 42 | - | 42 | |||||||||||||
Pension
benefits
|
117 | (11 | ) | 106 | - | 106 | ||||||||||||||
Deferred
tax liabilities - noncurrent
|
- | 88 | 88 | - | 88 | |||||||||||||||
Total
liabilities assumed
|
$ | 201 | $ | 72 | $ | 273 | - | $ | 273 | |||||||||||
Net
assets acquired
|
$ | 603 | $ | 12 | $ | 615 | $ | 3 | $ | 618 |
(1)
Includes a $7 million write-off of purchased in-process research and
development, the addition of transaction costs of $7 million in the
second half of 2007 and $15 million of working capital
adjustments.
|
In-Process
Research and Development Projects Acquired
In
millions
|
Date
of Acquisition
|
Estimated
Value
Assigned
to
IPR&D
|
|||
2008
|
|||||
Germplasm
from Triumph Seed Co., Inc.
|
February
29, 2008
|
$ | 4 | ||
Germplasm
from Dairyland Seed Co., Inc. and Bio-Plant Research Ltd.
|
August
29, 2008
|
23 | |||
Germplasm
from Südwestsaat GbR
|
December 16,
2008
|
17 | |||
Total
2008 IPR&D
|
$ | 44 | |||
2007
|
|||||
Germplasm
from Maize Technologies International
|
May
1, 2007
|
$ | 2 | ||
Manufacturing
process R&D from Wolff Walsrode
|
June
30, 2007
|
7 | |||
Germplasm
from Agromen Tecnologia Ltda.
|
August
1, 2007
|
26 | |||
Germplasm
from Duo Maize
|
August
30, 2007
|
3 | |||
Intellectual
property for crop trait discovery from Exelixis Plant
Sciences
|
September
4, 2007
|
19 | |||
Total
2007 IPR&D
|
$ | 57 |
Inventories
at December 31
In
millions
|
2008
|
2007
|
||||||
Finished
goods
|
$ | 3,351 | $ | 4,085 | ||||
Work
in process
|
1,217 | 1,595 | ||||||
Raw
materials
|
830 | 566 | ||||||
Supplies
|
638 | 639 | ||||||
Total
inventories
|
$ | 6,036 | $ | 6,885 |
Property
at December 31
|
Estimated
|
|||||||||||
In
millions
|
Useful
Lives
(Years)
|
2008
|
2007
|
|||||||||
Land
|
- | $ | 590 | $ | 602 | |||||||
Land
and waterway improvements
|
15-25 | 1,308 | 1,286 | |||||||||
Buildings
|
5-55 | 3,700 | 3,717 | |||||||||
Machinery
and equipment
|
3-20 | 36,285 | 36,266 | |||||||||
Utility
and supply lines
|
5-20 | 2,248 | 2,253 | |||||||||
Other
property
|
3-30 | 2,166 | 1,770 | |||||||||
Construction
in progress
|
- | 2,094 | 1,814 | |||||||||
Total
property
|
$ | 48,391 | $ | 47,708 |
In
millions
|
2008
|
2007
|
2006
|
|||||||||
Depreciation
expense
|
$ | 2,016 | $ | 1,959 | $ | 1,904 | ||||||
Manufacturing
maintenance and repair costs
|
$ | 1,622 | $ | 1,482 | $ | 1,376 | ||||||
Capitalized
interest
|
$ | 97 | $ | 85 | $ | 73 |
Principal
Nonconsolidated Affiliates at December 31
|
Ownership
Interest
|
|||||||||||
2008
|
2007
|
2006
|
||||||||||
Americas
Styrenics LLC
|
50 | % | - | - | ||||||||
Compañía
Mega S.A.
|
28 | % | 28 | % | 28 | % | ||||||
Dow
Corning Corporation
|
50 | % | 50 | % | 50 | % | ||||||
EQUATE
Petrochemical Company K.S.C.
|
42.5 | % | 42.5 | % | 42.5 | % | ||||||
Equipolymers
|
50 | % | 50 | % | 50 | % | ||||||
MEGlobal
|
50 | % | 50 | % | 50 | % | ||||||
The
OPTIMAL Group of Companies:
|
||||||||||||
OPTIMAL
Chemicals (Malaysia) Sdn. Bhd.
|
50 | % | 50 | % | 50 | % | ||||||
OPTIMAL
Glycols (Malaysia) Sdn. Bhd.
|
50 | % | 50 | % | 50 | % | ||||||
OPTIMAL
Olefins (Malaysia) Sdn. Bhd.
|
23.75 | % | 23.75 | % | 23.75 | % | ||||||
The
SCG-Dow Group:
|
||||||||||||
Pacific
Plastics (Thailand) Limited
|
- | 49 | % | 49 | % | |||||||
Siam
Polyethylene Company Limited
|
49 | % | 49 | % | 49 | % | ||||||
Siam
Polystyrene Company Limited
|
50 | % | 49 | % | 49 | % | ||||||
Siam
Styrene Monomer Co., Ltd.
|
50 | % | 49 | % | 49 | % | ||||||
Siam
Synthetic Latex Company Limited
|
50 | % | 49 | % | 49 | % | ||||||
Univation
Technologies, LLC
|
50 | % | 50 | % | 50 | % |
(1)
|
The
summarized income statement information for 2008 includes the
results
for Americas Styrenics LLC from May 1, 2008 through December 31,
2008.
|
Goodwill
In
millions
|
Performance
Plastics
|
Performance
Chemicals
|
Agricultural
Sciences
|
Basic
Plastics
|
Hydrocarbons
and
Energy
|
Total
|
||||||||||||||||||
Balance
at January 1, 2008
|
$ | 1,034 | $ | 995 | $ | 1,380 | $ | 100 | $ | 63 | $ | 3,572 | ||||||||||||
2008
acquisitions:
|
||||||||||||||||||||||||
Additional
51% interest in Pacific Plastics (Thailand) Limited
|
7 | - | - | - | - | 7 | ||||||||||||||||||
Additional
18% interest in Nantong DAS Chemical Co., Ltd.
|
- | - | 4 | - | - | 4 | ||||||||||||||||||
Triumph
Seed Co., Inc.
|
- | - | 3 | - | - | 3 | ||||||||||||||||||
Dairyland
Seed Co., Inc.
|
- | - | 1 | - | - | 1 | ||||||||||||||||||
Brodbeck
Seed Inc. assets
|
- | - | 2 | - | - | 2 | ||||||||||||||||||
Südwestsaat
GbR assets
|
- | - | 1 | - | - | 1 | ||||||||||||||||||
STEVENS
ROOFING SYSTEMS™
|
32 | - | - | - | - | 32 | ||||||||||||||||||
Adjustment
related to formation of Americas Styrenics LLC
|
- | - | - | (5 | ) | - | (5 | ) | ||||||||||||||||
Adjustments
related to 2007 acquisitions of:
|
||||||||||||||||||||||||
Wolff
Walsrode
|
- | 6 | - | - | - | 6 | ||||||||||||||||||
Hyperlast
Limited
|
11 | - | - | - | - | 11 | ||||||||||||||||||
Poly-Carb,
Inc.
|
(6 | ) | - | - | - | - | (6 | ) | ||||||||||||||||
UPPC
AG
|
11 | - | - | - | - | 11 | ||||||||||||||||||
Edulan
A/S
|
(6 | ) | - | - | - | - | (6 | ) | ||||||||||||||||
Impairment
losses:
|
||||||||||||||||||||||||
Dow
Automotive
|
(209 | ) | - | - | - | - | (209 | ) | ||||||||||||||||
Polypropylene
|
- | - | - | (30 | ) | - | (30 | ) | ||||||||||||||||
Balance
at December 31, 2008
|
$ | 874 | $ | 1,001 | $ | 1,391 | $ | 65 | $ | 63 | $ | 3,394 |
Hyperlast
Limited Intangible Assets
In
millions
|
Gross
Carrying
Amount
|
Weighted-average
Amortization
Period
|
|||
Intangible
assets with finite lives:
|
|||||
Trademarks
|
$ | 10 |
15
years
|
||
Other
(customer-related)
|
52 |
14
years
|
|||
Total
|
$ | 62 |
14
years
|
Wolff
Walsrode Intangible Assets
In
millions
|
Gross
Carrying
Amount
|
Weighted-average
Amortization Period
|
|||
Intangible
assets with finite lives:
|
|||||
Intellectual
property
|
$ | 46 |
10
years
|
||
Trademarks
|
6 |
10
years
|
|||
Software
|
7 |
5
years
|
|||
Other
(customer-related)
|
97 |
5
years
|
|||
Total
|
$ | 156 |
7
years
|
Other
Intangible Assets at December 31
|
2008 | 2007 | ||||||||||||||||||||||
In
millions
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Net
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Net
|
||||||||||||||||||
Intangible
assets with finite lives:
|
||||||||||||||||||||||||
Licenses
and intellectual property
|
$ | 316 | $ | (192 | ) | $ | 124 | $ | 302 | $ | (165 | ) | $ | 137 | ||||||||||
Patents
|
139 | (100 | ) | 39 | 145 | (104 | ) | 41 | ||||||||||||||||
Software
|
700 | (363 | ) | 337 | 575 | (318 | ) | 257 | ||||||||||||||||
Trademarks
|
169 | (61 | ) | 108 | 173 | (51 | ) | 122 | ||||||||||||||||
Other
|
330 | (109 | ) | 221 | 307 | (83 | ) | 224 | ||||||||||||||||
Total
other intangible assets
|
$ | 1,654 | $ | (825 | ) | $ | 829 | $ | 1,502 | $ | (721 | ) | $ | 781 |
Amortization
Expense
In
millions
|
2008
|
2007
|
2006
|
Other
intangible assets, excluding software
|
$92
|
$72
|
$50
|
Software,
included in “Cost of sales”
|
$48
|
$47
|
$45
|
Investing
Results
|
||||||||||||
In
millions
|
2008
|
2007
|
2006
|
|||||||||
Proceeds
from sales of available-for-sale securities
|
$ | 851 | $ | 1,994 | $ | 1,305 | ||||||
Gross
realized gains
|
$ | 56 | $ | 137 | $ | 55 | ||||||
Gross
realized losses
|
$ | (18 | ) | $ | (23 | ) | $ | (42 | ) |
Temporarily
Impaired Securities at December 31, 2008
|
||||||||||||||||||||||||
Less
than 12 months
|
12
months or more
|
Total
|
||||||||||||||||||||||
In
millions
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
||||||||||||||||||
Debt
securities:
|
||||||||||||||||||||||||
U.S.
Treasury obligations and direct obligations of U.S. government
agencies
|
$ | 14 | - | - | - | $ | 14 | - | ||||||||||||||||
Corporate
bonds
|
388 | $ | (35 | ) | $ | 8 | $ | (1 | ) | 396 | $ | (36 | ) | |||||||||||
Other
|
4 | - | 2 | - | 6 | - | ||||||||||||||||||
Total
debt securities
|
$ | 406 | $ | (35 | ) | $ | 10 | $ | (1 | ) | $ | 416 | $ | (36 | ) | |||||||||
Equity
securities
|
268 | (152 | ) | 37 | (25 | ) | 305 | (177 | ) | |||||||||||||||
Total
temporarily impaired securities
|
$ | 674 | $ | (187 | ) | $ | 47 | $ | (26 | ) | $ | 721 | $ | (213 | ) |
Temporarily
Impaired Securities at December 31, 2007
|
||||||||||||||||||||||||
Less
than 12 months
|
12
months or more
|
Total
|
||||||||||||||||||||||
In
millions
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
||||||||||||||||||
Debt
securities:
|
||||||||||||||||||||||||
U.S.
Treasury obligations and direct obligations of U.S. government
agencies
|
$ | 14 | - | $ | 6 | - | $ | 20 | - | |||||||||||||||
Federal
agency mortgage-backed securities
|
- | - | 4 | - | 4 | - | ||||||||||||||||||
Corporate
bonds
|
104 | $ | (3 | ) | 127 | $ | (3 | ) | 231 | $ | (6 | ) | ||||||||||||
Other
|
- | - | 6 | - | 6 | - | ||||||||||||||||||
Total
debt securities
|
$ | 118 | $ | (3 | ) | $ | 143 | $ | (3 | ) | $ | 261 | $ | (6 | ) | |||||||||
Equity
securities
|
220 | (9 | ) | 27 | (21 | ) | 247 | (30 | ) | |||||||||||||||
Total
temporarily impaired securities
|
$ | 338 | $ | (12 | ) | $ | 170 | $ | (24 | ) | $ | 508 | $ | (36 | ) |
Fair
Values of Derivative Instruments at December 31
|
|||||
In
millions
|
Balance
Sheet Classification
|
2008
|
|||
Asset
Derivatives
|
|||||
Derivatives
designated as hedges:
|
|||||
Foreign
currency
|
Accounts
and notes receivable – Other
|
$ | 77 | ||
Commodities
|
Accounts
and notes receivable – Other
|
68 | |||
Total
derivatives designated as hedges
|
$ | 145 | |||
Derivatives
not designated as hedges:
|
|||||
Foreign
currency
|
Accounts
and notes receivable – Other
|
$ | 235 | ||
Commodities
|
Accounts
and notes receivable – Other
|
63 | |||
Total
derivatives not designated as hedges
|
$ | 298 | |||
Total
asset derivatives
|
$ | 443 | |||
Liability
Derivatives
|
|||||
Derivatives
designated as hedges:
|
|||||
Foreign
currency
|
Accounts
payable – Other
|
$ | 69 | ||
Commodities
|
Accounts
payable – Other
|
262 | |||
Commodities
|
Other
noncurrent obligations
|
22 | |||
Total
derivatives designated as hedges
|
$ | 353 | |||
Derivatives
not designated as hedges:
|
|||||
Foreign
currency
|
Accounts
payable – Other
|
$ | 284 | ||
Commodities
|
Accounts
payable – Other
|
61 | |||
Total
derivatives not designated as hedges
|
$ | 345 | |||
Total
liability derivatives
|
$ | 698 |
Effect
of Derivative Instruments at December 31, 2008
In
millions
|
Change in
Unrealized
Gain (Loss)
in AOCI
(1,2)
|
Income
Statement Classification
|
Loss
Reclassified
from AOCI to
Income
(3)
|
Additional Loss Recognized in
Income
(3,4)
|
||||||||||||
Derivatives
designated as hedges:
|
||||||||||||||||
Fair
value:
|
||||||||||||||||
Interest
rates
|
- |
Interest
expense
(5)
|
- | $ | (2 | ) | ||||||||||
Cash
flow:
|
||||||||||||||||
Interest
rates
|
- |
Cost
of sales
|
$ | (12 | ) | - | ||||||||||
Interest
rates
|
- |
Interest
expense
(5)
|
(1 | ) | - | |||||||||||
Commodities
|
$ | (353 | ) |
Cost
of sales
|
(154 | ) | (1 | ) | ||||||||
Foreign
currency
|
7 |
Cost
of sales
|
(12 | ) | - | |||||||||||
Net
foreign investment:
|
||||||||||||||||
Foreign
currency
|
1 |
n/a
|
- | - | ||||||||||||
Total
derivatives designated as hedges
|
$ | (345 | ) | $ | (179 | ) | $ | (3 | ) | |||||||
Derivatives
not designated as hedges:
|
||||||||||||||||
Foreign
currency
(6)
|
- |
Sundry
income – net
|
- | $ | (167 | ) | ||||||||||
Commodities
|
- |
Cost
of sales
|
- | (34 | ) | |||||||||||
Total
derivatives not designated as hedges
|
- | - | $ | (201 | ) | |||||||||||
Total
derivatives
|
$ | (345 | ) | $ | (179 | ) | $ | (204 | ) |
(1)
|
Accumulated
other comprehensive income (loss)
(“AOCI”)
|
(2)
|
Net
unrealized gains/losses from hedges related to interest rates, commodities
and long-term debt are included in “Accumulated Derivative Gain (Loss) –
Net hedging results” in the consolidated statements of stockholders’
equity; net unrealized gains/losses from hedges related to foreign
currency (net of tax) are included in “Cumulative Translation Adjustments
– Translation adjustments” in the consolidated statements of stockholders’
equity.
|
(3)
|
Pre-tax
amounts.
|
(4)
|
Amounts
impacting income not related to AOCI reclassification; also includes
immaterial amounts of hedge
ineffectiveness.
|
(5)
|
Interest
expense and amortization of debt
discount.
|
(6)
|
Foreign
currency derivatives not designated as hedges under SFAS No. 133 are
offset by foreign exchange gains of $150 million resulting from the
underlying exposures of foreign currency denominated assets and
liabilities per SFAS No. 52, “Foreign Currency
Translation.”
|
Basis
of Fair Value Measurements at December 31, 2008
In
millions
|
Quoted
Prices
in
Active
Markets
for
Identical
Items
(Level
1)
|
Significant
Other
Observable
Inputs
(Level
2)
|
Counterparty
and Cash
Collateral
Netting
(1)
|
Total
|
||||||||||||
Assets
at fair value:
|
||||||||||||||||
Equity
securities
(2)
|
$ | 337 | $ | 21 | - | $ | 358 | |||||||||
Debt
securities
(2)
|
- | 1,495 | - | 1,495 | ||||||||||||
Derivatives
relating to:
(3)
|
||||||||||||||||
Foreign
currency
|
- | 312 | $ | (190 | ) | 122 | ||||||||||
Commodities
|
- | 131 | (66 | ) | 65 | |||||||||||
Total
assets at fair value
|
$ | 337 | $ | 1,959 | $ | (256 | ) | $ | 2,040 | |||||||
Liabilities
at fair value:
|
||||||||||||||||
Long-term
debt
(4)
|
- | $ | 8,983 | - | $ | 8,983 | ||||||||||
Derivatives
relating to:
(3)
|
||||||||||||||||
Foreign
currency
|
- | 353 | $ | (190 | ) | 163 | ||||||||||
Commodities
|
$ | 49 | 296 | (125 | ) | 220 | ||||||||||
Total
liabilities at fair value
|
$ | 49 | $ | 9,632 | $ | (315 | ) | $ | 9,366 |
|
(1)Cash
collateral is classified as “Accounts and notes receivable – Other” in the
consolidated balance sheets. Amounts represent the effect of legally
enforceable master netting arrangements between the Company and its
counterparties and the payable or receivable for cash collateral held or
placed with the same counterparty.
|
|
(2)The
Company’s investments in equity and debt securities are classified as
available-for-sale, and are included in “Other investments” in the
consolidated balance sheets.
|
|
(3)See
Note H for the classification of derivatives in the consolidated
balance sheets.
|
|
(4)See
Note H for information on fair value adjustments to long-term
debt.
|
Sundry
Income – Net
|
||||||||||||
In
millions
|
2008
|
2007
|
2006
|
|||||||||
Gain
on sales of assets and securities
|
$ | 91 | $ | 171 | $ | 156 | ||||||
Foreign
exchange gain (loss)
|
(17 | ) | 73 | 21 | ||||||||
Dividend
income
|
3 | 9 | 6 | |||||||||
Other
– net
(1)
|
12 | 71 | (46 | ) | ||||||||
Total
sundry income – net
|
$ | 89 | $ | 324 | $ | 137 | ||||||
(1)
2006 included the recognition of a loss contingency of $85 million
related to a fine imposed by the European Commission associated
with synthetic rubber industry matters (see Note K for additional
information).
|
Fixed
and Determinable Portion of Take-or-Pay and
Throughput
Obligations at December 31, 2008
In
millions
|
||||
2009
|
$ | 2,023 | ||
2010
|
1,708 | |||
2011
|
1,798 | |||
2012
|
1,392 | |||
2013
|
895 | |||
2014
and beyond
|
5,969 | |||
Total
|
$ | 13,785 |
Guarantees
at December 31, 2008
In
millions
|
Final
Expiration
|
Maximum
Future Payments
|
Recorded
Liability
|
||||||
Guarantees
|
2014
|
$ | 330 | $ | 23 | ||||
Residual
value guarantees
|
2015
|
985 | 4 | ||||||
Total
guarantees
|
$ | 1,315 | $ | 27 |
Guarantees
at December 31, 2007
In
millions
|
Final
Expiration
|
Maximum
Future Payments
|
Recorded
Liability
|
||||||
Guarantees
|
2014
|
$ | 354 | $ | 22 | ||||
Residual
value guarantees
|
2015
|
1,035 | 5 | ||||||
Total
guarantees
|
$ | 1,389 | $ | 27 |
Asset
Retirement Obligations
|
||||||||
In
millions
|
2008
|
2007
|
||||||
Balance
at January 1
|
$ | 116 | $ | 106 | ||||
Additional
accruals
|
7 | 25 | ||||||
Liabilities
settled
|
(14 | ) | (22 | ) | ||||
Accretion
expense
|
3 | 1 | ||||||
Revisions
in estimated cash flows
|
1 | - | ||||||
Other
|
(7 | ) | 6 | |||||
Balance
at December 31
|
$ | 106 | $ | 116 |
Notes
Payable at December 31
|
||||||||
In
millions
|
2008
|
2007
|
||||||
Commercial
paper
|
$ | 1,597 | $ | 1,162 | ||||
Notes
payable to banks
|
661 | 321 | ||||||
Notes
payable to related companies
|
102 | 65 | ||||||
Total
notes payable
|
$ | 2,360 | $ | 1,548 | ||||
Year-end
average interest rates
|
4.04 | % | 5.27 | % |
Long-Term
Debt at December 31
In
millions
|
2008
Average
Rate
|
2008
|
2007
Average
Rate
|
2007
|
||||||||||||
Promissory
notes and debentures:
|
||||||||||||||||
Final
maturity 2008
|
- | - | 5.75 | % | $ | 497 | ||||||||||
Final
maturity 2009
|
6.76 | % | $ | 682 | 6.76 | % | 686 | |||||||||
Final
maturity 2010
|
9.14 | % | 275 | 9.13 | % | 276 | ||||||||||
Final
maturity 2011
|
6.13 | % | 806 | 6.13 | % | 808 | ||||||||||
Final
maturity 2012
|
6.00 | % | 907 | 6.00 | % | 909 | ||||||||||
Final
maturity 2013
|
6.85 | % | 139 | 6.85 | % | 139 | ||||||||||
Final
maturity 2014 and thereafter
|
7.05 | % | 2,682 | 7.63 | % | 1,881 | ||||||||||
Other
facilities:
|
||||||||||||||||
U.S.
dollar loans, various rates and maturities
|
2.43 | % | 700 | 5.23 | % | 1 | ||||||||||
Foreign
currency loans, various rates and maturities
|
3.23 | % | 73 | 3.13 | % | 58 | ||||||||||
Medium-term
notes, varying maturities through 2022
|
6.25 | % | 1,072 | 6.17 | % | 576 | ||||||||||
Foreign
medium-term notes, various rates and maturities
|
4.13 | % | 1 | 4.13 | % | 1 | ||||||||||
Foreign
medium-term notes, final maturity 2010, Euro
|
4.37 | % | 561 | 4.37 | % | 587 | ||||||||||
Foreign
medium-term notes, final maturity 2011, Euro
|
4.63 | % | 690 | 4.63 | % | 718 | ||||||||||
Pollution
control/industrial revenue bonds, varying maturities through
2033
|
5.61 | % | 904 | 4.84 | % | 1,004 | ||||||||||
Capital
lease obligations
|
- | 46 | - | 50 | ||||||||||||
Unamortized
debt discount
|
- | (15 | ) | - | (24 | ) | ||||||||||
Unexpended
construction funds
|
- | (27 | ) | - | - | |||||||||||
Long-term
debt due within one year
|
- | (1,454 | ) | - | (586 | ) | ||||||||||
Total
long-term debt
|
- | $ | 8,042 | - | $ | 7,581 |
(a)
|
the
obligation to maintain the ratio of the Company’s consolidated
indebtedness to consolidated capitalization at no greater than 0.65 to
1.00 at any time the aggregate outstanding amount of loans under the
primary credit agreements exceeds $500 million,
|
(b)
|
a
default if the Company or an applicable subsidiary fails to make any
payment on indebtedness of $50 million or more when due, or any other
default under the applicable agreement permits the acceleration of
$200 million or more of principal, or results in the acceleration of
$100 million or more of principal,
and
|
(c)
|
a
default if the Company or any applicable subsidiary fails to discharge or
stay within 30 days after the entry of a final judgment of more than
$200 million.
|
Weighted-Average
Assumptions
for
All Pension Plans
|
Benefit
Obligations
at
December 31
|
Net
Periodic Costs
for
the Year
|
||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Discount
rate
|
6.35 | % | 6.30 | % | 6.33 | % | 5.56 | % | ||||||||
Rate
of increase in future compensation levels
|
4.14 | % | 4.13 | % | 4.14 | % | 4.12 | % | ||||||||
Expected
long-term rate of return on plan assets
|
- | - | 8.12 | % | 8.30 | % |
Weighted-Average
Assumptions
for
U.S. Pension Plans
|
Benefit
Obligations
at
December 31
|
Net
Periodic Costs
for
the Year
|
||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Discount
rate
|
6.61 | % | 6.75 | % | 6.75 | % | 5.98 | % | ||||||||
Rate
of increase in future compensation levels
|
4.50 | % | 4.50 | % | 4.50 | % | 4.50 | % | ||||||||
Expected
long-term rate of return on plan assets
|
- | - | 8.44 | % | 8.79 | % |
Pension
Plans with Accumulated Benefit Obligations in Excess of Plan Assets at
December 31
|
||
In
millions
|
2008
|
2007
|
Projected
benefit obligations
|
$13,514
|
$1,843
|
Accumulated
benefit obligations
|
$13,027
|
$1,677
|
Fair
value of plan assets
|
$9,536
|
$314
|
U.S.
Plan Assumptions for Other Postretirement Benefits
|
Benefit
Obligations
at
December 31
|
Net
Periodic Costs
for
the Year
|
||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Discount
rate
|
6.91 | % | 6.57 | % | 6.57 | % | 5.89 | % | ||||||||
Expected
long-term rate of return on plan assets
|
- | - | 6.75 | % | 9.00 | % | ||||||||||
Initial
health care cost trend rate
|
9.72 | % | 10.30 | % | 10.30 | % | 8.79 | % | ||||||||
Ultimate
health care cost trend rate
|
6.00 | % | 6.00 | % | 6.00 | % | 6.00 | % | ||||||||
Year
ultimate trend rate to be reached
|
2018
|
2014
|
2014
|
2011
|
Net
Periodic Benefit Cost for All Significant Plans
|
||||||||||||||||||||||||
Defined
Benefit Pension Plans
|
Other
Postretirement Benefits
|
|||||||||||||||||||||||
In
millions
|
2008
|
2007
|
2006
|
2008
|
2007
|
2006
|
||||||||||||||||||
Service
cost
|
$ | 264 | $ | 289 | $ | 288 | $ | 18 | $ | 21 | $ | 22 | ||||||||||||
Interest
cost
|
961 | 881 | 827 | 117 | 113 | 115 | ||||||||||||||||||
Expected
return on plan assets
|
(1,232 | ) | (1,179 | ) | (1,100 | ) | (29 | ) | (34 | ) | (27 | ) | ||||||||||||
Amortization
of prior service cost (credit)
|
32 | 23 | 22 | (4 | ) | (4 | ) | (4 | ) | |||||||||||||||
Amortization
of unrecognized loss (gain)
|
43 | 191 | 222 | (1 | ) | 3 | 7 | |||||||||||||||||
Termination
benefits/curtailment cost
(1)
|
54 | 11 | 33 | 34 | 6 | - | ||||||||||||||||||
Net
periodic benefit cost
|
$ | 122 | $ | 216 | $ | 292 | $ | 135 | $ | 105 | $ | 113 |
(1)
|
See
Note B for information regarding termination benefits/curtailment costs
recorded in 2008, 2007 and 2006.
|
Other
Changes in Plan Assets and Benefit Obligations Recognized in Other
Comprehensive Income for All Significant Plans
|
||||||||||||||||
Defined
Benefit Pension Plans
|
Other
Postretirement Benefits
|
|||||||||||||||
In
millions
|
2008
|
2007
|
2008
|
2007
|
||||||||||||
Net
loss (gain)
|
$ | 4,669 | $ | (1,593 | ) | $ | 23 | $ | (201 | ) | ||||||
Prior
service cost
|
4 | 140 | - | 2 | ||||||||||||
Amortization
of prior service (cost) credit
|
(32 | ) | (23 | ) | 4 | 4 | ||||||||||
Amortization
of unrecognized (loss) gain
|
(43 | ) | (191 | ) | 1 | (3 | ) | |||||||||
Total
recognized in other comprehensive loss (income)
|
$ | 4,598 | $ | (1,667 | ) | $ | 28 | $ | (198 | ) | ||||||
Total
recognized in net periodic benefit cost and other comprehensive loss
(income)
|
$ | 4,720 | $ | (1,451 | ) | $ | 163 | $ | (93 | ) |
Estimated
Future Benefit Payments at December 31, 2008
|
||||||||
In
millions
|
Defined
Benefit
Pension
Plans
|
Other
Postretirement
Benefits
|
||||||
2009
|
$ | 954 | $ | 168 | ||||
2010
|
1,089 | 165 | ||||||
2011
|
967 | 162 | ||||||
2012
|
986 | 156 | ||||||
2013
|
999 | 152 | ||||||
2014
through 2018
|
5,316 | 720 | ||||||
Total
|
$ | 10,311 | $ | 1,523 |
Weighted-Average
Allocation of All Plan Assets at December 31
|
||||||||
2008
|
2007
|
|||||||
Equity
securities
|
40 | % | 51 | % | ||||
Debt
securities
|
40 | % | 30 | % | ||||
Alternative
investments
|
20 | % | 19 | % | ||||
Total
|
100 | % | 100 | % |
2008
|
2007
|
2006
|
||||||||||
Dividend
yield
|
4.4 | % | 3.5 | % | 3.3 | % | ||||||
Expected
volatility
|
29.57 | % | 23.33 | % | 25.67 | % | ||||||
Risk-free
interest rate
|
3.42 | % | 4.89 | % | 4.55 | % | ||||||
Expected
life of stock options granted during period
|
6
years
|
6
years
|
6
years
|
|||||||||
Life
of Employees’ Stock Purchase Plan
|
6.5
months
|
6.6
months
|
6.6
months
|
Employees’
Stock Purchase Plans
|
2008
|
|||||||
Shares
in thousands
|
Shares
|
Exercise
Price
(1)
|
||||||
Outstanding
at beginning of year
|
- | - | ||||||
Granted
|
4,582 | $ | 35.57 | |||||
Exercised
|
(1,082 | ) | $ | 29.92 | ||||
Forfeited/Expired
|
(3,500 | ) | $ | 35.57 | ||||
Outstanding
and exercisable at end of year
|
- | - | ||||||
(1)
Weighted-average per share
|
Additional
Information about ESPPs
In
millions, except per share amounts
|
2008
|
2007
|
2006
|
|||||||||
Weighted-average
fair value per share of purchase rights granted
|
$ | 4.33 | $ | 10.62 | $ | 7.83 | ||||||
Total
compensation expense for ESPPs
|
$ | 20 | $ | 57 | $ | 34 | ||||||
Related
tax benefit
|
$ | 7 | $ | 21 | $ | 12 | ||||||
Total
amount of cash received from the exercise of purchase
rights
|
$ | 32 | $ | 145 | $ | 101 | ||||||
Total
intrinsic value of purchase rights exercised
(1)
|
$ | 3 | $ | 65 | $ | 15 | ||||||
Related
tax benefit
|
$ | 1 | $ | 24 | $ | 6 | ||||||
(1)
Difference between the market price at exercise and the price paid by the
employee to exercise the purchase rights
|
Stock
Options
|
2008
|
|||||||
Shares
in thousands
|
Shares
|
Exercise
Price
(1)
|
||||||
Outstanding
at beginning of year
|
48,002 | $ | 39.16 | |||||
Granted
|
9,176 | $ | 38.62 | |||||
Exercised
|
(1,364 | ) | $ | 30.30 | ||||
Forfeited/Expired
|
(2,037 | ) | $ | 36.47 | ||||
Outstanding
at end of year
|
53,777 | $ | 39.39 | |||||
Remaining
contractual life in years
|
5.31 | |||||||
Aggregate
intrinsic value in millions
|
- | |||||||
Exercisable
at end of year
|
37,459 | $ | 38.77 | |||||
Remaining
contractual life in years
|
3.95 | |||||||
Aggregate
intrinsic value in millions
|
- | |||||||
(1)
Weighted-average per share
|
Additional
Information about Stock Options
In
millions, except per share amounts
|
2008
|
2007
|
2006
|
|||||||||
Weighted-average
fair value per share of options granted
|
$ | 8.88 | $ | 9.81 | $ | 10.31 | ||||||
Total
compensation expense for stock option plans
|
$ | 79 | $ | 86 | $ | 87 | ||||||
Related
tax benefit
|
$ | 29 | $ | 32 | $ | 32 | ||||||
Total
amount of cash received from the exercise of options
|
$ | 40 | $ | 235 | $ | 122 | ||||||
Total
intrinsic value of options exercised
(1)
|
$ | 12 | $ | 103 | $ | 49 | ||||||
Related
tax benefit
|
$ | 4 | $ | 38 | $ | 18 | ||||||
(1)
Difference between the market price at exercise and the price paid
by the employee to exercise the options
|
Deferred
Stock
|
2008
|
|||||||
Shares
in thousands
|
Shares
|
Grant Date
Fair Value
(1)
|
||||||
Nonvested
at beginning of year
|
6,633 | $ | 45.49 | |||||
Granted
|
1,996 | $ | 38.38 | |||||
Vested
|
(267 | ) | $ | 45.85 | ||||
Canceled
|
(246 | ) | $ | 45.38 | ||||
Nonvested
at end of year
|
8,116 | $ | 43.73 | |||||
(1)
Weighted-average per share
|
Additional
Information about Deferred Stock
|
||||||||||||
In
millions, except per share amounts
|
2008
|
2007
|
2006
|
|||||||||
Weighted-average
fair value per share of deferred stock granted
|
$ | 38.38 | $ | 43.61 | $ | 43.34 | ||||||
Total
fair value of deferred stock vested and delivered
(1)
|
$ | 11 | $ | 24 | $ | 48 | ||||||
Related
tax benefit
|
$ | 4 | $ | 9 | $ | 18 | ||||||
Total
compensation expense for deferred stock awards
|
$ | 95 | $ | 76 | $ | 67 | ||||||
Related
tax benefit
|
$ | 35 | $ | 28 | $ | 25 |
(1)
|
Includes
the fair value of shares vested in prior years and delivered in the
reporting year.
|
Performance
Deferred Stock
|
2008
|
|||||||
Shares
in thousands
|
Shares
|
Grant Date
Fair Value
(1)
|
||||||
Nonvested
at beginning of year
|
1,861 | $ | 40.32 | |||||
Granted
|
1,070 | $ | 38.62 | |||||
Vested
|
(865 | ) | $ | 36.78 | ||||
Canceled
|
(71 | ) | $ | 40.23 | ||||
Nonvested
at end of year
|
1,995 | $ | 40.95 | |||||
(1)
Weighted-average per share
|
Additional
Information about Performance Deferred Stock
|
|||
In
millions
|
2008
|
2007
|
2006
|
Total
fair value of performance deferred stock vested and delivered
(1)
|
$166
|
$127
|
$52
|
Related
tax benefit
|
$62
|
$47
|
$19
|
Total
compensation expense for performance deferred stock awards
|
$17
|
$69
|
$86
|
Related
tax benefit
|
$6
|
$26
|
$32
|
(1)
|
Includes
the fair value of shares vested in prior years and delivered in the
reporting year.
|
Reserved
Treasury Stock at December 31
|
|||
Shares
in millions
|
2008
|
2007
|
2006
|
Stock
option and deferred stock plans
|
57.0
|
41.0
|
23.3
|
Provision
(Credit) for Income Taxes
|
||||||||||||||||||||||||||||||||||||
2008
|
2007
|
2006
|
||||||||||||||||||||||||||||||||||
In
millions
|
Current
|
Deferred
|
Total
|
Current
|
Deferred
|
Total
|
Current
|
Deferred
|
Total
|
|||||||||||||||||||||||||||
Federal
|
$ | 3 | $ | (526 | ) | $ | (523 | ) | $ | 77 | $ | 141 | $ | 218 | $ | 367 | $ | 401 | $ | 768 | ||||||||||||||||
State
and local
|
6 | (16 | ) | (10 | ) | 87 | 4 | 91 | 82 | (99 | ) | (17 | ) | |||||||||||||||||||||||
Foreign
|
918 | 282 | 1,200 | 586 | 349 | 935 | 602 | (198 | ) | 404 | ||||||||||||||||||||||||||
Total
|
$ | 927 | $ | (260 | ) | $ | 667 | $ | 750 | $ | 494 | $ | 1,244 | $ | 1,051 | $ | 104 | $ | 1,155 |
Deferred
Tax Balances at December 31
|
2008
|
2007
|
||||||||||||||
In
millions
|
Deferred Tax
Assets
(1)
|
Deferred
Tax
Liabilities
|
Deferred Tax
Assets
(1)
|
Deferred
Tax
Liabilities
|
||||||||||||
Property
|
$ | 99 | $ | 1,908 | $ | 162 | $ | 2,157 | ||||||||
Tax
loss and credit carryforwards
|
2,226 | - | 2,142 | - | ||||||||||||
Postretirement
benefit obligations
|
2,642 | 950 | 1,066 | 912 | ||||||||||||
Other
accruals and reserves
|
1,462 | 306 | 1,278 | 570 | ||||||||||||
Inventory
|
139 | 200 | 154 | 203 | ||||||||||||
Long-term
debt
|
3 | 89 | 4 | 110 | ||||||||||||
Investments
|
186 | 1 | 154 | 2 | ||||||||||||
Other
– net
|
847 | 229 | 1,275 | 455 | ||||||||||||
Subtotal
|
$ | 7,604 | $ | 3,683 | $ | 6,235 | $ | 4,409 | ||||||||
Valuation
allowance
|
(487 | ) | - | (323 | ) | - | ||||||||||
Total
|
$ | 7,117 | $ | 3,683 | $ | 5,912 | $ | 4,409 | ||||||||
(1)
Included in current deferred tax assets are prepaid tax assets totaling
$141 million in 2008 and $135 million in 2007.
|
Total
Gross Unrecognized Tax Benefits
|
||||||||
In
millions
|
2008
|
2007
|
||||||
Balance
at January 1
|
$ | 892 | $ | 865 | ||||
Increases
related to positions taken on items from prior years
|
41 | 99 | ||||||
Decreases
related to positions taken on items from prior years
|
(191 | ) | (164 | ) | ||||
Increases
related to positions taken in the current year
|
34 | 110 | ||||||
Settlement
of uncertain tax positions with tax authorities
|
(29 | ) | (1 | ) | ||||
Decreases
due to expiration of statutes of limitations
|
(11 | ) | (17 | ) | ||||
Balance
at December 31
|
$ | 736 | $ | 892 |
|
·
|
Products
: BETAFOAM™ NVH
and structural foams; BETAMATE™ structural adhesives; BETASEAL™ glass
bonding systems; DOW™ polyethylene resins; IMPAXX™ energy management foam;
INSPIRE™
performance
polymers; INTEGRAL™ adhesive films; ISONATE™ pure and modified methylene
diphenyl diisocyanate (MDI) products; MAGNUM™ ABS resins; PELLETHANE™
thermoplastic polyurethane elastomers; Premium brake fluids and
lubricants; PULSE™ engineering resins; SPECFLEX™ semi-flexible
polyurethane foam systems; VORACTIV™ polyether and copolymer
polyols
|
|
·
|
Products
: FROTH-PAK™
polyurethane spray foam; GREAT STUFF™ polyurethane foam sealant;
INSTA-STIK™ roof insulation adhesive; SARAN™ vapor retarder film and tape;
STYROFOAM™ brand insulation products (including XPS and polyisocyanurate
rigid foam sheathing products); THERMAX™ brand insulation; TILE BOND™ roof
tile adhesive; WEATHERMATE™ weather barrier solutions (housewraps, sill
pans, flashings and tapes)
|
|
·
|
Products
: AIRSTONE™
epoxy systems; D.E.H.™ epoxy curing agents or hardeners; D.E.N.™ epoxy
novolac resins; D.E.R.™ epoxy resins (liquids, solids and solutions);
Epoxy resin waterborne emulsions and dispersions; Epoxy intermediates
(acetone, allyl chloride, bisphenol A, epichlorohydrin, and phenol);
FORTEGRA™ epoxy tougheners; Glycidyl methacrylate (GMA); UCAR™ solution
vinyl resins
|
|
·
|
Products
: ECHELON™
polyurethane prepolymer; ENFORCER™ and ENHANCER™ for polyurethane carpet
and turf backing; HYPOL™ prepolymers; ISONATE™ MDI; MONOTHANE™ single
component polyurethane elastomers; PAPI™ polymeric MDI; Propylene glycol;
Propylene oxide; RENUVA™ Renewable Resource Technology; SPECFLEX™
copolymer
polyols; TRAFFIDECK™ and VERDISEAL™ waterproofing systems; VORACOR™ and
VORALAST™ polyurethane systems and VORALAST™ R renewable content
system; VORALUX™ and VORAMER™ MR series; VORANATE™ isocyanate; VORANOL™
VORACTIV™ polyether and copolymer polyols; VORASTAR™ polyurethane systems;
XITRACK™ polyurethane rail ballast stabilization
systems
|
|
·
|
Products
: AFFINITY™
polyolefin plastomers (POPs); AMPLIFY™
functional
polymers; CALIBRE™ polycarbonate resins; DOW XLA™ elastic fiber; EMERGE™
advanced resins; ENGAGE™ polyolefin elastomers; FLEXOMER™ very low density
polyethylene (VLDPE) resins; INTEGRAL™ adhesive films; ISOPLAST™
engineering thermoplastic polyurethane resins; MAGNUM™ ABS resins; NORDEL™
hydrocarbon rubber; PELLETHANE™ thermoplastic
polyurethane elastomers; PRIMACOR™ copolymers; PROCITE™ window
envelope films; PULSE™ engineering resins; REDI-LINK™ polyethylene-based
wire & cable insulation compounds; SARAN™ PVDC resin and SARAN™ PVDC
film; SARANEX™ barrier films; SI-LINK™ polyethylene-based low voltage
insulation compounds; TRENCHCOAT™ protective films; TYRIL™ SAN
resins; TYRIN™ chlorinated polyethylene; UNIGARD™ HP high-performance
flame-retardant compounds; UNIGARD™ RE reduced emissions flame-retardant
compounds; UNIPURGE™ purging compound; VERSIFY™ plastomers and
elastomers
|
|
·
|
Products
:
LP OXO™ SELECTOR™
technology and NORMAX™ catalysts; METEOR™ EO/EG process technology and
catalysts; PTA process technology; UNIPOL™ PP process technology and SHAC™
and SHAC™ ADT catalyst systems
|
|
·
|
Products and Services
:
Acrolein derivatives; Basic nitroparaffins and nitroparaffin-based
specialty chemicals; CANGUARD™ BIT preservatives; CELLOSIZE™ hydroxyethyl
cellulose; Chiral compounds and biocatalysts; CLEAR+STABLE™ carboxymethyl
cellulose; CYCLOTENE™ advanced electronics resins; DOW™
electrodeionization; DOW™ latex powders; DOW™ ultrafiltration; DOWEX™ ion
exchange resins; DOWICIDE™ antimicrobial bactericides and fungicides;
FILMTEC™ elements; FORTEFIBER™ soluble dietary fiber; Hydrocarbon resins;
Industrial biocides; METHOCEL™ cellulose ethers; POLYOX™ water-soluble
resins; Quaternaries; Reverse osmosis, electrodeionization and
ultrafiltration modules; SATINFX™ delivery system; SATISFIT™ Weight Care
Technology; SILK™ semiconductor dielectric resins; SOLTERRA™ boost; UCARE™
polymers; WALOCEL™ cellulose polymers; WALSRODER™
nitrocellulose
|
|
·
|
Products
: EVOCAR™ vinyl
acetate ethylene; FOUNDATIONS™ latex; NEOCAR™ branched vinyl ester
latexes; Styrene-acrylic latex; Styrene-butadiene latex; UCAR™
all-acrylic, styrene-acrylic and vinyl-acrylic latexes;
UCAR™ POLYPHOBE™
rheology modifiers; UCARHIDE™
opacifier
|
|
·
|
Products
: Acrylic
acid/Acrylic esters; AMBITROL™ and NORKOOL™ industrial coolants; Butyl
CARBITOL™ and Butyl CELLOSOLVE™ solvents; CARBOWAX™ and CARBOWAX™ SENTRY™
polyethylene glycols and methoxypolyethylene glycols; DOW™ polypropylene
glycols; DOWANOL™ glycol ethers; DOWCAL™, DOWFROST™ and DOWTHERM™ heat
transfer fluids; DOWFAX™, TERGITOL™ and TRITON™ surfactants; Dow
Haltermann Custom Processing and Haltermann Products; Ethanolamines;
Ethyleneamines; SAFE-TAINER™ closed-loop delivery system; SYNALOX™
lubricants; UCAR™ deicing fluids; UCARSOL™ formulated solvents; UCON™
fluids and VERSENE™ chelating
agents
|
|
·
|
Products
: AGROMEN™
seeds; BRODBECK™ seed; CLINCHER™ herbicide; DAIRYLAND™ seed; DELEGATE™
insecticide; DITHANE™ fungicide; EXZACT™ precision traits; FORTRESS™
fungicide; GARLON™ herbicide; GLYPHOMAX™ herbicide; GRANITE™ herbicide;
HERCULEX™ I, HERCULEX™ RW and HERCULEX™ XTRA insect protection;
KEYSTONE™ herbicides; LAREDO™ fungicide; LONTREL™
herbicide;
LORSBAN™ insecticides; MILESTONE™ herbicide; MUSTANG™ herbicide; MYCOGEN™
seeds; NEXERA™ canola and sunflower seeds; PHYTOGEN™ brand cottonseeds;
PROFUME™ gas fumigant; RENZE™ seed; SENTRICON™ termite colony elimination
system; SIMPLICITY™ herbicide; STARANE™ herbicide; TELONE™ soil fumigant;
TORDON™ herbicide; TRACER™ NATURALYTE™ insect control; TRIUMPH™ seed;
VIKANE™ structural fumigant; WIDESTRIKE™ insect
protection
|
|
·
|
Products
: ASPUN™ fiber
grade resins; ATTANE™ ultra low density polyethylene (ULDPE) resins;
CONTINUUM™ bimodal polyethylene resins; DOW™ high density polyethylene
(HDPE) resins; DOW™ low density polyethylene (LDPE) resins; DOWLEX™
polyethylene resins; ELITE™ enhanced polyethylene (EPE) resins; TUFLIN™
linear low density polyethylene (LLDPE) resins; UNIVAL™ HDPE
resins
|
|
·
|
Products
: STYRON A-TECH™
and C-TECH™ advanced technology polystyrene resins and a full line of
STYRON™ general purpose polystyrene resins; STYRON™ high-impact
polystyrene resins
|
|
·
|
Products
: Acids;
Alcohols; Aldehydes; Caustic soda; Chlorine; Chloroform; COMBOTHERM™
blended deicer; DOWFLAKE™ calcium chloride; DOWPER™ dry cleaning solvent;
Esters; Ethylene dichloride (EDC); LIQUIDOW™ liquid calcium chloride;
MAXICHECK™ procedure for testing the strength of reagents; MAXISTAB™
stabilizers for chlorinated solvents; Methyl chloride; Methylene chloride;
Monochloroacetic acid (MCAA); Oxo products; PELADOW™ calcium chloride
pellets; Perchloroethylene; Trichloroethylene; Vinyl acetate monomer
(VAM); Vinyl chloride monomer (VCM); Vinylidene chloride
(VDC)
|
|
·
|
Products
: Ethylene
glycol (EG); Ethylene oxide (EO)
|
|
·
|
Products
: Benzene;
Butadiene; Butylene; Cumene; Ethylene; Propylene; Styrene; Power, steam
and other utilities
|
In
millions
|
2008
|
2007
|
2006
|
|||||||||
EBIT
|
$ | 1,883 | $ | 4,683 | $ | 5,403 | ||||||
+
Interest income
|
86 | 130 | 185 | |||||||||
- Interest
expense and amortization of debt discount
|
648 | 584 | 616 | |||||||||
- Provision
for income taxes
|
667 | 1,244 | 1,155 | |||||||||
- Minority
interests’ share in income
|
75 | 98 | 93 | |||||||||
Net
Income Available for Common Stockholders
|
$ | 579 | $ | 2,887 | $ | 3,724 |
(1)
Due to a decline in the share count during 2008 and a loss in the 4th
quarter, the sum of the four quarters does not equal the earnings per
share
|
|||||
amount
calculated for the year.
|
|||||
(2)
Composite price as reported by the New York Stock
Exchange.
|
|||||
(3)
Due to a decline in the share count during 2007, the sum of the four
quarters does not equal the earnings per share amount calculated for the
year.
|
|
·
|
pertain
to the maintenance of records that, in reasonable detail, accurately and
fairly reflect the transactions and dispositions of the assets of the
Company;
|
|
·
|
provide
reasonable assurance that transactions are recorded properly to allow for
the preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the
Company are being made only in accordance with authorizations of
management and Directors of the Company;
|
|
·
|
provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the Company’s assets that
could have a material effect on the consolidated financial statements;
and
|
|
·
|
provide
reasonable assurance as to the detection of fraud.
|
/s/
ANDREW N. LIVERIS
|
/s/
GEOFFERY E. MERSZEI
|
|
Andrew
N. Liveris
President,
Chief Executive Officer and
Chairman
of the Board
|
Geoffery
E. Merszei
Executive
Vice President and Chief Financial Officer
|
|
/s/
WILLIAM H. WEIDEMAN
|
||
William
H. Weideman
Vice
President and Controller
|
||
February
11, 2009
|
/s/
DELOITTE & TOUCHE LLP
|
||
Deloitte
& Touche
LLP
Midland,
Michigan
|
||
February
17, 2009
|
|
The
Company’s 2008 Consolidated Financial Statements and the Report of
Independent Registered Public Accounting Firm are included in Part II,
Item 8. Financial Statements and Supplementary
Data.
|
|
Financial
Statement Schedules – The following Financial Statement Schedule should be
read in conjunction with the Consolidated Financial Statements and Report
of Independent Registered Public Accounting Firm included in Part II, Item
8 of this Annual Report on Form
10-K:
|
Schedule
II
|
Valuation
and Qualifying Accounts
|
|
Exhibits
– See the Exhibit Index on pages 134-137 of this Annual Report on Form
10-K for exhibits filed with this Annual Report on Form 10-K or
incorporated by reference. The following exhibits, listed on the Exhibit
Index, are filed with this Annual Report on Form
10-K:
|
Exhibit
No.
|
Description of Exhibit
|
A
copy of The Dow Chemical Company Executives’ Supplemental Retirement Plan,
as amended, restated and effective as of January 1,
2009.
|
|
A
copy of The Dow Chemical Company 1988 Award and Option Plan, as amended
and restated on December 10, 2008, effective as of January 1,
2009.
|
|
A
copy of The Dow Chemical Company 1994 Executive Performance Plan, as
amended and restated on December 10, 2008, effective as of
January 1, 2009.
|
|
A
copy of the Summary Plan Description for The Dow Chemical Company
Company-Paid Life Insurance Plan, Employee-Paid Life Insurance Plan, and
Dependent Life Insurance Plan, amended and restated on October 21,
2008, effective as of December 1, 2008.
|
|
A
copy of the Summary Plan Description for The Dow Chemical Company Retiree
Company-Paid Life Insurance Plan, Retiree Optional Life Insurance Plan,
and Retiree Dependent Life Insurance Plan, amended and restated on
October 21, 2008, effective as of December 1, 2008.
|
|
A
copy of the Performance Shares Deferred Stock Agreement Pursuant to The
Dow Chemical Company 1988 Award and Option Plan, as amended, restated and
effective as of January 1, 2009.
|
|
A
copy of the Deferred Stock Agreement Pursuant to The Dow Chemical Company
1988 Award and Option Plan, as amended, restated and effective as of
January 1, 2009.
|
|
A
copy of the Non-Qualified Stock Option Agreement Pursuant to The Dow
Chemical Company 1988 Award and Option Plan, as amended, restated and
effective as of January 1, 2009.
|
|
A
copy of The Dow Chemical Company Voluntary Deferred Compensation Plan for
Non-Employee Directors, effective for deferrals after January 1, 2005, as
amended and restated on December 10, 2008, effective as of
January 1, 2009.
|
|
A
copy of The Dow Chemical Company Elective Deferral Plan, effective for
deferrals after January 1, 2005, as amended, restated and effective
as of January 1, 2009.
|
|
A
copy of an employment agreement dated February 14, 2006, between
Heinz Haller and The Dow Chemical
Company.
|
2008
|
2007
|
2006
|
||||||||||
(1)
Deductions represent:
|
||||||||||||
Notes
and accounts receivable written off
|
$ | 23 | $ | 22 | $ | 44 | ||||||
Credits
to profit and loss
|
6 | - | 1 | |||||||||
Miscellaneous
other
|
4 | (4 | ) | 11 | ||||||||
$ | 33 | $ | 18 | $ | 56 |
THE
DOW CHEMICAL COMPAY
|
||
By:
|
/s/
W.
H. WEIDEMAN
|
|
W.
H. Weideman, Vice President and
Controller
|
/s/
A.
A. ALLEMANG
|
/s/
G.
E. MERSZEI
|
|
A.
A. Allemang, Director
|
G.
E. Merszei, Director, Executive Vice President and Chief Financial
Officer
|
|
/s/
J.
K. BARTON
|
/s/
D.
H. REILLEY
|
|
J.
K. Barton, Director
|
D.
H. Reilley, Director
|
|
/s/
J. A. BELL
|
/s/
J.
M. RINGLER
|
|
J.
A. Bell, Director
|
J.
M. Ringler, Director
|
|
/s/
J.
M. FETTIG
|
/s/
R.
G. SHAW
|
|
J.
M. Fettig, Director
|
R.
G. Shaw, Director
|
|
/s/
B.
H. FRANKLIN
|
/s/
P.
G. STERN
|
|
B.
H. Franklin, Director
|
P.
G. Stern, Presiding Director
|
|
/s/
J.
B. HESS
|
/s/
W.
H. WEIDEMAN
|
|
J.
B. Hess, Director
|
W.
H. Weideman, Vice President and Controller
|
|
/s/
A.
N. LIVERIS
|
||
A.
N. Liveris, Director, President, Chief Executive Officer and Chairman of
the Board
|
||
|
2(a)
|
Agreement
and Plan of Merger dated as of August 3, 1999 among Union Carbide
Corporation, The Dow Chemical Company and Transition Sub Inc.,
incorporated by reference to Annex A to the proxy statement/prospectus
included in The Dow Chemical Company’s Registration Statement on Form S-4,
File No. 333-88443, filed October 5,
1999.
|
|
2(b)
|
Agreement
and Plan of Merger, dated as of July 10, 2008, among The Dow Chemical
Company, Ramses Acquisition Corp. and Rohm and Haas Company, incorporated
by reference to Exhibit 2.1 to The Dow Chemical Company Current
Report on Form 8-K filed on July 10,
2008.
|
|
2(c)
|
Joint
Venture Formation Agreement, dated November 28, 2008, between The Dow
Chemical Company and Petroleum Industries Company (K.S.C.), incorporated
by reference to Exhibit 2.1 to The Dow Chemical Company Current
Report on Form 8-K filed on February 19,
2009.
|
|
3(i)
|
The
Restated Certificate of Incorporation of The Dow Chemical Company as filed
with the Secretary of State, State of Delaware on May 11, 2007,
incorporated by reference to Exhibit 3(i) to The Dow Chemical Company
Quarterly Report on Form 10-Q for the quarter ended June 30,
2007.
|
|
3(ii)
|
The
Bylaws of The Dow Chemical Company, as amended and re-adopted in full on
October 8, 2008, effective October 9, 2008, incorporated by
reference to Exhibit 99.1 to The Dow Chemical Company Current Report
on Form 8-K filed on October 14,
2008.
|
|
4
|
Indenture,
dated as of April 1, 1992, between The Dow Chemical Company and the First
National Bank of Chicago, as trustee (incorporated by reference to Exhibit
4.1 to The Dow Chemical Company’s Registration Statement on Form S-3, File
No. 333-88617 (the "S-3 Registration Statement")), as amended by the
Supplemental Indenture, dated as of January 1, 1994, between The Dow
Chemical Company and The First National Bank of Chicago, as trustee
(incorporated by reference to Exhibit 4.2 to the S-3 Registration
Statement), as amended by the Second Supplemental Indenture, dated as of
October 1, 1999, between The Dow Chemical Company and Bank One Trust
Company, N.A. (formerly The First National Bank of Chicago), as trustee
(incorporated by reference to Exhibit 4.3 to the S-3 Registration
Statement), as amended by the Third Supplemental Indenture, dated as of
May 15, 2001, between The Dow Chemical Company and Bank One Trust Company,
N.A. (formerly The First National Bank of Chicago), as trustee
(incorporated by reference to Exhibit 4.4 to The Dow Chemical Company’s
Registration Statement on Form S-4, File No. 333-67368); and all other
such indentures that define the rights of holders of long-term debt of The
Dow Chemical Company and its consolidated subsidiaries as shall be
requested to be furnished to the Securities and Exchange Commission
pursuant to Item 601(b)(4)(iii)(A) of Regulation
S-K.
|
|
10(a)
|
A
copy of The Dow Chemical Company Executives’ Supplemental Retirement Plan,
as amended, restated and effective as of January 1,
2009.
|
|
10(b)
|
The
Dow Chemical Company 1979 Award and Option Plan, as amended through May
1983 (included as part of and incorporated by reference to the Prospectus
contained in Post-Effective Amendment No. 4 to The Dow Chemical Company’s
Registration Statement on Form S-8, File No. 2-64560, filed June 23,
1983), as amended April 12, 1984 (incorporated by reference to Exhibit
10(ff) to The Dow Chemical Company Annual Report on Form 10-K for the year
ended December 31, 1984), as amended April 18, 1985 (incorporated by
reference to Exhibit 10(fff) to The Dow Chemical Company Annual Report on
Form 10-K for the year ended December 31, 1985), as amended October 30,
1987 (incorporated by reference to Exhibit 10(j) to The Dow Chemical
Company Annual Report on Form 10-K for the year ended December 31,
1987).
|
|
10(c)
|
The
Dow Chemical Company Voluntary Deferred Compensation Plan for Outside
Directors (for deferrals made through December 31, 2004), as amended
effective as of July 1, 1994, incorporated by reference to Exhibit 10(f)
to The Dow Chemical Company Annual Report on Form 10-K for the year ended
December 31, 1994, as amended in the manner described in the
definitive Proxy Statement for the Annual Meeting of Stockholders of The
Dow Chemical Company held on May 14, 1998, incorporated by
reference.
|
|
10(d)
|
Intentionally
left blank.
|
|
10(e)
|
The
Dow Chemical Company Dividend Unit Plan, incorporated by reference to
Exhibit 10(j) to The Dow Chemical Company Annual Report on Form 10-K for
the year ended December 31, 1992.
|
|
10(f)
|
A
copy of The Dow Chemical Company 1988 Award and Option Plan, as
amended and restated on December 10, 2008, effective as of
January 1, 2009.
|
|
10(g)
|
Intentionally
left blank.
|
|
10(h)
|
A
copy of The Dow Chemical Company 1994 Executive Performance Plan, as
amended and restated on December 10, 2008, effective as of
January 1, 2009.
|
|
10(i)
|
The
Dow Chemical Company 1994 Non-Employee Directors’ Stock Plan, incorporated
by reference to Exhibit 10(o) to The Dow Chemical Company Annual Report on
Form 10-K for the year ended December 31,
1994.
|
|
10(j)
|
Intentionally
left blank.
|
|
10(k)
|
A
written description of the 1998 Non-Employee Directors’ Stock Incentive
Plan, incorporated by reference to the definitive Proxy Statement for the
Annual Meeting of Stockholders of The Dow Chemical Company held on May 14,
1998.
|
|
10(l)
|
A
written description of compensation for Directors of The Dow Chemical
Company, incorporated by reference to the definitive Proxy Statement for
the Annual Meeting of Stockholders of The Dow Chemical Company to be held
on May 14, 2009.
|
|
10(m)
|
A
written description of the manner in which compensation is set for the
Executive Officers of The Dow Chemical Company, incorporated by reference
to the definitive Proxy Statement for the Annual Meeting of Stockholders
of The Dow Chemical Company to be held on May 14,
2009.
|
|
10(n)
|
A
resolution adopted by the Board of Directors of The Dow Chemical Company
on May 5, 1971, and most recently amended on July 9, 1998, describing the
employee compensation program for decelerating Directors, incorporated by
reference to Exhibit 10(p) to The Dow Chemical Company Annual Report on
Form 10-K for the year ended December 31, 1998; as amended, re-adopted in
full and restated on March 21, 2003, incorporated by reference to
Exhibit 10(n) to The Dow Chemical Company Quarterly Report on Form 10-Q
for the quarter ended March 31, 2003; as amended, re-adopted in full
and restated on February 10, 2005, incorporated by reference to
Exhibit 10(n) to The Dow Chemical Company Quarterly Report on Form 10-Q
for the quarter ended March 31,
2005.
|
|
10(o)
|
The
template used for The Dow Chemical Company Key Employee Insurance Program
(“KEIP”), which provides benefits using insurance policies that replace
benefits otherwise payable under The Dow Chemical Company Executives’
Supplemental Retirement Plan and Company-Paid Life Insurance Plan,
incorporated by reference to Exhibit 10(o) to The Dow Chemical Company
Annual Report on Form 10-K for the year ended December 31, 2002. KEIP
is a component of the annual pension benefits listed in and incorporated
by reference to the definitive Proxy Statement for the Annual Meeting of
Stockholders of The Dow Chemical Company to be held on May 14,
2009.
|
|
10(p)
|
The
Dow Chemical Company Elective Deferral Plan (for deferrals made through
December 31, 2004), amended and restated as of September 1,
2006, incorporated by reference to Exhibit 10(p) to The Dow Chemical
Company Quarterly Report on Form 10-Q for the quarter ended
September 30, 2006.
|
|
10(q)
|
Intentionally
left blank.
|
|
10(r)
|
Intentionally
left blank.
|
|
10(s)
|
A
copy of the Summary Plan Description for The Dow Chemical Company
Company-Paid Life Insurance Plan, Employee-Paid Life Insurance Plan, and
Dependent Life Insurance Plan, amended and restated on October 21,
2008, effective as of December 1,
2008.
|
|
10(t)
|
A
copy of the Summary Plan Description for The Dow Chemical Company Retiree
Company-Paid Life Insurance Plan, Retiree Optional Life Insurance Plan,
and Retiree Dependent Life Insurance Plan, amended and restated on
October 21, 2008, effective as of December 1,
2008.
|
|
10(u)
|
Amended
and Restated 2003 Non-Employee Directors’ Stock Incentive Plan, adopted by
the Board of Directors of The Dow Chemical Company on December 10,
2007,incorporated by reference to Exhibit 10(u) to The Dow Chemical
Company Annual Report on Form 10-K for the year ended December 31,
2007.
|
|
10(v)
|
Non-Qualified
Stock Option Agreement Pursuant to The Dow Chemical Company 1994
Non-Employee Directors’ Stock Plan, incorporated by reference to
Exhibit 10.1 to The Dow Chemical Company Current Report on
Form 8-K filed on September 3,
2004.
|
|
10(w)
|
Non-Qualified
Stock Option Agreement Pursuant to The Dow Chemical Company 2003
Non-Employee Directors’ Stock Incentive Plan, incorporated by reference to
Exhibit 10(w) to The Dow Chemical Company Quarterly Report on
Form 10-Q for the quarter ended September 30,
2004.
|
|
10(x)
|
A
copy of the Performance Shares Deferred Stock Agreement Pursuant to The
Dow Chemical Company 1988 Award and Option Plan, as amended, restated and
effective as of January 1,
2009.
|
|
10(y)
|
A
copy of the Deferred Stock Agreement Pursuant to The Dow Chemical Company
1988 Award and Option Plan, as amended, restated and effective as of
January 1, 2009.
|
|
10(z)
|
A
copy of the Non-Qualified Stock Option Agreement Pursuant to The Dow
Chemical Company 1988 Award and Option Plan, as amended, restated and
effective as of January 1,
2009.
|
|
10(aa)
|
Settlement
Agreement and General Release between Richard L. Manetta and The Dow
Chemical Company dated December 10, 2004, incorporated by reference
to Exhibit 10.1 to The Dow Chemical Company Current Report on
Form 8-K filed on December 16,
2004.
|
|
10(bb)
|
Deferred
Compensation Agreement between Richard L. Manetta and The Dow Chemical
Company dated December 10, 2004, incorporated by reference to Exhibit 10.2
to The Dow Chemical Company Current Report on Form 8-K filed on
December 16, 2004.
|
|
10(cc)
|
A
copy of The Dow Chemical Company Voluntary Deferred Compensation Plan for
Non-Employee Directors, effective for deferrals after January 1, 2005, as
amended and restated on December 10, 2008, effective as of
January 1, 2009.
|
|
10(dd)
|
A
copy of The Dow Chemical Company Elective Deferral Plan, effective for
deferrals after January 1, 2005, as amended, restated and effective
as of January 1, 2009.
|
|
10(ee)
|
The
template for communication to employee Directors who are decelerating
pursuant to The Dow Chemical Company Retirement Policy for Employee
Directors, incorporated by reference to Exhibit 10(ee) to The Dow Chemical
Company Quarterly Report on Form 10-Q for the quarter ended June 30,
2005.
|
|
10(ff)
|
Purchase
and Sale Agreement dated as of September 30, 2005 between Catalysts,
Adsorbents and Process Systems, Inc. and Honeywell Specialty Materials
LLC, incorporated by reference to Exhibit 10(ff) to The Dow Chemical
Company Quarterly Report on Form 10-Q for the quarter ended September 30,
2005.
|
|
10(gg)
|
Employment
agreement with Geoffery Merszei, Executive Vice President and Chief
Financial Officer, incorporated by reference to Exhibit 10(gg) to The Dow
Chemical Company Annual Report on Form 10-K for the year ended December
31, 2005.
|
|
10(hh)
|
Employment
agreement dated June 18, 2005, between William F. Banholzer and The
Dow Chemical Company, incorporated by reference to the Current Report on
Form 8-K filed on March 16,
2006.
|
|
10(ii)
|
A
copy of an employment agreement dated February 14, 2006, between Heinz
Haller and The Dow Chemical
Company.
|
|
10(jj)
|
Change
in Control Executive Severance Agreement - Tier 1, incorporated by
reference to Exhibit 10(jj) to The Dow Chemical Company Annual Report on
Form 10-K for the year ended December 31,
2007.
|
|
10(kk)
|
Change
in Control Executive Severance Agreement - Tier 2, incorporated by
reference to Exhibit 10(kk) to The Dow Chemical Company Annual Report on
Form 10-K for the year ended December 31,
2007.
|
|
10(ll)
|
Voting
Agreement dated as of July 10, 2008, by and among Rohm and Haas
Company, The Dow Chemical Company and each of the persons and entities
listed on Schedule I thereto, incorporated by reference to
Exhibit 10.1 to The Dow Chemical Company Current Report on Form 8-K
filed on July 10, 2008.
|
|
10(mm)
|
Term
Loan Agreement, dated as of September 8, 2008, among The Dow Chemical
Company, as borrower, the lenders party thereto and Citibank, N.A, as
administrative agent for the lenders, incorporated by reference to
Exhibit 99.1 to The Dow Chemical Company Current Report on
Form 8-K filed on September 9,
2008.
|
|
10(nn)
|
Investment
Agreement, dated as of October 27, 2008, between The Dow Chemical
Company and Berkshire Hathaway Inc., incorporated by reference to
Exhibit 10.1 to The Dow Chemical Company Current Report on
Form 8-K filed on October 27,
2008.
|
|
10(oo)
|
Investment
Agreement, dated as of October 27, 2008, between The Dow Chemical
Company and The Kuwait Investment Authority, incorporated by reference to
Exhibit 10.2 to The Dow Chemical Company Current Report on
Form 8-K filed on October 27,
2008.
|
|
12.1
|
Computation
of Ratio of Earnings to Fixed
Charges.
|
|
14
|
Code
of Ethics for Principal Executive Officer, Principal Financial Officer and
Principal Accounting Officer, incorporated by reference to Exhibit 14
to The Dow Chemical Company Annual Report on Form 10-K for the year
ended December 31, 2003.
|
|
23(a)
|
Consent
of Independent Registered Public Accounting
Firm.
|
The
|
following
trademarks or service marks of The Dow Chemical Company and certain
affiliated companies of Dow appear in this
report:
AFFINITY, AIRSTONE, AMBITROL, AMPLIFY, ASPUN,
ATTANE, BETAFOAM, BETAMATE, BETASEAL, CALIBRE, CANGUARD, CARBITOL,
CARBOWAX, CELLOSIZE, CELLOSOLVE, CLEAR+STABLE, COMBOTHERM, CONTINUUM,
CYCLOTENE, D.E.H., D.E.N., D.E.R., DOW, DOW XLA, DOWANOL, DOWCAL, DOWEX,
DOWFAX, DOWFLAKE, DOWFROST, DOWICIDE, DOWLEX, DOWPER, DOWTHERM, ECHELON,
ELITE, EMERGE, ENFORCER, ENGAGE, ENHANCER, EVOCAR, FILMTEC, FLEXOMER,
FORTEFIBER, FORTEGRA, FOUNDATIONS, FROTH-PAK, GREAT STUFF, HYPOL, IMPAXX,
INSITE, INSPIRE, INSTA-STIK, INTEGRAL, ISONATE, ISOPLAST, LIQUIDOW, LP
OXO, MAGNUM, MAXICHECK, MAXISTAB, METEOR, METHOCEL, MONOTHANE, NEOCAR,
NORDEL, NORKOOL, NORMAX, PAPI, PELADOW, PELLETHANE, POLYOX, POLYPHOBE,
PRIMACOR, PROCITE, PULSE, REDI-LINK, RENUVA, SAFE-TAINER, SARAN, SARANEX,
SATINFX, SATISFIT, SELECTOR, SENTRY, SHAC, SI-LINK, SILK, SOLTERRA,
SPECFLEX, STEVENS ROOFING SYSTEMS, STYROFOAM, STYRON, STYRON A-TECH,
STYRON C-TECH, SYNALOX, TERGITOL, THERMAX, TILE BOND, TRAFFIDECK,
TRENCHCOAT, TRITON, TUFLIN, TYRIL, TYRIN, UCAR, UCARE, UCARHIDE, UCARSOL,
UCON, UNIGARD, UNIPOL, UNIPURGE, UNIVAL, VERDISEAL, VERSENE, VERSIFY,
VORACOR, VORACTIV, VORALAST, VORALUX, VORAMER, VORANATE, VORANOL,
VORASTAR, WALOCEL, WALSRODER, WEATHERMATE,
XITRACK
|
The
|
following
trademarks or service marks of Dow AgroSciences LLC and certain affiliated
companies of Dow AgroSciences LLC appear in this
report: AGROMEN, BRODBECK,
CLINCHER, DAIRYLAND, DELEGATE,
DITHANE, EXZACT, FORTRESS, GARLON, GLYPHOMAX, GRANITE, HERCULEX, KEYSTONE,
LAREDO, LONTREL, LORSBAN, MILESTONE, MUSTANG, MYCOGEN, NEXERA, PHYTOGEN,
PROFUME, RENZE, SENTRICON, SIMPLICITY, STARANE, TELONE, TORDON, TRACER
NATURALYTE, TRIUMPH, VIKANE,
WIDESTRIKE
|
The
following registered service mark of American Chemistry Council appears in
this report: Responsible
Care
|
1.01
|
AVERAGE
COMPENSATION
for purposes of the Supplemental Retirement Benefit of
a Prior UCC Program Participant who was in the Union Carbide Compensation
Deferral Program on February 6, 2001 and who shall attain at least age 50
and have at least 10 years of Eligibility Service, as defined under the
Dow Employees' Pension Plan, as of or before December 31, 2005, shall
equal the highest three year average compensation ("HC3A") as defined in
the Dow Employees' Pension Plan but using Compensation as defined in the
Plan, without regard to incentive compensation, plus the highest three
year average, as defined in the former Union Carbide Corporation Enhanced
Retirement Income Plan (attached as Exhibit I), of incentive compensation
averaged separately. For calendar years 2004 and 2005,
incentive compensation shall mean Compensation as defined in the Plan
without regard to either deferred or paid base
compensation. This Average Compensation shall be used to
calculate benefits as specified under Section
3.04.
|
1.02
|
BENEFICIARY
shall mean that person or persons designated by the Participant to receive
a distribution of any amounts payable under the Plan due to the death of
the Participant. The beneficiary of a Participant shall be
deemed to be such Participant's spouse, if married, unless such spouse
agrees in writing to waive this right, or their domestic partner, if in an
approved domestic partner relationship (as defined in the Dow Employees'
Pension Plan) (written waiver does not apply to a domestic
partner). If the Participant is not married or in an approved
domestic partner relationship and fails to designate a Beneficiary, the
amounts payable, if any, under this Plan due to the death of the
Participant shall be paid in the following
order: (a) to the children of the Participant; (b)
to the beneficiary of the Company Paid Life Insurance of the Participant;
(c) to the beneficiary of any Company-sponsored life insurance policy for
which the Company pays all or part of the premium of the Participant; or
(d) to the estate of the
Participant.
|
1.03
|
CADRE
BENEFITS
shall mean the
benefits described in Section 3.06.
|
1.04
|
CADRE
EMPLOYEE
shall mean an employee who has been authorized by Dow
Europe GmbH to participate in the Cadre Pension Plan and who earns
compensation while on assignment to the
U.S.
|
1.05
|
CHANGE OF
CONTROL
, for purposes of the Plan,
shall
be deemed to have occurred on:
|
|
(a)
|
the
date that any one person, or more than one person acting as a group,
acquires ownership of stock of The Dow Chemical Company that, together
with stock held by such person or group, constitutes more than 50 percent
of the total fair market value or total voting power of the stock of The
Dow Chemical Company;
|
|
(b)
|
the
date that a majority of the members of the Board of Directors of The Dow
Chemical Company is replaced during any 12-month period by directors whose
appointment or election is not endorsed by a majority of the directors
before the date of the appointment or
election;
|
|
(c)
|
the
date that any one person, or more than one person acting as a group,
acquires (or has acquired during the 12-month period ending on the date of
the most recent acquisition by such person or persons) ownership of stock
of The Dow Chemical Company possessing 30 percent or more of the total
voting power of the stock of The Dow Chemical Company;
or
|
|
(d)
|
the
date that any one person, or more than one person acting as a group,
acquires (or has acquired during the 12-month period ending on the date of
the most recent acquisition by such person or persons) assets from The Dow
Chemical Company that have a total gross fair market value equal to or
more than 40 percent of the total gross fair market value of all of the
assets of The Dow Chemical Company immediately before such acquisition or
acquisitions, provided that the following asset transfers shall not result
in a Change of Control: (i) a transfer of assets to a
stockholder of The Dow Chemical Company in exchange for or with respect to
its stock, (ii) a transfer to a corporation, 50 percent or more of the
total value or voting power of which is owned directly or indirectly, by
The Dow Chemical Company, (iii) a transfer to a person, or more than one
person acting as a group, that owns 50 percent or more of the stock of The
Dow Chemical Company, or (iv) a transfer to an entity, at least 50 percent
of the total value or voting power of which is owned, directly or
indirectly, by a person described in clause
(iii).
|
1.06
|
COMPANY
shall mean The Dow Chemical Company and any other entity authorized
to participate in the Plan by the Corporate Vice President of Human
Resources of the Company or her/his
delegate.
|
1.07
|
COMPENSATION
shall mean the sum of:
|
|
(a)
|
compensation
as defined under the Dow Employees' Pension Plan without regard to Code
limitations; and
|
|
(b)
|
deferred
compensation to The Dow Chemical Company Elective Deferral
Plan.
|
1.08
|
DEPP
COMPONENT
shall mean benefits accrued under the provisions
contained in the Dow Employees' Pension Plan applicable to the DEPP
component of such Plan.
|
1.09
|
DEPP
COMPONENT SUPPLEMENTAL RETIREMENT BENEFITS
shall mean the benefits
accrued by Participants and Prior UCC Program Participants in accordance
with Section 3.04 of the Plan that would have been provided under the DEPP
Component of the Dow Employees' Pension Plan but for the statutory
limitations in Code sections 415 and 401(a)(17) and based upon the
alternative definitions of Compensation and Average Compensation, as
applicable, provided in this Plan.
|
1.10
|
EMPLOYEE
shall mean someone who is employed by the Company to perform
personal services in an employer-employee relationship who receives
compensation from the Company, other than a retirement benefit, severance
pay, retainer, or fee under
contract.
|
1.11
|
KEY
EMPLOYEE
means a Participant who has a job level of 820 points or
higher as of his Separation from
Service.
|
1.12
|
PARTICIPANT
shall mean:
|
|
(a)
|
an
Employee who is entitled to a Restricted Benefit under this Plan as
determined by the Corporate Vice President of Human Resources of the
Company or her/his delegate;
|
|
(b)
|
an
Employee who is a Board member who is an officer or Employee of the
Company and who may relinquish line
responsibility;
|
|
(c)
|
an
Employee whose benefits under the Dow Employees' Pension Plan are limited
by the Code or ERISA;
|
|
(d)
|
an
Employee who is part of a select group of management or highly compensated
Employees, as determined by the Corporate Vice President of Human
Resources of the Company or her/his delegate, who receives forms of
compensation that do not constitute compensation as defined in the Dow
Employees' Pension Plan;
|
|
(e)
|
a
Prior UCC Program Participant; or
|
|
(f)
|
a
Cadre Employee.
|
1.13
|
PLAN YEAR
shall mean the twelve (12) month period beginning January 1 and
ending December 31.
|
1.14
|
PPA
COMPONENT
shall mean benefits accrued under the provisions
contained in the Dow Employees' Pension Plan applicable to the Personal
Pension Account or PPA component of such
plan.
|
1.15
|
PPA
COMPONENT SUPPLEMENTAL RETIREMENT BENEFITS
shall mean the benefits
accrued by Participants in accordance with Section 3.05 of the Plan that
would have been provided under the PPA Component of the Dow Employees'
Pension Plan but for the statutory limitations in Code sections 415 and
401(a)(17) and based upon the alternative definition of Compensation, as
applicable, provided in this Plan.
|
1.16
|
RESTRICTED
BENEFIT
shall mean the benefits described in Part A of Article
III.
|
1.17
|
SEPARATION
FROM SERVICE or SEPARATES FROM SERVICE
shall mean a "separation
from service" within the meaning of Section 409A of the Code, except that
in applying Section 1563(a)(1), (2), and (3) of the Code for purposes of
determining a controlled group of corporations under Section 414(b) and
(c) of the Code, and in applying Treasury Regulation section 1.414(c)-2
for purposes of determining trades or businesses that are
under
|
2.01
|
ELIGIBILITY
AND PARTICIPATION
|
|
(a)
|
Each
Employee who is participating in Dow Employees' Pension Plan and is
specifically named by the Corporate Vice President of Human Resources of
the Company or her/his delegate shall be eligible to participate in the
Plan.
|
|
(b)
|
Each
Employee who is a member of a select group of management or a highly
compensated Employee, Board member of the Company and/or whose benefits
are statutorily limited shall be eligible to participate in the
Plan. Each former employee of Union Carbide Corporation who
transferred to the Company after the merger of the Company with Union
Carbide Corporation who was in the Union Carbide Compensation Deferral
Program on February 6, 2001 and who shall attain at least age 50 and have
at least 10 years of Eligibility Service, as defined under the Dow
Employees' Pension Plan, as of or before December 31, 2005 shall also be a
Participant in the Plan ("Prior UCC Program
Participants").
|
|
(c)
|
Each
Employee who is determined by the Corporate Vice President of Human
Resources of the Company to be entitled to a Restricted Benefit shall be
eligible to participate under this
Plan.
|
|
(d)
|
Each
Cadre Employee who has been authorized by Dow Europe GmbH to
participate in the Company's Cadre Pension Plan shall be eligible to
participate in the Plan while such employee is on assignment to the
U.S.
|
2.02
|
MEANING
OF PARTICIPATION
|
2.03
|
TERMINATION
OF PARTICIPATION
|
3.01
|
CALCULATION
OF RESTRICTED BENEFITS
|
|
(a)
|
The
amount of retirement benefits payable under the Dow Employees' Pension
Plan to Participants who transfer from (i) a Dow foreign entity to a Dow
U.S. entity covered by the Dow Employees' Pension Plan, (ii) a controlled
group entity that does not participate in the Dow Employees' Pension Plan,
or (iii) a non-controlled group entity or non-affiliated company
(collectively, a "Prior Company"), may not include compensation and
service with the Prior Company. The intent of this Section is
to ensure that Participants, as named by the Corporate Vice President of
Human Resources or her/his delegate (the "VP"), receive (I) eligibility
and vesting service under the Dow Employees' Pension Plan for such service
with a Prior Company, as determined by the VP, and/or (II) a pension
benefit based on their aggregate service (and compensation) rendered to
Dow and the Prior Company, as determined by the VP (the "Approved
Service"), but that benefits attributable to such Approved Service not
result in a duplication of benefits. However, Restricted
Benefits attributable to such Approved Service shall be reduced by the
value of any benefit payable under the Dow Employees' Pension Plan or any
other tax-qualified retirement savings vehicle sponsored by a member of
the Dow controlled group, attributable to such Approved
Service. For purposes of calculating the Participant's
Restricted Benefits, the amount of retirement benefits payable under the
Dow Employees' Pension Plan to Participants with Approved Service shall be
calculated as provided in Section 3.01(a)(i), (ii) or (iii), as applicable
to the Participant.
|
|
(i)
|
No Proration
Method
. Under this method, the Restricted Benefits shall be
determined by counting the Approved Service as eligibility and vesting
service under the Dow Employees' Pension
Plan.
|
|
(ii)
|
Equivalent Benefits
Method
. Under this method, the Restricted Benefits shall
be determined by using the entire Approved Service as credited service,
and such benefit shall be reduced by the accrued benefit under the plan
maintained by the Prior Company, as determined under (iv)
below.
|
|
(iii)
|
Proration
Method
. Under this method, the Restricted Benefits shall be
determined under the proration rules set forth in the Global Pension
Relocation Policy (the "Policy"), and in accordance with section
3.01(a)(iv) below.
|
|
(iv)
|
The
Employee's accrued benefit under the plan maintained by the Prior Company
shall be determined
under the terms
and provisions of such plan as of the date of the Employee's transfer to
this Plan. To the extent such plan provides a fixed value based
on compensation and service (or other factors) earned prior to
participation in the Plan, the value shall be fixed and determinable as of
the date of transfer. To the extent such plan provides an
accrued benefit that is not reasonably ascertainable as of the date of
transfer, such benefit shall be determined based on objectively
determinable factors set forth under such plan as of the date of transfer
(e.g., conversion rate, age or service, interest rates, actuarial
assumptions), and shall not be subject to the discretion of any Employee,
Company, or Prior Company.
|
|
(b)
|
The
amount of retirement benefits payable under the Dow Employees' Pension
Plan to Participants who transfer to (i) a Dow foreign entity not covered
by the Dow Employees' Pension Plan, (ii) a controlled group entity that
does not participate in the Dow Employees' Pension Plan, or (iii) a
non-controlled group entity or non-affiliated company (collectively, a
"Nonparticipating Company"), may not include compensation and service with
the Nonparticipating Company. The intent of this Section is to
ensure that Participants, as named by the VP receive (I) eligibility and
vesting service under the Dow Employees' Pension Plan for such service
with a Nonparticipating Company, as determined by the VP, and/or (II) a
pension benefit based on their aggregate service (and compensation)
rendered to Dow and the Nonparticipating Company, as determined by the VP
(the "Approved Service"), but that benefits attributable to such Approved
Service not result in a duplication of benefits
.
Any such
Restricted Benefits shall be determined under the proration rules set
forth in the Policy, and in accordance with the rules in Section
3.01(a)(iv), and shall be reduced by any benefit payable under the Dow
Employees' Pension Plan or any other tax-qualified retirement savings
vehicle sponsored by a member of the Dow controlled group, attributable to
such Approved Service
.
|
|
(c)
|
For
this purpose, the value of the Dow Employees' Pension Plan benefit shall
be determined under the terms of such plan (as modified by 3.01(a) above)
as in effect on the earlier of Separation from Service or
death.
|
3.02
|
VESTING
OF RESTRICTED BENEFITS
|
3.03
|
ADDITIONAL
RESTRICTED BENEFITS TO RETURNING
CEO
|
|
(a)
|
The
amount of benefit calculated under the terms of the frozen Key Employee
Insurance Program, modified as
follows:
|
|
(i)
|
the
highest three years of Compensation shall be used, whether or not
consecutive; and
|
|
(ii)
|
provided
that the Returning CEO does not leave the positions of President and CEO
without the prior concurrence of the Company's Board of Directors, before
December 31, 2004, Compensation for the years 2003 and 2004 shall be
defined as follows:
|
|
(A)
|
2003: (a)
the total base salary paid in 2003 as posted in Dow's Global Human
Resources Information System; plus (b) the percentage established as of
March 1 for the Executive Performance Plan target performance award
multiplied by the base salary paid in 2003 as described in subsection
3.03(a)(i)(B)(1)(a); and
|
|
(B)
|
2004: (a)
the total base salary paid from January 1, 2004 to October 31, 2004 as
posted in Dow's Global Human Resources Information System; plus (b) the
percentage established as of March 1 for the Executive Performance Plan
target performance award multiplied by the base salary paid the month of
October, 2004 multiplied by 10; plus (c) the deceleration base salary for
November 1 to December 31, 2004 as posted in Dow's Global Human Resources
Information System;
|
|
(b)
|
The
amount of benefit calculated under the terms of the frozen Key Employee
Insurance Program without
modification.
|
3.07
|
ESRP
BENEFIT CALCULATIONS
|
4.01
|
PAYMENT
OF RESTRICTED BENEFITS, DEPP COMPONENT AND PPA COMPONENT SUPPLEMENTAL
RETIREMENT BENEFITS
|
|
(a)
|
Form
of Payment
|
|
(i)
|
Restricted Benefits, DEPP
Component Supplemental Retirement Benefits, and Cadre
Benefits
|
|
(D)
|
For
the Restricted Benefits and/or DEPP Component Supplemental Retirement
Benefits, to the extent the Participant is eligible to elect it, any of
the three options described above – single life annuity, 50% joint and
survivor annuity, or 100% joint and survivor annuity – with a Guaranteed
Payout Option.
|
|
(iii)
|
Small
Benefits
|
|
(i)
|
Restricted
Benefits, DEPP Component Supplemental Retirement Benefits, and Cadre
Benefits
|
|
(ii)
|
PPA
Component Supplemental Retirement
Benefits
|
|
A
Participant's vested PPA Component Supplemental Retirement Benefits
accrued under the Plan shall be payable in the seventh month following the
Participant's Separation from
Service.
|
|
(iii)
|
Small
Benefits
|
|
(iv)
|
Delay
for Key Employees
|
|
(v)
|
Change
of Control
|
|
(c)
|
Benefit
Payments upon Death
|
|
(i)
|
Death Prior to Commencement of
Benefit Payments.
In the event of a Participant's death
before the month in which benefit payments commence under Section 4.01(b),
death benefits equal to
the Participant's
vested Restricted Benefits, vested DEPP Component Supplemental Retirement
Benefits, vested PPA Component Supplemental Retirement Benefits, and/or
vested Cadre Benefits, as applicable, shall be paid in the first month
following the month in which the Participant dies. The death
benefit shall be payable in a lump sum to the Participant's
Beneficiary.
|
|
(ii)
|
Death after Commencement of
Benefit Payments.
In the event of a Participant's death
after benefit payments have commenced under Section 4.01(b), the death
benefit, if any, payable hereunder shall be paid in accordance with the
applicable form of payment specified in Section 4.01(a) and any optional
form of payment elected by the Participant (if
applicable).
|
|
(d)
|
Benefit
Payments upon Inclusion in Income
|
|
If
a Participant's vested Restricted Benefits, vested DEPP Component
Supplemental Retirement Benefits, vested PPA Component Supplemental
Retirement Benefits, and/or vested Cadre Benefits under this Plan are
includible in income pursuant to Code section 409A, such benefits shall be
distributed immediately to the
Participant.
|
|
(e)
|
Permitted
Delays in Distribution
|
|
(i)
|
The
Company's deduction with respect to such payment would be eliminated by
application of Code section 162(m);
or
|
|
(ii)
|
The
making of the payment would violate Federal securities laws or other
applicable law;
|
|
ARTICLE
V
|
5.01
|
FINANCING
OF BENEFITS
|
5.02
|
GENERAL
CREDITOR
|
5.03
|
LIABILITY
OF THE COMPANY
|
5.04
|
ASSIGNMENT
|
6.01
|
PLAN
IS BINDING
|
|
6.02
|
ENTIRE
PLAN
|
6.03
|
NO
GUARANTEE OF EMPLOYMENT
|
6.04
|
GOVERNING
LAW
|
6.05
|
TERMINATION
|
6.06
|
WITHHOLDING
TAXES
|
6.07
|
OVERPAYMENTS
|
7.01
|
ADMINISTRATION
AND AMENDMENT
|
7.02
|
CLAIMS
SUBMISSION AND REVIEW PROCEDURE
|
|
(b)
|
Initial
Claim for Benefits
|
|
(c)
|
Appeal
of Denied Claims
|
|
As
amended and restated on December 10, 2008, effective January 1,
2009.
|
1.
|
Establishment and Purpose of
the Plan:
The Dow Chemical Company 1988 Award and Option
Plan is hereby established upon the following terms and
conditions. The purpose of the Plan is to attract and retain in
the employ of the Company and its Subsidiaries and Affiliates people of
ability, training and experience by providing such people, in
consideration of services performed, an incentive for outstanding
performance to the end of furthering the continued growth and
profitability of the Company, and to encourage ownership of the Company’s
stock by such people.
|
2.
|
Definitions
|
2.01
|
Affiliate:
Any
entity in which the Company has a substantial direct or indirect equity
interest, as determined by the
Committee.
|
2.02
|
Award:
An
award of Deferred Stock, Restricted Stock, Options or Stock Appreciation
Rights under the Plan.
|
2.03
|
Awardee:
An
Employee to whom an Award is made.
|
2.04
|
Board of
Directors:
The Board of Directors of the
Company.
|
2.05
|
Change in
Control:
A
Change in Control shall be deemed to have
occurred
on (A)
the date that there is a change in ownership of a
corporation where one person, or more than one person acting as a group
acquires ownership of stock of the corporation that, together with stock
held by such person or group, constitutes more than 50 percent
of the total fair market value or total voting power of the stock of such
corporation, or (B) notwithstanding that there hasn’t been
a change in ownership under (A),
the date
there is a change in the effective control of the corporation
under which
either: (1) any one person, or more than one person acting as a group
acquires (or has acquired during the 12 month period ending on the date of
the most recent acquisition by such person or persons) ownership of stock
of the corporation possessing 30% or more of the total voting power of the
stock of the corporation; or (2) a majority of members of the
corporation’s board of directors is replaced during any 12 month period by
directors whose appointment or election is not endorsed by a majority of
the members of the corporation’s board of directors prior to the date of
the appointment or election
. This definition of “Change in
Control” is intended to conform to the definition of a “change in
ownership or effective control of a corporation, or a change in the
ownership of a substantial portion of the assets of a corporation” as
defined under Code section 409A and any subsequent authority issued
pursuant thereto, and no corporate event shall be considered a Change in
Control unless it meets such
requirements.
|
2.06
|
Code:
The
Internal
Revenue Code of 1986, as amended
.
|
2.07
|
Common
Stock:
The Common Stock of the Company, par value $2.50
a share, or such other class or kind of shares or other securities as may
be applicable under Section 10.
|
2.08
|
Company:
The
Dow Chemical Company, a Delaware corporation, or any successor to
substantially all its business.
|
2.09
|
Committee:
The
Compensation Committee of the Board of Directors, or such other committee
designated by the Board of Directors, designated to administer the Plan
under Section 4, which committee shall have at least three members, each
of which shall be a Disinterested
Person.
|
2.10
|
Deferred
Stock:
Common Stock awarded by the Compensation
Committee under Section 6 of the
Plan.
|
2.11
|
Disinterested
Person:
A person defined in Rule 16b-3(d)(3) promulgated
by the Securities and Exchange Commission under the Securities Exchange
Act of 1934 as amended, or any successor definition adopted by the
Commission.
|
2.12
|
Employee:
An
employee of the Company or a Subsidiary, including an officer or director
who is such an employee, who at the time an Award is made has a work
schedule of 50% or more of the standard hours defined as full-time in such
employee’s work location, but excluding any employee who has provided to
the Company a written irrevocable election not to be
eligible.
|
2.13
|
Fair Market
Value:
As applied to a specific date, the closing market
price of Common Stock, as reported on the consolidated transaction
reporting system for New York Stock Exchange issues on such date or, if
Common Stock was not traded on such date, on the next preceding day on
which the Common Stock was traded. However, in the case of
an Incentive Stock Option, if such method of determining Fair Market Value
shall not be consistent with the then current regulations of the U.S.
Secretary of the Treasury, Fair Market Value shall be determined in
accordance with those regulations.
|
2.14
|
Incentive Stock
Option:
Any Option intended to meet the requirements of
an incentive stock option as defined in Section 422A of the U.S. Internal
Revenue Code of 1986 as amended or any statutory provision that may
replace such Section.
|
2.15
|
Key Employee:
Any employee of the Company who has a job level of
820 points or higher as of his Separation from
Service.
|
2.16
|
Non-Qualified
Option:
Any Option not intended to be an Incentive Stock
Option.
|
2.17
|
Options:
Any
option or options granted from time to time under the Plan, including both
Non-Qualified Options and Incentive Stock
Options.
|
2.18
|
Plan:
The Dow
Chemical Company 1988 Award and Option Plan herein set forth, as the same
may from time to time be amended.
|
2.19
|
Restricted
Stock:
Common stock awarded by the Committee under
Section 7 of the Plan.
|
2.20
|
Separation from Service or
Separates from Service:
A "separation from service" within the meaning of
Code section 409A.
|
2.21
|
Stock Appreciation
Rights:
Rights awarded by the Committee under Section 9
of the Plan.
|
2.22
|
Subsidiary:
Any
business association (including a corporation or a partnership, other than
the Company) in an unbroken chain of such associations beginning with the
Company if each of the associations other than the last association in the
unbroken chain owns equity interests (including stock or partnership
interests) possessing 50% or more of the total combined voting power of
all classes of equity interests in one of the other associations in such
chain.
|
3.
|
Eligibility
|
4.
|
Plan
Administration
|
4.01
|
Administrator:
The
Plan shall be administered by the
Committee.
|
4.02
|
Administrative
Powers:
The Committee shall have full power to interpret
and administer the Plan and full authority to act in selecting the
Employees to whom Awards will be granted, in determining the type and
amount of Award to be granted to each such Employee, the terms and
conditions of Awards granted under the Plan, subject to the provisions of
Section 409A of Internal Revenue Code of 1986, as amended and any
subsequent authority promulgated Section 409A and the terms of
agreements which will be entered into with Awardees. The
Committee shall have the power to make regulations for carrying out the
Plan and to make changes in such regulations as they from time to time
deem proper. Any interpretation by the Committee of the terms
and provisions of the Plan and the administration thereof, and all action
taken by the Committee, shall be final, binding and conclusive on the
Company, its stockholders, Subsidiaries, Affiliates, all Employees, their
respective legal representatives, successors and assigns and upon all
other persons claiming under or through any of them. As to the
selection of and grants of awards to Awardees who are not subject to
Sections 16(a) and 16(b) of the Securities Exchange Act of 1934, the
Committee may delegate any or all of its responsibilities to members of
the Company’s administration.
|
4.03
|
Limitation on
Liability:
Members of the Board of Directors and members
of the Committee acting under the Plan shall be fully protected in relying
in good faith upon the advice of counsel and shall incur no liability
except for gross negligence or willful misconduct in the performance of
their duties.
|
5.
|
Shares Subject to the
Plan
|
5.01
|
Subject
to adjustment as provided in Section 10, the total number of shares of
Common Stock available for grant under the Plan in each calendar year
during any part of which the Plan is effective shall be one and one-half
percent (1.5%) of the total outstanding shares of Common Stock as of the
first day of such year for which the Plan is in effect;
provided
that such
number shall be increased in any year by fifty percent (50%) of the shares
available for grant hereunder in each of the previous three years, but not
covered by Awards granted hereunder in such years; and
provided, further
that
no more than thirty million (30,000,000) shares shall be cumulatively
available for the grant of Incentive Stock Options under the Plan. Awards
of Deferred Stock and Restricted Stock are limited to fifteen (15%) of the
aggregate limit as provided in this Section, such percentage to be
calculated as the annual average over any ten year period of time. In
addition, the Company may increase the shares available for Awards through
an advance of up to fifty percent (50%) of the subsequent year’s
allocation (determined by using fifty percent (50%) of the currentyear’s
allocation). In addition, any shares issued by the Company
through the assumption or substitution of outstanding grants from an
acquired company shall not reduce the shares available for grants under
the Plan. Any shares issued hereunder may consist, in whole or
in part, of authorized and unissued shares or treasury
shares. If any shares subject to any Award granted hereunder
are forfeited or such Award otherwise terminates without the issuance of
such shares or of other consideration in lieu of such shares, the shares
subject to such Award, to the extent of any such forfeiture or
termination, shall again be available for grant under the
Plan.
|
5.02
|
Individual
Limits:
Notwithstanding anything to the contrary
elsewhere in this Plan, and subject to adjustment as provided in Section
10, in any calendar year, the maximum number of shares of common stock
covered by Awards of Options and Stock Appreciation Rights granted to any
individual shall not exceed one million, two hundred thousand
(1,200,000). In addition, any shares that remain ungranted
under the foregoing limitation for the prior calendar year for that
individual may be carried forward to the current year, and any number of
shares may be borrowed against that individual’s limit for the succeeding
year. In no event, however, shall the total number of shares
carried forward and borrowed in any year for any individual pursuant to
this Section 5.02 exceed the maximum number stated in the first sentence
of this Section 5.02. For purposes of this Section 5.02, shares
shall be counted first against the current year, then against the prior
year, and finally against the succeeding year. Aggregate awards
of Deferred Stock and Restricted Stock to any individual shall not exceed
nine hundred thousand (900,000) shares during any three-calendar-year
period.
|
6.
|
Deferred Stock Rules and
Conditions
|
The
grant of Deferred Stock shall be upon the following rules and
conditions:
|
6.01
|
Deferred Stock
Grants:
Deferred Stock shall be evidenced by Deferred
Stock agreements. Such agreements shall conform to the
requirements of the Plan, contain the time and form of payment, and may
contain such other provisions (including provisions for the protection of
and/or the payment of
Deferred Stock
in the event of
a Change in Control
)
as set forth in Section 15.07.
|
6.02
|
Crediting of Deferred
Stock:
Upon determination of the number of shares of
Deferred Stock to be granted to an Awardee the Committee shall direct that
the same be credited to the Awardee’s account on the books of the Company
but that issuance and delivery of
shares
shall be deferred until the date or
dates provided in
this Plan and the
applicable Deferred Stock agreements
. Prior to issuance
and delivery hereunder the Awardee shall have no rights as a stockholder
with respect to any shares of Deferred Stock credited to his or her
account.
|
6.03
|
Payment Equivalent to
Dividends:
During the period that shares of Deferred
Stock remain credited to the account of an Awardee and before their
issuance and delivery, the Company shall pay or accrue to the Awardee on
each date dividends on Common Stock are paid, a sum of money equal to what
would have been received if the shares of Deferred Stock credited to the
account had been owned
("Dividend
Equivalents")
, subject to such conditions as the Committee may deem
appropriate.
The time and form of
such payment of the Dividend Equivalents shall be specified in the
Deferred Stock
agreements.
|
6.04
|
Delivery:
Subject
to the terms and conditions described herein, the shares of Deferred Stock
credited to the account of an Awardee shall be issued and delivered to the
Awardee in one or more installments
on
such date(s) as
specified
in the Deferred Stock
agreements.
|
7.
|
Restricted Stock Rules and
Conditions
|
The
grant of Restricted Stock shall be upon the following rules and
conditions:
|
7.01
|
Restricted Stock
Grants:
Restricted Stock shall be evidenced by
Restricted Stock agreements. Such agreements shall conform to
the requirements of the Plan and may contain such other provisions
(including provision for the protection of Restricted Stock in the
event of
a Change in Control as set forth
in Section
15.07).
|
7.02
|
Issuance of Restricted
Stock:
Upon determination of the number of shares of
Restricted Stock to be granted to an Awardee the Committee shall direct
that a certificate representing the number of shares of Common Stock be
issued to the Awardee with the Awardee as the registered
owner. The certificate representing such shares shall either be
legended as to sale, transfer, assignment, pledge or other encumbrances
during the restricted period or deposited by the Awardee, together with a
stock power endorsed in blank, with the
Company.
|
7.03
|
Dividends and Voting
Rights:
During the restricted period the Awardee shall
have the right to receive dividends from and to vote the shares of
Restricted Stock.
|
7.04
|
Delivery:
The
Restricted Stock agreement shall specify the duration of the restricted
period and the performance and/or employment conditions under which the
Restricted Stock may be forfeited to the Company. At the end of
the restricted period the restrictions imposed hereunder shall lapse with
respect to the number of shares of Restricted Stock as determined by the
Committee, and the legend shall be removed or the shares delivered, as the
case may be, with respect to such number. The Committee may, in
its sole discretion, modify or accelerate the
vesting
of
shares of Restricted
Stock.
|
8.
|
Option Rules and
Conditions
|
The
grant of Options shall be upon the following rules and
conditions:
|
8.01
|
Option
Grants:
Options shall be evidenced by Option
agreements. Such agreements shall conform to the requirements
of the Plan, and may contain such other provisions (including restrictions
upon the exercise of the Option
and
provisions for the protection of Options in the event of a Change in
Control
).
|
8.02
|
Option
Price:
Except for adjustments permitted by Section 10,
the price at which Common Stock may be purchased upon exercise of an
Option shall be determined by the Committee, but shall be not less than
the greater of the Fair Market Value of such shares on the date the Option
is granted or the par value of such Common
Stock.
|
8.03
|
Terms of
Options:
The Option agreements shall specify when an
Option may be exercisable and the terms and conditions applicable in the
event of the Awardee’s
Separation from
Service
during the Option’s term. In the case of
Separation
from
Service
during the Option’s term, in no
event shall an Option term be extended beyond the term for exercise
originally specified in the Option agreement. In any case, the
term of an Option shall in no event be greater than ten years, and no
Option may be exercisable less than one year from date of
grant.
|
8.04
|
Incentive Stock
Option:
Each provision of the Plan and each Option
agreement relating to an Incentive Stock Option shall be construed so that
each Incentive Stock Option shall be incentive stock option as defined in
Section 422A of the Internal Revenue Code of 1986 as amended or any
statutory provision that may replace such Section,
and
any provisions thereof that can not be
so construed shall be disregarded. In no event may an Awardee
be granted Incentive Stock Options which do not comply with such grant and
vesting limitations as may be prescribed by Section 422A(b)(7) of the
Internal Revenue Code of 1986 as amended, or any successor section or
limitation and any implementing
regulations.
|
8.05
|
Payment of Option
Price:
The Option price of the shares of Common Stock
for which an Option shall be exercised shall be paid in full in cash at
the time of the exercise or, with the consent of the Committee, in whole
or in part in Common Stock valued at Fair Market Value. An
Awardee shall have no rights of a stockholder with respect to any shares
of Common Stock subject to an Option unless and until a stock certificate
of such shares shall have been issued to him or
her.
|
9.
|
Stock Appreciation
Rights
|
The
grant of Stock Appreciation Rights (“SARs”) shall be subject to the
following rules and conditions:
|
9.01
|
Stock Appreciation Right
Grants:
Stock Appreciation Rights are rights to receive
a payment in cash, Common Stock, Restricted Stock or Deferred Stock as
selected by the Committee and shall be set forth in Stock
Appreciation Right agreements. Stock Appreciation
Rights are
determined by the appreciation
in Common Stock. Such agreements shall conform to the
requirements of the Plan.
A
SAR may be granted in tandem
with all or a portion of a related stock option under the Plan (“Tandem
SAR”), or may be granted separately (“Freestanding
SAR”).
|
9.02
|
SAR
Price:
The exercise price of a Tandem SAR shall be the
option price under the related stock option. The exercise price
of a Freestanding SAR shall be not less than 100% of the fair market value
of the Common Stock, as determined by the Committee on the date of grant
of the Freestanding SAR. Notwithstanding the foregoing, the
Committee may unilaterally limit the appreciation in value of the Common
Stock attributable to the SAR at any time prior to its
exercise.
|
9.03
|
Exercise of
SAR:
A Tandem SAR and a Freestanding SAR shall entitle
the recipient to receive a payment equal to the excess of the fair market
value of the shares of Common Stock covered by the SAR on the date of
exercise over the exercise price of the SAR or such lesser amount as
determined by the Committee. Such payment may be in cash, in
shares of Common Stock, in shares of Deferred Stock, Restricted Stock or
any combination, as the Committee shall determine. Upon
exercise of a Tandem SAR as to some or all of the shares covered by the
grant, the related stock option shall be canceled automatically to the
extent of the number of shares covered by such exercise, and such shares
shall no longer be available for grant under Section
8. Conversely, if the related stock option is exercised as to
some or all of the shares covered by the grant, the related Tandem SAR, if
any, shall be canceled automatically to the extent of the number of shares
covered by the stock option exercise. To the extent an SAR (or
the related stock option) has not been exercised on its expiration, it
will be exercised automatically and paid in the form determined by the
Committee.
|
9.04
|
Terms of
SAR:
SARs shall be subject to the same terms and
conditions applicable to options as stated in Section
8.03. SARs shall also be subject to such other terms and
conditions not inconsistent with the Plan as shall be determined by the
Committee.
|
10.
|
Adjustments Upon Changes in
Capitalization
|
In
the event of a reorganization, recapitalization, stock split, stock
dividend, combination of shares, merger, consolidation or any other change
in the corporate structure of the Company affecting Common Stock, or a
sale by the Company of all or part of its assets, or any distribution to
stockholders other than a normal cash dividend, the Board of Directors
shall make appropriate adjustment in the number and kind of shares
authorized by the Plan. No fractional shares of Common Stock shall be
issued pursuant to such an adjustment, however, and the Fair Market Value
of any fractional shares resulting from adjustments pursuant to this
Section shall be paid in cash to the Awardee at the time of exercise of an
Option
or SAR, the delivery of
deferred shares, or the lifting of restrictions on restricted stock.
Notwithstanding anything in this
Section 10 to the contrary, an adjustment to an Option or SAR under this
Section 10 shall be made in a manner that will not result in the grant of
a new Option or SAR under Code Section
409A
.
|
11.
|
Effective Date, Termination and
Amendment
|
The
Plan became effective on May 12, 1988, by approval of Company
shareholders. The Plan shall remain in full force and effect
until terminated by the Board of Directors, who shall have the power to
amend, suspend or terminate the Plan at any time, provided that no such
amendment shall be made without stockholder approval which
shall:
|
11.01
|
Increase
(except as provided in Section 10) the total number of shares available
for issuance pursuant to the Plan.
|
11.02
|
Change
the class of employees eligible to be
Awardees.
|
11.04
|
Withdraw
the administration of the Plan from the
Committee.
|
11.05
|
Change
the provisions of this Section
11.
|
12.
|
Forfeiture
|
Awards
may be forfeited if the Awardee terminates his or her employment with the
Company, a Subsidiary or an Affiliate for any reason other than death,
disability, retirement or a special separation situation as defined in the
Terms and Conditions. Awards may furthermore be forfeited by an
Awardee if the Committee determines that the Awardee has at anytime
engaged in any activity harmful to the interest of or in competition with
the Company, its Subsidiaries or Affiliates or accepts employment with a
competitor.
|
13.
|
Non-Assignability
|
Awards
may not be pledged, assigned or transferred for any reason during the
Awardee’s lifetime, and any attempt to do so shall be void and the
relevant Award shall be forfeited.
|
14.
|
Beneficiary upon Awardee’s
death
|
An
Awardee’s Award shall be transferable at his or her death to the
beneficiary designated by the Awardee on forms prescribed by and filed
with the Committee. Upon the death of an Awardee,
such beneficiary shall succeed to the rights of the Awardee. If
no such designation of a beneficiary has been made, the Awardee’s Awards
shall succeed to his or her legal representative and shall be transferable
by will or pursuant to the laws of descent and
distribution.
|
15.
|
General
Provisions
|
15.01
|
Nothing
contained in the Plan, or in any Award granted pursuant to the Plan, shall
confer upon any Employee any right with respect to continuance of
employment by the Company, a Subsidiary or Affiliate, nor interfere in any
way with the right of the Company, a Subsidiary or Affiliate to terminate
the employment of any Employee at any time with or without assigning any
reason therefor.
|
15.02
|
For
purposes of this Plan, transfer of employment between the Company and its
Subsidiaries and Affiliates shall not be deemed termination of
employment.
|
15.03
|
Appropriate
provision may be made for all taxes required to be withheld in connection
with any Award, the exercise thereof and the transfer of shares of Common
Stock in respect of any federal, state or local withholding
taxes whether domestic or foreign. In the case of the payment
of Awards in the form of Common Stock, the Company shall have the right to
retain the number of shares of Common Stock whose fair market value equals
the amount to be withheld.
|
15.04
|
If
any day on or before which action under the Plan must be taken falls on a
Saturday, Sunday or legal holiday, such action may be taken on the next
succeeding day not a Saturday, Sunday or legal
holiday.
|
15.05
|
Without
amending the Plan, awards may be granted to Employees who are foreign
nationals or employed outside the United States or both, on such terms and
conditions different from those specified in the Plan as may, in the
judgment of the Committee, be necessary or desirable to further the
purpose of the Plan.
|
15.06
|
To
the extent that federal laws (such as the Securities Exchange Act of 1934,
the Internal Revenue Code of 1986 or the Employee Retirement Income
Security Act of 1974) do not otherwise control, the Plan and all
determinations made and actions taken pursuant hereto shall be governed by
the law of Delaware and construed
accordingly.
|
15.08
|
Notwithstanding
any other provision of the Plan to the
contrary:
|
(i)
|
Deferred
Stock:
Upon the occurrence of a Change in
Control, an Awardee’s right to receive the number of shares of
Deferred Stock credited to the account of the Awardee shall not be
forfeitable under any circumstances.
In the event an Awardee incurs an involuntary
Separation from Service during the two-year period following the Change in
Control, to the extent such Separation from Service occurs prior to the
payment date set forth in the Awardee's applicable Deferred Stock
agreement, then the
Company shall deliver to the Awardee the
number of
shares of Deferred Stock credited
to the account of the Awardee on the thirtieth day following
such Separation from
Service
.
|
(ii)
|
Restricted
Stock:
Upon the occurrence of a Change in Control, all
of the restrictions on Restricted Stock shall lapse and be of no effect
whatsoever and such shares shall not thereafter be forfeitable under any
circumstances. The Company shall deliver to the holder of shares
of Restricted Stock certificates representing the number of
shares
|
(iii)
|
Management Objectives for
Certain Awards of Deferred Stock and Restricted
Stock:
Any Award of Deferred Stock or Restricted Stock
may specify management objectives which, if achieved, will result in the
vesting
of Deferred Stock, or
termination or early termination of the applicable restrictions in the
case of Restricted Stock. Any Award that specifies management
objectives shall specify a minimum acceptable level of achievement in
respect of the specified management objective below which no payment will
be made in the case of Deferred Stock, or there will be a complete
forfeiture of shares in the case of Restricted
Stock. Management objectives may be described in terms of
Company-wide objectives or objectives that are related to the performance
of the individual Employee or Subsidiary in which the Employee is
employed. The management objectives may be relative to the
performance of other companies or entities. If any individual
is, or is determined by the Committee to be likely to become, a covered
employee within the meaning of Section 162(m) of the Internal Revenue
Code, then Awards to that individual that specify management objectives
shall be based on specified levels of, or growth in, one or more of the
following criteria: (i) earnings, (ii) earnings per share,
(iii) share price, (iv) revenues, (v) total shareholder return, (vi)
return on invested capital, equity, or assets, (vii) operating margins,
(viii) sales growth, (ix) productivity improvement, (x) market share, and
(xi) economic profit. Except as may be permitted under Section
162(m) of the Internal Revenue Code of 1986 as amended, or any successor
provision, the Committee may not adjust management objectives after the
grant of any Award that specifies management
objectives.
|
1.
|
Establishment and Purpose of
the Plan:
The Dow Chemical Company 1994 Executive
Performance Plan is hereby established upon the following terms and
conditions. The purpose of the Plan is to recognize and reward on an
annual basis the individual and team performance of Executive Officers of
The Dow Chemical Company toward the overall profitability of the
Company.
|
2.03.
|
Cash:
Funds in U.S.
dollars or such other currency used as a medium of payment for an annual
Executive Performance Award. Conversion from the U.S. dollar to other
currencies shall be at the intercompany exchange rate in effect at the
time of payment.
|
2.04.
|
Change in Control:
For
purposes of this Plan, a “Change of Control” shall be deemed to have
occurred on: (a) the date that any one person, or more than one person
acting as a group acquires, ownership of stock of The Dow Chemical Company
that, together with stock held by such person or group, constitutes more
than 50% of the total fair market value or total voting power of the stock
of The Dow Chemical Company, (b) the date that a majority of the members
of the Board of Directors of The Dow Chemical Company is replaced during
any 12-month period by directors whose appointment or election is not
endorsed by a majority of the directors before the date of the appointment
or election, (c) the date that any one person, or more than one person
acting as a group, acquires (or has acquired during the 12-month period
ending on the date of the most recent acquisition by such person or
persons) ownership of stock of The Dow Chemical Company possessing 30% or
more of the total voting power of the stock of such corporation, (d) the
date that any one person, or more than one person acting as a group,
acquires (or has acquired during the 12-month period ending on the date of
the most recent acquisition by such person or persons) assets from The Dow
Chemical Company that has a total gross fair market value equal to or more
than 40% of the total gross fair market value of all of the assets of The
Dow Chemical Company immediately before such acquisition or acquisitions,
provided that the following asset transfers shall not result in a Change
of Control: (i) a transfer of assets to a
stockholder of The Dow Chemical Company in exchange for or with respect to
its stock, (ii) a transfer to a corporation, 50% or more of the
total value or voting power of which is owned, directly or indirectly, by
The Dow Chemical Company, (iii) a transfer to a person, or more than one
person acting as a group, that owns 50% or more of the stock of The Dow
Chemical Company, or (iv) a transfer to an entity, at least 50%
of the total value or voting power of which is owned, directly or
indirectly, by a person described in clause
(iii).
|
|
This
definition of “Change of Control” is intended to conform to the definition
of a “change in ownership or effective control of a corporation, or a
change in the ownership of a substantial portion of the assets of a
corporation” as defined under Section 409A of the Internal Revenue Code of
1986, as amended, and any subsequent authority issued pursuant thereto,
and no corporate event shall be considered a Change of Control unless it
meets such requirements.
|
2.05.
|
Commission:
The
Securities and Exchange Commission.
|
2.06.
|
Committee:
The
Compensation Committee of the Board of Directors, or such other committee
designated by the Board of Directors, designated to administer the Plan
under Section 4, which committee shall have at least three members, each
of which shall be a Disinterested Person and an Outside
Director.
|
2.07.
|
Common Stock:
The Common
Stock of the Company, par value $2.50 per share, or such other class or
kind of shares or other securities as may be applicable under Section
11.
|
2.08.
|
Company:
The Dow
Chemical Company, a Delaware corporation, or any successor to
substantially all its business.
|
2.09.
|
Elective Deferral:
A
Performance Award that is designated to be received under The Dow Chemical
Company Elective Deferral Plan (“Elective Deferral Plan”) instead of
immediately in cash.
|
2.10.
|
Deferred Stock:
A
Performance Award that is designated to be received in Deferred Stock is
Common Stock received at a time in the future on a date or dates selected
by the Committee. The number of shares of Deferred Stock is determined by
dividing the Performance Award amount by the Fair Market Value of Common
Stock as of a date to be specified by the Compensation Committee or its
delegate, which date must be in the year prior to the year for which the
Performance Award may be earned. Fractional units are paid in Cash. The
Awardee will receive from the Company Dividend Equivalents on shares of
Deferred Stock from the date the Performance Award is granted pursuant to
Section 6.03 until the date the actual shares are issued to the
Awardee.
|
2.11.
|
Disinterested Person:
A
person described in Rule 16b-3 promulgated by the Securities and Exchange
Commission under the Exchange Act, or any successor definition adopted by
the Commission.
|
2.12.
|
Dividend Equivalents:
An
amount equal to any actual dividend paid by the Company on one share of
Common Stock.
|
2.13.
|
This
paragraph is intentionally left
blank.
|
2.14
.
|
Exchange Act:
The
Securities Exchange Act of 1934, as
amended.
|
2.15.
|
Executive Officer:
Any
person, who, at the time a Performance Award is granted pursuant to
Section 6.03, is subject to the provisions of Item 402, Regulation S-K, of
the Exchange Act, and the provisions of Section 162(m) of the Internal
Revenue Code.
|
2.16.
|
Fair Market Value:
As
applied to a specific date, the closing price of Common Stock, as reported
on the consolidated transaction reporting system for the New York Stock
Exchange issues on such date, or if Common Stock was not traded on such
date, on the next preceding day on which the Common Stock was
traded.
|
2.17.
|
Internal Revenue Code:
The Internal Revenue Code of 1986, as
amended.
|
2.18.
|
Negative Discretion:
Other factors to be applied by the Committee in determining the size of
the Performance Award if the Performance Goal has been achieved if, in the
Committee's sole judgment, such application is appropriate in order to act
within the best interest of the Company and its stockholders. The Negative
Discretion factors include the Company's performance as measured primarily
by earnings per common share, the achievement of measurable individual
performance objectives established by the Committee and communicated to
the Executive Officer in advance of the period in which the service is to
be performed, and competitive pay practices. In no event shall any
discretionary authority granted to the Committee by the Plan be used to
increase the Performance Award above the Maximum Amount Payable
established in Section 6.02 of the
Plan.
|
2.19.
|
Net Income:
Net income
available for common stockholders as reported in the Company's audited
consolidated financial statements, but not including extraordinary items,
the cumulative effect of accounting changes and the after-tax amount of
any special or restructuring charges reported by Dow Corning
Corporation.
|
2.20.
|
Outside Director:
A
person defined in proposed Regulation 1.162-27 (e)(3) promulgated under
the Internal Revenue Code, or any successor definition
adopted.
|
2.21.
|
Performance Award:
An
award of Cash, Deferred Cash, Deferred Stock, Dividend Units or any
combination thereof under the Plan.
|
2.22.
|
Performance Goal:
The
required performance upon which payment of a Performance Award is
contingent, as described in Section 6 of the Plan. Its accomplishment must
be determinable by a third party with knowledge of the relevant
facts.
|
2.23.
|
Plan:
The Dow Chemical
Company 1994 Executive Performance Plan herein set forth, as the same may
from time to time be amended.
|
2.24.
|
Service:
The Internal
Revenue Service.
|
3.
|
Eligibility:
Any
Executive Officer of the Company as defined herein is eligible to receive
an Award under the Plan.
|
4.
|
Plan
Administration
|
4.01.
|
Administrator:
The Plan
shall be administered by the
Committee.
|
4.02.
|
Administrative Powers:
The Committee, or its delegate shall have the full power to interpret and
administer the Plan and full authority to act in selecting the Executive
Officers to whom Performance Awards will be granted, in applying Negative
Discretion pursuant to Section 6.02 of the Plan, in determining the type
and amount of Performance Award to be granted to each such Executive
Officer, the terms and conditions of Performance Awards granted under the
Plan and the terms of agreements which will be entered into with Awardees.
The Committee shall have the power to make regulations for carrying out
the Plan and to make changes in such regulations as they from time to time
deem proper. Any interpretation by the Committee of the terms and
provisions of the Plan and the administration thereof, and all action
taken by the Committee, shall be final, binding and conclusive on the
Company, its stockholders, employees, Executive Officers, their respective
legal representatives, successors and assigns and upon all other persons
claiming under or through any of
them.
|
4.03.
|
Limitation on Liability:
Members of the Board of Directors and members of the Committee and their
delegates acting under the Plan shall be fully protected in relying in
good faith upon the advice of counsel and shall incur no liability except
for gross negligence or willful misconduct in the performance of their
duties.
|
5.
|
Election of the Form of Award:
Prior to January 1 of any fiscal year, the Executive Officer shall
select the form of payment for any Performance Award that may be earned
for that fiscal year's service. The forms of payment available
to Awardees are as follows. For Awardees who are eligible under
the Elective Deferral Plan, the choices are: cash, or receiving the Award
through the Elective Deferral Plan. For Awardees who are not
eligible for the Elective Deferral Plan, the choices are: cash, or
receiving Deferred Stock.
|
6.
|
Performance
Goal and Determination of Performance
Award
|
6.01.
|
Performance Goal:
In
order for any Executive Officer to earn a Performance Award under the Plan
for any given fiscal year, Net Income in excess of U.S. $700 million for
that same fiscal year must be achieved. The amount of the maximum annual
Performance Award payable for each Executive Officer (the "Maximum Amount
Payable") is dependent upon the amount of the Company's Net Income for the
subject fiscal year, increasing only in proportion to increases in Net
Income. In no event shall a Performance Award under the Plan be payable to
any Executive Officer in any year in which the Net Income is less than
$700 million.
|
6.02.
|
Maximum Amount Payable:
No single individual Performance Award for any single year shall exceed
two tenths of one percent (0.2%) of the Company's Net Income for that
same fiscal year. In determining the actual size of any individual
Performance Award, the Committee may reduce the amount of the Performance
Award below the Maximum Amount Payable through the use of Negative
Discretion, if in its sole judgment, such reduction is appropriate. The
Committee may not increase the amount of a Performance Award above the
Maximum Amount Payable under the Plan through the use of positive
discretion.
|
6.03.
|
Determination of Performance
Award:
Each year, when the Net Income for the prior fiscal year has
been calculated, the Committee shall: (1) determine whether the
Performance Goal for the prior fiscal year has been met and so certify in
writing in the Committee minutes or elsewhere, (2) establish the
individual Maximum Amounts Payable under the terms of the Plan, (3) review
each Executive Officer's performance, (4) apply Negative Discretion as the
Committee may deem appropriate, (5) calculate the amount of each
Performance Award to be awarded that year under the Plan and (6) grant any
such Performance Awards. Executive Officers who leave the employment of
the Company during the subject fiscal year due to normal or early
retirement may be paid a pro rata share of the Performance Award earned
through the date of retirement pursuant to the terms of this Section 6.03
during the time they were Executive Officers, provided they are not
otherwise within the forfeiture provisions of Section
14.
|
7.
|
Shares Subject to the
Plan:
Subject to adjustment as provided in Section 11,
the total number of shares of Common Stock available under the Plan is
100,000 shares. Shares issued hereunder may consist of authorized and
unissued shares or treasury shares. If any shares subject to any
Performance Award granted hereunder are forfeited or such Performance
Award otherwise terminates without the issuance of such shares or of other
consideration in lieu of such shares, the shares subject to such
Performance Award, to the extent of any such forfeiture or termination,
shall again be available for grant under the
Plan.
|
8.
|
Cash:
The
grant of an Award of cash shall be paid to the Awardee between January 1
and March 15 of the year following the performance
year.
|
9.
|
Elective Deferral
Plan:
The grant of an Award through the Elective
Deferral Plan shall be governed by the terms of the Elective Deferral
Plan.
|
10.
|
Deferred Stock Rules and
Conditions:
The grant of Deferred Stock shall be upon
the following rules and conditions:
|
10.01.
|
Deferred Stock
Agreements:
Deferred Stock shall be evidenced by Deferred Stock
agreements. Such agreements shall conform to the requirements of the Plan
and may contain such other provisions (including provisions for the
protection of Deferred Stock in the event of mergers, consolidations,
dissolutions and liquidations affecting either the agreement or the stock
issued thereunder) as the Committee shall deem
advisable.
|
10.02.
|
Crediting of Deferred
Stock:
Upon determination of the number of shares of Deferred Stock
to be granted to an Awardee, the Committee shall direct that the same be
credited to the Awardee's account on the books of the Company, but that
issuance and delivery of the same shall be deferred until the date or
dates provided in Section 10.04 hereof. Prior to issuance and delivery
hereunder, the Awardee shall have no rights as a stockholder with respect
to any shares of Deferred Stock credited to his or her
account.
|
10.03.
|
Payment of Dividend
Equivalents:
During the period that shares of Deferred Stock remain
credited to the account of an Awardee and before their issuance and
delivery, the Company shall pay or accrue to the Awardee, on each Common
Stock dividend record date, a sum of cash equal to what would have been
received if the shares of Deferred Stock credited to the account had been
owned, subject to such conditions as the Committee may deem
appropriate. Dividend equivalents will be paid as specified in
the applicable Deferred Stock
agreement.
|
10.04.
|
Delivery:
Subject to the
terms and conditions described herein, the shares of Deferred Stock
credited to the account of an Awardee shall be issued and delivered to the
Awardee in one or more installments beginning with such date as the
Committee may determine, as specified in the applicable Deferred Stock
agreement.
|
11.
|
Adjustments Upon Changes in
Capitalization:
In the event of a reorganization, recapitalization,
stock split, stock dividend, combination of shares, merger, consolidation
or any other change in the corporate structure of the Company affecting
Common Stock, or a sale by the Company of all or part of its assets, or
any distribution to stockholders other than a normal cash dividend, the
Board of Directors shall make appropriate adjustment in the number and
kind of shares authorized by the Plan and any adjustments to outstanding
Awards as it determines appropriate. No fractional shares of Common Stock
shall be issued pursuant to such adjustment, however, and the Fair Market
Value of any fractional shares resulting from adjustments pursuant to this
section shall be paid in cash to the
Awardee.
|
12.
|
Effective Date and Termination
of the Plan:
The Plan shall be effective as of January 1, 1994,
subject to approval by the Company's stockholders. The Plan shall remain
in full force and effect until terminated by the Board of
Directors.
|
13.
|
Amendment of the Plan:
The Board of Directors shall have the power to amend, suspend or
terminate the Plan at any time except for any amendment requiring
stockholder approval pursuant to the provisions of the Exchange Act or the
Internal Revenue Code.
|
14.
|
Forfeiture:
Prior to a
Performance Award grant pursuant to Section 6.03, Performance Awards may
be forfeited if the Awardee terminates his or her employment for any
reason other than death or retirement. Performance Awards may also be
forfeited if the Committee determines that the Awardee has at any time
engaged in activity harmful to the interest of or in competition with the
Company, its subsidiaries or affiliates, except that the Committee shall
have the authority to provide for the continuation of Performance Awards
in whole or in part whenever in its judgment it shall determine that such
continuation is in the best interests of the Company. After the
Performance Award grant has been made pursuant to Section 6.03, the award
is non-forfeitable.
|
15.
|
Non-Assignability:
Performance Awards may not be pledged, assigned or transferred for
any reason during the Awardee's lifetime, and any attempt to pledge,
assign or transfer shall be void and the relevant Performance Award shall
be forfeited, other than by will or the laws of descent and distribution
or pursuant to a qualified domestic relations order as defined by the
Internal Revenue Code, or Title I of the Employee Retirement Income
Security Act, or the rules thereunder. The naming of a beneficiary does
not constitute a transfer.
|
16.
|
Beneficiary Upon Awardee's
Death:
An Awardee's Performance Award shall be transferable at his
or her death to the beneficiary designated by the Awardee on forms
prescribed by and filed with the Committee, but not including Performance
Awards for which an election has been made to receive Dividend Units. Upon
the death of an Awardee, such beneficiary shall succeed to the rights of
the Awardee. If no such designation of a beneficiary has been made, the
Performance Awards shall succeed to his or her legal representatives and
shall be transferable by will or pursuant to the laws of descent and
distribution. No provision of this Section 16 shall however reduce
Performance Goal requirements of Section 6. Death of the Awardee prior to
the end of the performance period may result in a reduced Performance
Award, based upon a pro rata evaluation by the Committee of the portion of
the goal achieved prior to the Awardee's death. Payment will
occur in the same time and in the same manner as if the awardee had not
died prior to completion of the performance
period.
|
17.
|
General
Provisions
|
17.01.
|
Nothing
contained in the Plan, or in any Performance Award granted pursuant to the
Plan, shall confer upon any Executive Officer any right with respect to
continuance of employment by the Company, a subsidiary or affiliate, nor
interfere in any way with the right of the Company, a subsidiary or
affiliate to terminate the employment of any Executive Officer at any time
with or without assigning any reason therefore, nor confer any right with
respect to continuance as an Executive Officer, member of the Executive
Committee or member of the Board of
Directors.
|
17.02.
|
Appropriate
provision may be made for all taxes required to be withheld in connection
with any Performance Award, the maturity thereof and the transfer of
shares of Common Stock with respect to any federal, state or local
withholding taxes whether domestic or foreign. In the case of the payment
of Performance Awards in the form of Common Stock, the Company shall have
the right to retain the number of shares of Common Stock whose Fair Market
Value equals the amount to be withheld or to allow the Awardee to pay the
withholding tax in such stock.
|
17.03.
|
If
any day on or before which action under the Plan must be taken falls on a
Saturday, Sunday or legal holiday, such action may be taken on the next
succeeding day not a Saturday, Sunday or legal
holiday.
|
17.04.
|
Without
amending the Plan, Performance Awards may be granted to Executive Officers
who are foreign nationals or employed outside the United States or both,
on such terms and conditions different from those specified in the Plan as
may, in the judgment of the Committee, be necessary or desirable to
further the purpose of the Plan or to accommodate differences in local
law, tax policy or custom. Moreover, the Committee may approve such
supplements to, or amendments, restatements or alternative versions of,
this Plan as it may consider necessary or appropriate for such purposes
without thereby affecting the terms of this Plan as in effect for any
other purpose; and the Secretary or any Assistant Secretary of the Company
is authorized to certify the approval of any such supplements, amendments,
restatements or alternative versions as though they were approved by the
shareholders of the Company provided, however, that no such supplements,
amendments, restatements or alternative versions shall (a) increase the
limitations contained in Section 6.02 of this Plan or (b) cause this Plan
to cease to satisfy any conditions of Rule 16b-3 under the Exchange Act or
Section 162(m) of the Internal Revenue
Code.
|
17.05
.
|
To
the extent the U.S. federal laws (such as the Securities Exchange Act of
1934, the Internal Revenue Code of 1986 or the Employee Retirement Income
Security Act of 1974, all as amended) do not otherwise control, the Plan
and all determinations made and actions taken pursuant hereto shall be
governed by the law of Delaware and construed
accordingly.
|
17.06.
|
The
Committee may amend any outstanding Performance Awards to the extent it
deems appropriate consistent with the reporting requirements of the
Exchange Act and the Internal Revenue Code. Such amendment may be
unilateral by the Company, except in the case of amendments adverse to the
Awardee, in which case the Awardee's consent is required to any such
amendment.
|
18.
|
Rule 16b-3 Transition:
The Plan is intended to comply with and be subject to Rule 16b-3 of
the Exchange Act, as in effect prior to May 1, 1991. The Committee may at
any time elect that the Plan shall be subject to Rule 16b-3 as in effect
on and after May 1, 1991.
|
19.
|
Awardees' Rights Unsecured:
The right of the Awardee or his or her designated beneficiary to
receive a distribution of Deferred Cash or Deferred Stock hereunder shall
be an unsecured claim against the general assets of the Company, and
neither the Awardee nor his or her designated beneficiary shall have any
rights in or against any amount credited to his or her account or any
other specific assets of the Company. All amounts credited to an account
shall constitute general assets of the Company and may be disposed of by
the Company at such time and for such purposes as it may deem appropriate.
An account may not be encumbered or assigned by an Awardee or any
beneficiary.
|
|
a.
|
is
employed by a Participating Employer to perform personal services in an
employer-employee relationship which is subject to taxation under the
Federal Insurance Contribution Act or similar federal statute;
and
|
|
b.
|
receives
payment for services performed for the Participating Employer directly
from the Company’s U.S. Payroll Department, or another Participating
Employer’s U.S. Payroll Department;
and
|
|
c.
|
is
either a Salaried individual who is classified by the Participating
Employer as having “regular full-time status” or “less-than-full-time
status”, or a Bargained-for individual who is classified by the
Participating Employer as having “regular full-time active status”,
and
|
|
d.
|
if
Localized, is Localized in the U.S.,
and
|
|
e.
|
if
on an international assignment, is either a U.S. citizen or Localized in
the U.S.
|
|
1.
|
Employees
enrolled in the Key Employee Insurance Program (“KEIP”) are not eligible
for active Employee or Retiree Company-Paid Life Insurance coverage,
except that on the later of “program completion date” or “retirement” (as
those terms are defined in KEIP), if the Employee would otherwise have
been eligible for coverage under the Company-Paid Life Insurance Plan, the
Employee may resume eligibility for the Plan;
and
|
|
2.
|
Employees
who were enrolled in The Dow Chemical Company Executive Split Dollar Life
Insurance Plan (“Dow Split Dollar”) on September 30, 2002, who have not
waived their rights under The Dow Chemical Company Executive Split Dollar
Life Insurance Agreement, are not eligible for coverage under the
Company-Paid Life Insurance Plan.
|
·
|
the
date the Group Policy ends;
|
·
|
the
date you no longer meet the eligibility requirements of the Plan;
or
|
·
|
the
date your employment ends.
|
·
|
the
amount of Company-Paid Life Insurance for you that ends under
the Group Policy less the amount of life insurance for which you become
eligible under any group policy within 31 days after the date insurance
ends under the Group Policy; or
|
·
|
$2,000.
|
·
|
Your
Spouse or Domestic Partner; or
|
·
|
Your
children; or
|
·
|
Your
parent(s); or
|
·
|
Your
sibling(s).
|
·
|
On
or before your employment date, with coverage to begin on your first day
of active employment if you provide a copy of your birth certificate or
other proof of your age that the Plan Administrator deems
appropriate. If you do not provide proof of your age that
is satisfactory to the Plan Administrator within the time required by the
Plan Administrator, you will not be
covered.
|
·
|
Within
90 days after your first day of active employment with coverage to begin
on your enrollment date if you provide a copy of your birth certificate or
other proof of your age that the Plan Administrator deems
appropriate. If you do not provide proof of your age that is
satisfactory to the Plan Administrator within the time required by the
Plan Administrator, you will not be
covered.
|
·
|
Within
90 days of a Change-in-Status, provided you are Actively at Work. Coverage
begins on the date your enrollment form is received by the Plan, or you
enroll by calling the HR Service Center, provided the Plan receives proof
of Change-in-Status and proof of age that is satisfactory to the Plan
Administrator within the time required and you are Actively at
Work. If you do not provide the requisite proofs that are
satisfactory to the Plan Administrator within the time required by the
Plan Administrator, you will not be
covered.
|
·
|
During
the Choices enrollment period, you will be allowed to increase your
coverage by 1 increment (one-half times (1/2X) base annual salary)
provided you are Actively at Work on the January 1 following the Choices
enrollment period and you do not exceed the amount you are eligible to
enroll in. If you are not Actively at Work on the January
1 following the Choices enrollment period, any increase to your life
insurance will not be effective until you return to Active
Work.
|
·
|
At
any other time you are Actively at Work, by providing proof of
insurability, your coverage begins on the date that MetLife accepts your
proof of insurability. MetLife will pay for the fee of a
paramedical exam, if requested by MetLife, with no cost to the
employee/applicant when a MetLife physician is
used.
|
Failure
to provide the prerequisite proofs will result in cancellation of
coverage, including retroactive cancellation, and may require you to
reimburse the Plan for any benefits paid by the Plan. The Plan
Administrator may request proof of your age at any
time.
|
|
·
|
Events
that change your legal marital status, including Marriage, Domestic
Partnership, death of Spouse/Domestic Partner, divorce or annulment or
similar event with respect to a Domestic
Partnership.
|
|
·
|
Birth,
adoption, placement for adoption or death of
Dependent.
|
|
·
|
A
termination or commencement of employment by you, your Spouse/Domestic
Partner or Dependent.
|
|
·
|
A
reduction or increase in hours of employment by the Employee,
Spouse/Domestic Partner or
Dependent.
|
|
·
|
Dependent
satisfies or ceases to satisfy the requirements for unmarried
Dependents.
|
|
·
|
A
change in the place of residence or work for you, your Spouse/Domestic
Partner or Dependent.
|
|
·
|
Within
90 days of a change in your personal status, such as Marriage, Domestic
Partnership, a change in your Spouse's/Domestic Partner’s employment, or
the addition of a Dependent child, provided you are Actively at Work and
provided the HR Service Center receives proof of change in status that is
satisfactory to the Plan
Administrator.
|
|
·
|
At
any time you are Actively at Work, by providing proof of insurability to
MetLife. MetLife will pay for the fee of a paramedical exam, if requested
by MetLife, with no cost to the employee/applicant when MetLife a
physician is used.
|
|
·
|
During
Choices enrollment you may increase one increment (1/2X) without providing
proof of insurability, provided you are Actively at
Work.
|
·
|
the
amount of Employee-Paid Life Insurance for you that ends under
the Group Policy less the amount of life insurance for which you become
eligible under any group policy within 31 days after the date insurance
ends under the Group Policy; or
|
·
|
$2,000.
|
·
|
Your
Spouse or Domestic Partner; or
|
·
|
Your
children; or
|
·
|
Your
parent(s); or
|
·
|
Your
sibling(s).
|
|
·
|
at
least 15 days old:
|
|
·
|
under
age 25 and who is:
|
|
·
|
a
full-time student at an accredited school, college, or university that is
licensed in the jurisdiction where it is
located;
|
|
·
|
unmarried
|
|
·
|
supported
by You, and
|
|
·
|
not
employed on a full-time basis
|
This
term does not include any person
who:
|
|
·
|
is
in the military of any country or subdivision of any
country;
|
|
·
|
lives
outside the United States or Canada;
or
|
|
·
|
is
insured under the Group Policy as an
employee.
|
|
·
|
Already
covered as a dependent of another Dow Employee or Dow Retiree. All covered
children in a family must be enrolled by the same
parent.
|
|
·
|
Married
or ever was married.
|
|
·
|
Employed
full-time.
|
|
·
|
Age
25 years or older.
|
·
|
On
or before your date of hire, with coverage to begin on your first day of
work if you complete the enrollment form and submitted proof of Dependent
eligibility and proof of age. Failure to provide the required
proofs satisfactory to the Plan Administrator within the time required
will result in no coverage.
|
·
|
Within
90 days after your first day of active employment, with coverage to begin
on your submission of the completed enrollment form and proof of Dependent
eligibility and proof of age. Failure to provide the required
proofs satisfactory to the Plan Administrator within the time required
will result in no coverage.
|
·
|
Within
90 days of a Change-in-Status, provided you are Actively at
Work. Coverage begins on the date that the Plan receives your
enrollment form or you enroll by calling the HR Service
Center. Failure to provide the required proofs satisfactory to
the Plan Administrator within the time required will result in no
coverage.
|
·
|
During
the Choices Enrollment period, provided you are Actively at Work on the
January 1 following the Choices Enrollment period. You will be
allowed to increase your Dependent Spouse/Domestic Partner coverage by one
increment. There is no incremental limit on increased coverage for
Dependent child(ren) during Choices Enrollment. If you are not
Actively at Work on the January 1 following the Choices Enrollment period,
any increase in life insurance will not be effective until you return to
Active Work. Proof of eligibility must be submitted prior to
December 31 of the year before coverage
begins.
|
·
|
At
any other time you are Actively at Work, by providing proof of
insurability. Your coverage begins on the date that MetLife accepts your
proof of insurability. MetLife will pay for the fee of a paramedical exam,
if requested by MetLife, with no cost to the employee/applicant when a
MetLife physician is used.
|
|
·
|
Events
that change your legal marital status, including Marriage, Domestic
Partnership, death of Spouse/Domestic Partner, divorce or annulment or
similar event with respect to a Domestic
Partnership.
|
|
·
|
Birth,
adoption, placement for adoption or death of
Dependent.
|
|
·
|
A
termination or commencement of employment by you, your Spouse/Domestic
Partner or Dependent.
|
|
·
|
A
reduction or increase in hours of employment by the Employee,
Spouse/Domestic Partner or
Dependent.
|
|
·
|
Dependent
satisfies or ceases to satisfy the requirements for unmarried
Dependents.
|
|
·
|
A
change in the place of residence or work for you, your Spouse/Domestic
Partner or Dependent.
|
|
|
Amount
of Coverage
|
·
|
Spouse/Domestic
Partner insurance coverage ranges from a minimum of $10,000 to a maximum
of $250,000 in increments of $10,000. The monthly cost is based on your
Spouse’s/Domestic Partner’s age, the amount of insurance and whether your
Spouse/Domestic Partner is a “non-tobacco
user”.
|
·
|
For
eligible Dependent child(ren) there are three levels of coverage: $2,000,
$5,000 or $10,000.
|
·
|
LTD
participants are not eligible for Spouse/Domestic Partner and Dependent
Life Coverage.
|
·
|
At
any time you are Actively at Work, by providing proof of insurability to
MetLife
.
MetLife
will pay for the fee of a paramedical exam, if requested by MetLife, with
no cost to the employee/applicant when a MetLife physician is
used.
|
·
|
Within
90 days of a change in status event, such as Marriage, Domestic
Partnership, divorce, Termination of Domestic Partnership or the addition
of a Dependent child, provided you are Actively at Work and provided the
Plan receives proof of the change in status that is satisfactory to the
Plan Administrator.
|
·
|
During
Choices enrollment, if you are Actively at Work, you may increase your
Spouse’s/Domestic Partner’s coverage one increment without showing proof
of insurability.
|
·
|
the
amount of Life Insurance for the Dependent that ends under the MetLife
group policy less the amount of life insurance for Dependents for which
you become eligible under any group policy within 31 days after the date
insurance ends under the Dependent Life Insurance provisions of
the MetLife group policy;
or
|
·
|
$2,000.
|
·
|
Your
Spouse or Domestic Partner; or
|
·
|
Your
children; or
|
·
|
Your
parent(s); or
|
·
|
Your
sibling(s).
|
·
|
Examine,
without charge, at the Plan Administrator’s office and at other specified
locations, the Plan Documents and the latest annual reports filed with the
U.S. Department of Labor and available at the Public Disclosure Room of
the Pension and Welfare Benefit
Administration.
|
·
|
Obtain,
upon written request to the Plan Administrator, copies of the Plan
Documents and Summary Plan Descriptions. The Administrator may
charge a reasonable fee for the
copies.
|
·
|
Receive
a summary of each Plan’s annual financial report. The Plan
Administrator is required by law to furnish each Participant with a copy
of this summary annual report.
|
|
1)
|
to
provide benefits for Participants in accordance with the Plan,
and/or
|
|
2)
|
to
pay third parties to provide such benefits,
and/or
|
|
3)
|
to
pay expenses of the Plan and/or the Trust holding the Plan's assets,
and/or
|
|
4)
|
To
provide cash for Participants, as long as the cash is not provided
disproportionately to officers, shareholders, or Highly Compensated
Employees.
|
Plan
Sponsor:
|
The
Dow Chemical Company
Employee
Development Center
Midland,
MI 48674
1-877-623-8079
|
||
Employer
Identification Number:
|
38-1285128
|
||
Plan
Number:
|
507
|
||
Group
Policy Number:
|
11700-G
|
||
Plan
Administrator:
|
The
Dow Chemical Company
Employee
Development Center
Midland,
MI 48674
1-877-623-8079
|
||
To
Apply For a Benefit Contact:
|
See
Claims Procedures Appendix to this SPD.
|
||
To
Appeal a Benefit Determination, File with:
|
See
Claims Procedures Appendix to this SPD.
|
||
To
Serve Legal Process, File With:
|
General
Counsel
The
Dow Chemical Company
Corporate
Legal Department
2030
Dow Center
Midland,
MI 48674
|
||
Claims
Administration:
|
Metropolitan
Life Insurance Company administers
claims
under a group policy issued to
The
Dow Chemical Company
MetLife,
Inc.
Group
Life Claims
Oneida
County Industrial Park
Utica,
NY 13504-6115
|
||
To
Serve Legal Process, File With:
|
General
Counsel
The
Dow Chemical Company
Corporate
Legal Department
2030
Dow Center
Midland,
MI 48674
|
||
Claims
Administration:
|
Metropolitan
Life Insurance Company administers claims under a group policy issued
to
The
Dow Chemical Company
MetLife,
Inc.
Group
Life Claims
Oneida
County Industrial Park
Utica,
NY 13504-6115
|
||
Plan
Year:
|
The
Plan's fiscal records are kept on a plan year beginning January 1 and
ending December 31
|
||
Funding:
|
Dow
pays the entire premium for the Plan. Benefits are funded
through a group insurance contract with MetLife, Inc The assets of the
“Program” may be used at the discretion of the Plan Administrator to pay
for any benefits provided under the “Program”, as the “Program” may be
amended from time to time, as well as to pay for any expenses of the
“Program”. Such expenses may include, and are not limited to,
consulting fees, actuarial fees, attorney fees, third party administrator
fees and other administrative
expenses.
|
Plan
Sponsor:
|
The
Dow Chemical Company
Employee
Development Center
Midland,
MI 48674
1-877-623-8079
|
||
Employer
Identification Number:
|
38-1285128
|
||
Plan
Number:
|
515
|
||
Group
Policy Number:
|
11700-G
|
||
Plan
Administrator:
|
The
Dow Chemical Company
Employee
Development Center
Midland,
MI 48674
1-877-623-8079
|
||
To
Apply For a Benefit Contact:
|
See
Claims Procedures Appendix to this SPD.
|
||
To
Appeal a Benefit Determination, File with:
|
See
Claims Procedures Appendix to this SPD.
|
||
To
Serve Legal Process, File With:
|
General
Counsel
The
Dow Chemical Company
Corporate
Legal Department
2030
Dow Center
Midland,
MI 48674
|
||
Claims
Administration:
|
Metropolitan
Life Insurance Company administers
claims
under a group policy issued to
The
Dow Chemical Company
MetLife,
Inc.
Group
Life Claims
Oneida
County Industrial Park
Utica,
NY 13504-6115
|
||
To
Serve Legal Process, File With:
|
General
Counsel
The
Dow Chemical Company
Corporate
Legal Department
2030
Dow Center
Midland,
MI 48674
|
||
Claims
Administration:
|
Metropolitan
Life Insurance Company administers claims under a group policy issued
to
The
Dow Chemical Company
MetLife,
Inc.
Group
Life Claims
Oneida
County Industrial Park
Utica,
NY 13504-6115
|
||
Plan
Year:
|
The
Plan's fiscal records are kept on a plan year beginning January 1 and
ending December 31
|
||
Funding:
|
Employees
pay the premiums. Benefits are funded through a group insurance contract
with MetLife. The assets of the “Program” may be used at the
discretion of the Plan Administrator to pay for any benefits provided
under the “Program”, as the “Program” may be amended from time to time, as
well as to pay for any expenses of the “Program”. Such expenses
may include, and are not limited to, consulting fees, actuarial fees,
attorney fees, third party administrator fees, and other administrative
expenses..
|
|
·
|
State
the name of the Employee, and also the name of the person (Employee,
Spouse/Domestic Partner, Dependent child, as applicable) for whom the
Eligibility
Determination
is being
requested
|
|
·
|
Name
the benefit plan for which the
Eligibility
Determination
is being
requested
|
|
·
|
If
the
Eligibility
Determination
is for the Employee’s Dependent, describe the
relationship for whom an
Eligibility
Determination
is being requested to the Employee (e.g.
Spouse/Domestic Partner, child,
etc.)
|
|
·
|
Provide
documentation of such relationship (e.g. marriage certificate, Statement
of Domestic Partnership, birth certificate,
etc)
|
|
·
|
Name
of Employee
|
|
·
|
Name
of Dependent or beneficiary, if the Dependent or beneficiary is the person
who is
appealing the Administrator’s
decision
|
|
·
|
Name
of the benefit Plan
|
|
·
|
Reference
to the Initial Determination
|
|
·
|
Explain
reason why you are appealing the Initial
Determination
|
|
a.
|
the
Participating Employer’s place of business;
or;
|
|
b.
|
an
alternate place approved by the Participating Employer;
or
|
|
c.
|
a
place to which the Participating Employer’s business requires you to
travel.
|
|
1.
|
the
two people must have lived together for at least twelve (12) consecutive
months immediately prior to receiving coverage for benefits under the
Plan, and
|
|
2.
|
the
two people are not Married to other persons either now, or at any time
during the twelve month period, and
|
|
3.
|
during
the twelve month period, and now, the two people have been and are each
other's sole domestic partner in a committed relationship similar to a
legal Marriage relationship and with the intent to remain in the
relationship indefinitely, and
|
|
4.
|
each
of the two people must be legally competent and able to enter into a
contract, and
|
|
5.
|
the
two people are not related to each other in a way which would prohibit
legal Marriage between opposite sex individuals,
and
|
|
6.
|
in
entering the relationship with each other, neither of the two people are
acting fraudulently or under duress,
and
|
|
7.
|
during
the twelve month period and now, the two people have been and are
financially interdependent with each other,
and
|
|
8.
|
each
of the two people have signed a statement acceptable to the Plan
Administrator and have provided it to the Plan
Administrator.
|
|
1.
|
Evidence
satisfactory to the Plan Administrator is provided that the two people are
registered as domestic partners, or partners in a civil union in a state
or municipality or country that legally recognizes such domestic
partnerships or civil unions, and
|
|
2.
|
each
of the two people have signed a statement acceptable to the
Plan
|
|
Administrator
and have provided it to the Plan
Administrator.
|
|
a.
|
is
employed by a Participating Employer to perform personal services in an
employer-employee relationship which is subject to taxation under the
Federal Insurance Contribution Act or similar federal statute;
and
|
|
b.
|
receives
payment for services performed for the Participating Employer directly
from the Company’s U.S. Payroll Department, or another Participating
Employer’s U.S. Payroll Department;
and
|
|
c.
|
is
either a Salaried individual who is classified by the Participating
Employer as having “regular full-time status or “less-than-full-time
status’, or a Bargained-for individual who is classified by the
Participating Employer as having “regular full –time active status”,
and
|
|
d.
|
if Localized,
is Localized in the U.S., and
|
|
e.
|
if
on an international assignment, is either a U.S. citizen or Localized in
the U.S.
|
·
|
Former
Employees who were hired on or after January 1, 2008
1
;
|
·
|
Former
Employees who are eligible for any kind of life insurance coverage
available to active employees of a Participating Employer, other than
accidental death and dismemberment, business travel or occupational
accident insurance, are not eligible under this Plan while they are
covered under the active employee
coverage;
|
·
|
Hourly
Employees who retired from Michigan Operations prior to January 1,
2008;
|
·
|
Hampshire
Hourly Employees who retired from the Waterloo, NY facility on or after
March 1, 1988 through December 31,
1999;
|
·
|
Hampshire
Hourly Employees who retired from the Owensboro, KY or Nashua, NH
facilities on or after March 1, 1988 through December 31,
1998;
|
·
|
Texas
Operations Employees who retired prior to January 1,
2003;
|
·
|
Retired
Split Dollar Participants;
|
·
|
Post-65
Executive Life Insurance Participants;
and
|
·
|
Union
Carbide Employees who retired prior to February 7,
2003;
|
·
|
Dow
AgroSciences Employees who retired prior to January 1,
2006;
|
·
|
Poly-Carb
Inc. and GNS Employees who Retire;
|
·
|
Agrigenetics
Inc. d/b/a Mycogen Seeds employees who retired prior to January 1,
2001;
|
·
|
Individuals
who were employed by a subsidiary, joint venture, or any other business
entity or affiliate that was acquired by, formed,by, merged with, or
created by the Company on or after January 1, 2008, except as provided in
the footnote below
2
;
|
·
|
Poly-Carb
Inc. and GNS Employees who retire are not eligible fo this
Plan;
|
·
|
Former
Employees who terminated employment from a Participating Employer (other
than Americas Styrenics) and were subsequently hired by Americas Styrenics
who did not have the required amount of Service to be eligible for the
Plan at the time of termination of employment from such Participating
Employer; Former Employees of Americas Styrenics who retire from Americas
Styrenics, unless they terminated employment from a Participating Employer
prior to working for Americas Styrenics and met the age and service
requirements of the Plan when they terminated employment from such
Participating Employer.
|
Age
|
Coverage Amount
|
65
|
½
x annual pay at time of Retirement ($5,000
minimum)
|
66
|
80%
of benefit at Retirement ($5,000 minimum)
|
67
|
60%
of benefit at Retirement ($5,000 minimum)
|
68
|
40%
of benefit at Retirement ($5,000 minimum)
|
69
|
20%
of benefit at Retirement ($5,000 minimum)
|
70+
|
$5,000
|
i.
|
A
person who: (a) was a Retiree on or before September 30, 2003, and (b)
was enrolled in The Dow Chemical Company Executive Split Dollar
Life Insurance Plan on or before September 30, 2003, and (c) signed a
waiver of all his or her rights under The Dow Chemical Company Executive
Split Dollar Life Insurance Agreement between him or her and The Dow
Chemical Company; or
|
ii.
|
A
person who: (a) was a Retiree on or before October 31, 2003, and (b) was
enrolled in the Union Carbide Corporation Executive Life Insurance Plan on
October 31, 2003, and (c) for whom the Agreement and Collateral Assignment
between him or her and Union Carbide Corporation was terminated on or
about October 31, 2003, and (d) whose coverage level under the Union
Carbide Executive Life Insurance Plan just prior to termination of the
Agreement and Collateral Assignment was two times his or her annual
salary, for which he or she had to pay a premium;
or
|
iii.
|
A
person who: (a) was an active Employee on September 30, 2002, and (b)
was enrolled in The Dow Chemical Company Executive Split Dollar
Life Insurance Plan on September 30, 2002, and (c) signed a waiver of all
his or her rights under The Dow Chemical Company Executive Split Dollar
Life Insurance Agreement between him or her and The Dow Chemical Company,
and (d) on the day preceding his or her Retirement, was covered under
the
|
|
Company-Paid
Life Insurance Plan component of The Dow Chemical Company Group Life
Insurance Program that is available to active Employees, and (e) is now a
Retiree; or
|
iv.
|
A
person who: (a) was an active Employee on or before October 31, 2002, and
(b) was enrolled in the Union Carbide Corporation Executive Life Insurance
Plan on October 31, 2002, and (c) for whom the Agreement and Collateral
Assignment between him or her and Union Carbide Corporation was terminated
on or about October 31, 2002, and (d) on the day preceding his or her
Retirement, was covered under the Company-Paid Life Insurance Plan
component of The Dow Chemical Company Group Life Insurance Program that is
available to active Employees, and (e) is now a Retiree;
or
|
v.
|
A
person who: (a) was an active Employee on October 31, 2003, and (b) was
enrolled in the Union Carbide Corporation Executive Life Insurance Plan on
October 31, 2003, and (c) for whom the Agreement and Collateral Assignment
between him or her and Union Carbide Corporation was terminated on or
about October 31, 2003, and (d) whose coverage level under the Union
Carbide Executive Life Insurance Plan just prior to termination of the
Agreement and Collateral Assignment was two times his or her annual
salary, for which he or she had to pay a premium, and (e) on the day
preceding his or her Retirement, was covered under the Company-Paid Life
Insurance Plan component of The Dow Chemical Company Group Life Insurance
Program that is available to active Employees, and (f) is now a Retiree;
or
|
vi.
|
A
person who: (a) was a Retiree on or before October 31, 2003, and (b) was
enrolled in the Union Carbide Corporation Executive Life Insurance Plan on
October 31, 2005, and (c) for whom the Agreement and Collateral Assignment
between him or her and Union Carbide Corporation was terminated on or
about October 31, 2005, and (d) whose coverage level under the Union
Carbide Executive Life Insurance Plan just prior to termination of the
Agreement and Collateral Assignment was two times his or her annual
salary, for which he or she had to pay a premium,
or
|
vii.
|
A
person who is not described in viabove, and (a) was a Retiree on or before
October 31, 2003, and (b) was enrolled in the Union Carbide Corporation
Executive Life Insurance Plan on October 31, 2005, and (c) for whom the
Agreement and Collateral Assignment between him or her and Union Carbide
Corporation was terminated on or about October 31, 2005. For
purposes of the Plan, “1X” means either 1 times your final
annual salary at Union Carbide or 40% of your final annual salary at Union
Carbide, or 2 times your final annual salary at Union Carbide, depending
on the amount of coverage you had under the Union Carbide Corporation
Executive Life Insurance Plan on October 31,
2005.
|
·
|
Your
Spouse or Domestic Partner; or
|
·
|
Your
children; or
|
·
|
Your
parent(s); or
|
·
|
Your
sibling(s).
|
·
|
the
date you elected to terminate your coverage;
or
|
·
|
the
date you no longer meet the eligibility requirements of the
Plan.
|
·
|
If
your Company-Paid Life Insurance coverage ends because Dow has cancelled
the Company-Paid Life Insurance coverage under the MetLife group life
insurance policy, or Dow has amended the Company-Paid Life Insurance Plan
to exclude coverage for your eligible group, you may convert your
Company-Paid Life Insurance coverage to an individual non-term MetLife
policy; provided you have been covered under the Company-Paid Life
Insurance Plan for at least 5 years immediately prior to losing coverage
under the Company-Paid Life Insurance Plan. The amount you may
convert is limited to the lesser
of:
|
·
|
the
amount of Company-Paid Life Insurance for you that ends under
the Group Policy less the amount of life insurance for which you become
eligible under any group policy within 31 days after the date insurance
ends under the Group Policy; or
|
·
|
$2,000.
|
·
|
Former
Employees who were hired on or after January 1, 2008
17
.;
|
·
|
Former
Employees who are eligible for any kind of life insurance coverage
available to active employees of a Participating Employer, other than
accidental death and dismemberment, business travel or occupational
accident insurance, are not eligible under this Plan while they are
covered under the active employee
coverage;
|
·
|
Hourly
Employees who retired from Michigan Operations prior to January 1,
2008;
|
·
|
Hampshire
Hourly Employees who retired from the Waterloo, NY facility on or after
March 1, 1988 through December 31,
1999;
|
·
|
Hampshire
Hourly Employees who retired from the Owensboro, KY or Nashua, NH
facilities on or after March 1, 1988 through December 31,
1998;
|
·
|
Texas
Operations Employees who retired prior to prior to January 1,
2003;
|
·
|
Retired
Split Dollar Participants;
|
·
|
Union
Carbide Employees who retired prior to February 7,
2003;
|
·
|
Dow
AgroSciences employees who retired prior to January 1,
2006;
|
·
|
Poly-Carb
Inc. and GNS Employees who Retire;
|
·
|
Agrigenetics
Inc. d/b/a Mycogen Seeds employees who retired prior to January 1,
2001;
|
·
|
Individuals
who were employed by a subsidiary, joint venture, or any other business
entity or affiliate that was acquired by, formed,by, merged with, or
created by the Company on or after January 1, 2008, except as provided in
the footnote below
18
;
|
·
|
Poly-Carb
Inc. and GNS Employees who retire are not eligible fo this
Plan;
|
·
|
Former
Employees who terminated employment from a Participating Employer (other
than Americas Styrenics) and were subsequently hired by Americas Styrenics
who did not have the required amount of Service to be eligible for the
Plan at the time of termination of employment from such Participating
Employer;
|
·
|
Former
Employees of Americas Styrenics who retire from Americas Styrenics, unless
they terminated employment from a Participating Employer prior to working
for Americas Styrenics and met the age and service requirements of the
Plan when they terminated employment from such Participating
Employer.
|
·
|
Your
Spouse or Domestic Partner; or
|
·
|
Your
children; or
|
·
|
Your
parent(s); or
|
·
|
Your
sibling(s).
|
·
|
·
|
you
no longer meet the eligibility requirements under the retiree optional
life insurance provisions provided under the MetLife group policy
;or
|
·
|
the
date you elect to terminate your coverage
.
|
·
|
If
your coverage under the MetLife group policy ends because Dow cancels its
Group Policy with MetLife or Dow amends the eligibility requirements of
the Plan to exclude your work group from eligibility for retiree optional
life coverage, you may convert to an individual non-term policy rhough
MetLife; provided you were insured under the retiree optional
life provisions of the MetLife group policy for at least 5
years immediately prior to losing group coverage. The
amount you may convert will be limited to the lesser
of:
|
·
|
the
amount of life insurance that ends under the MetLife group policy less the
amount of life insurance for which you become eligible under
any other group policy within 31 days after the date
your insurance ends under the MetLife group policy;
or
|
·
|
$2,000.
|
·
|
. You
must file a conversion application with MetLife and make the required
premium payment to MetLife within 31 days of the date your Dow coverage is
lost or decreases. Contact the Dow Retiree Service Center to
obtain a form for converting your coverage. Once you have
obtained the form, contact the MetLife Conversion Group at 1-877- 275-6387
to file your form, or to obtain further information. You are
responsible for initiating the conversion process within the appropriate
timeframes.
|
·
|
The
cost of this individual coverage will probably be significantly higher
than your group plan. Although not required, providing proof of
insurability may help reduce your
cost.
|
·
|
Former
Employees who were hired on or after January 1, 2008, except as provided
in the footnote below
22
.;
|
·
|
Former
Employees who are eligible for any kind of life insurance coverage
available to active employees of a Participating Employer, other than
accidental death and dismemberment, business travel or occupational
accident insurance, are not eligible under this Plan while they are
covered under the active employee
coverage;
|
·
|
Hampshire
Hourly Employees who retired from the Waterloo, NY facility on or after
March 1, 1988 through December 31,
1999;
|
·
|
Hampshire
Hourly Employees who retired from the Owensboro, KY or Nashua, NH
facilities on or after March 1, 1988
through December 31, 1998;
|
·
|
Texas
Hourly Employees who retired prior to October 1, 1989;
and
|
·
|
Union
Carbide Employees who retired prior to February 7,
2003.
|
·
|
Dow
AgroSciences Employees who retired prior to January 1,
2006;
|
·
|
Poly-Carb
Inc. and GNS Employees who Retire;
|
·
|
Agrigenetics
Inc. d/b/a Mycogen Seeds employees who retired prior to January 1,
2001;
|
·
|
Individuals
who were employed by a subsidiary, joint venture, or any other business
entity or affiliate that was acquired by, formed,by, merged with, or
created by the Company on or after January 1, 2008, except as provided in
the footnote below
23
;
|
·
|
Poly-Carb
Inc. and GNS Employees who retire are not eligible fo this
Plan;
|
·
|
Former
Employees who terminated employment from a Participating Employer (other
than Americas Styrenics) and were subsequently hired by Americas Styrenics
who did not have the required amount of Service to be eligible for the
Plan at the time of termination of employment from such Participating
Employer;
|
·
|
Former
Employees of Americas Styrenics who retire from Americas Styrenics, unless
they terminated employment from a Participating Employer prior to working
for Americas Styrenics and met the age and service requirements of the
Plan when they terminated employment from such Participating
Employer.
|
·
|
at
least 15 days old:
|
·
|
under
age 25 and who is:
|
·
|
a
full-time student at an accredited school, college, or university that is
licensed in the jurisdiction where it is
located;
|
·
|
unmarried
|
·
|
supported
by You, and
|
·
|
not
employed on a full-time basis
|
·
|
This
term does not include any person
who:
|
·
|
is
in the military of any country or subdivision of any
country;
|
·
|
lives
outside the United States or Canada;
or
|
·
|
is
insured under the Group Policy as an
employee.
|
·
|
Already
covered as a dependent of another Dow Employee or Dow Retiree. All covered
children in a family must be enrolled by the same
parent.
|
·
|
Married
or ever was married.
|
·
|
Employed
full-time.
|
·
|
Age
25 years or older.
|
·
|
Your
Spouse or Domestic Partner; or
|
·
|
Your
children; or
|
·
|
Your
parent(s); or
|
·
|
Your
sibling(s).
|
·
|
The
date the Group Policy ends;
|
·
|
The
date 31 days following the date of your
death;
|
·
|
The
date 31 days following the date you no longer meet the eligibility
requirements of the Plan;
|
·
|
The
date 31 days following the date your Spouse of Record/Domestic Partner of
Record or Dependent child no longer meet the eligibility requirements of
the Plan;
|
·
|
The
end of the period for which your last premium has been paid;
or
|
·
|
The
date you elect to terminate your Spouse of Record/Domestic Partner of
Record or Dependent child coverage.
|
·
|
·
|
of
your death; or
|
·
|
he
or she no longer meets eligibility
requirements;
|
·
|
you
have elected to terminate your Spouse of Record/Domestic Partner of Record
or Dependent child coverage;
|
·
|
their
coverage may be converted to an individual non-term policy through
MetLife, Inc. without having to prove insurability. (In the
case of minor children, the parent or legal guardian may act on their
behalf.)
|
·
|
If
your Spouse of Record/Domestic Partner of Record or Dependent child loses
coverage under the Retiree Dependent Life Insurance Plan because Dow has
cancelled the dependent life coverage under the group policy with MetLife,
or Dow has amended the eligibility requirements of the Plan to exclude you
or your dependents from eligibility under the Plan, you may convert
coverage to an individual non-term MetLife policy for your Dependent;
provided you have been enrolled in coverage for your
Dependent under the Retiree Dependent Life Insurance Plan for
at least 5 years immediately prior to the date the MetLife group
coverage for our Dependent ended. The amount that
may be converted is limited to the lesser
of:
|
·
|
the
amount of Life Insurance for the Dependent that ends under the MetLife
group policy less the amount of life insurance for Dependents for which
you become eligible under any group policy within 31 days after the date
insurance ends under the Retiree Dependent Life Insurance provisions of
the MetLife group policy;
or
|
·
|
$2,000.
|
·
|
Examine,
without charge, at the Plan Administrator’s office and at other specified
locations, the Plan Documents and the latest annual reports
filed with the U.S. Department of Labor and available at the Public
Disclosure Room of the Pension and Welfare Benefit
Administration.
|
·
|
Obtain,
upon written request to the Plan Administrator, copies of the Plan
Documents and Summary Plan Descriptions. The Administrator may
charge a reasonable fee for the
copies.
|
·
|
Receive
a summary of each Plan’s annual financial report. The Plan
Administrator is required by law to furnish each Participant with a copy
of this summary annual report.
|
1)
|
to
provide benefits for Participants in accordance with the Plan,
and/or
|
2)
|
to
pay third parties to provide such benefits,
and/or
|
3)
|
to
pay expenses of the Plan and/or the Trust holding the Plan's assets,
and/or
|
4)
|
to
provide cash for Participants, as long as the cash is not
provided disproportionately to officers, shareholders, or Highly
Compensated Employees.
|
Funding:
|
Except
for Plan Option I, the Participating Employers pay the entire premium for
the Plan. For Plan Option I, the Retiree and the Participating Employer
share the premiums. Benefits are funded through a group
insurance contract with Metropolitan Life Insurance Company. The assets of
the Plans may be used at the discretion of the Plan Administrator to pay
for any benefits provided under the Plans, as the Plans may be amended
from time to time, as well as to pay for any expenses of the
Plans. Such expenses may include, and are not limited to,
consulting fees, actuarial fees, attorney’s fees, third party
administrator fees, and other administrative
expenses.
|
The assets of the Plan may be used at the discretion of the
Plan
|
Administrator to pay for any benefits provided under the Plan, as
the
|
Plan may be amended from time to time, as well as to pay for any
expenses
|
of the Plan. Such expenses may include, and are not limited
to,
|
consulting fees, actuarial fees, attorneys fees, third party administrator
fees,
|
and other administrative expenses.
|
Plan
Administrator
|
and
Fiduciary:
|
The
Dow Chemical Company
|
|
Employee Development Center
|
|
Midland,
MI 48674
|
|
1-877-623-8079
|
To Apply For A
Benefit:
|
See
Claims Procedures Appendix to this
SPD
|
To
Appeal A Benefit
|
|
Determination:
|
See
Claims Procedures Appendix to this
SPD
|
·
|
State
the name of the Employee, and also the name of the person (Employee,
Spouse of Record/Domestic Partner of Record, Dependent child, as
applicable) for whom the
Eligibility
Determination
is being
requested
|
·
|
Name
the benefit plan for which the
Eligibility
Determination
is being
requested
|
·
|
If
the
Eligibility
Determination
is for the Employee’s Dependent, describe the
relationship for whom an
Eligibility
Determination
is being requested to the Employee (eg. Spouse of
Record/Domestic Partner of Record, Dependent child,
etc.)
|
·
|
Provide
documentation of such relationship (eg. marriage certificate/statement of
Domestic Partnership, birth certificate,
etc)
|
·
|
Name
of Employee
|
·
|
Name
of Dependent or beneficiary, if the Dependent or beneficiary is the person
who is appealing the Administrator’s
decision
|
·
|
Name
of the benefit Plan
|
·
|
Reference
to the Initial Determination
|
·
|
Explain
reason why you are appealing the Initial
Determination
|
a.
|
the
Participating Employer’s place of business;
or;
|
b.
|
an
alternate place approved by the Participating Employer;
or
|
c.
|
a
place to which the Participating Employer’s business requires you to
travel.
|
1.
|
the
two people must have lived together for at least twelve (12) consecutive
months immediately prior to receiving coverage for benefits under the
Plan, and
|
2.
|
the
two people are not Married to other persons either now, or at any time
during the twelve month period, and
|
3.
|
during
the twelve month period, and now, the two people have been and are each
other's sole domestic partner in a committed relationship similar to a
legal Marriage relationship and with the intent to remain in the
relationship indefinitely, and
|
4.
|
each
of the two people must be legally competent and able to enter into a
contract, and
|
5.
|
the
two people are not related to each other in a way which would prohibit
legal Marriage between opposite sex individuals,
and
|
6.
|
in
entering the relationship with each other, neither of the two people are
acting fraudulently or under duress,
and
|
7.
|
during
the twelve month period and now, the two people have been and are
financially interdependent with each other,
and
|
8.
|
each
of the two people have signed a statement acceptable to the
Plan Administrator and have provided it to the Plan
Administrator.
|
1.
|
Evidence
satisfactory to the Plan Administrator is provided that the two people are
registered as domestic partners, or partners in a civil union or marriage
in a state or municipality or country that legally recognizes such
domestic partnerships, civil unions, or marriages,
and
|
2.
|
each
of the two people have signed a statement acceptable to the
Plan
|
|
Administrator
and have provided it to the Plan
Administrator.
|
a.
|
is
employed by a Participating Employer to perform personal services in an
employer-employee relationship which is subject to taxation under the
Federal Insurance Contribution Act or similar federal statute;
and
|
b.
|
receives
payment for services performed for the Participating Employer directly
from the Company’s U.S. Payroll Department, or another Participating
Employer’s U.S. Payroll Department;
and
|
c.
|
is
either a Salaried individual who is classified by the Participating
Employer as having “regular full-time status or “less-than-full-time
status’, or a Bargained-for individual who is classified by the
Participating Employer as having “regular full –time active status”,
and
|
d.
|
if Localized,
is Localized in the U.S., and
|
e.
|
if
on an international assignment, is either a U.S. citizen or Localized in
the U.S..
|
1.
|
This
Agreement is in all respects subject to the provisions of the Plan, as the
Plan may be amended from time to time. The Plan is incorporated by
reference. In the event of any conflict between this Agreement and the
Plan, as the Plan may be amended from time to time, the provisions of the
Plan shall govern and this Agreement shall be deemed to be modified
accordingly.
|
2.
|
The
target number of performance shares of Deferred Stock you are awarded
under this Agreement (“Target Shares”) is outlined in the accompanying
award letter with ___________ as the effective date of the grant. Shares
are earned over a three-year period beginning ___________ and ending on
___________ (the "Performance Period") by meeting or exceeding the
Company’s strategic financial performance objective of Return on Capital
(ROC) defined in the accompanying documents. The maximum number of shares
that can be earned totals 250 percent of Target
Shares.
|
3.
|
The
total number of shares earned under this grant as specified in paragraph 2
above (“Shares Earned”) will be determined and released into your account
on ___________. Prior to issuance and delivery of the Deferred Stock you
shall have no rights as a stockholder with respect to the Deferred Stock
earned under this Agreement. In each year prior to issuance and delivery,
you (or your successors) shall make arrangements satisfactory to the
Compensation Committee for the payment of any taxes required to be
withheld in connection with your right to shares of Deferred Stock under
all applicable laws and regulations of any governmental authority, whether
federal, state or local and whether domestic or foreign. The Company and
its Subsidiaries or Affiliates (collectively and individually a “Dow
Company”) and their directors, officers, employees, or agents shall not be
liable for any delay in issuance or receipt of any shares pursuant to this
Agreement.
|
4.
|
This
Agreement shall terminate and your rights under this Agreement shall be
forfeited if your employment with any Dow Company is terminated for any
reason other than death, disability or retirement, or a Special Separation
Situation. In the event of your retirement death or disability, your
current year’s Performance Share Grant will be prorated based on the
period of time worked during the year. If you take a leave of absence from
a Dow Company, for any reason, your grant under this Agreement will be
subject to the leave of absence policy established by the Compensation
Committee for Plan awards. For purposes of this
Agreement, “retirement” is defined in your home country retirement policy
in effect at the inception of this Agreement. You shall be considered to
be disabled for purposes of this Agreement in the event you, by reason of
any medically determinable physical or mental impairment which can be
expected to result in death or which can be expected to last for a
continuous period of not less than 12 months, are receiving income
replacement benefits for a period of not less than 3 months under an
accident and health plan or arrangement covering employees of the
Company. Your death or disability shall not accelerate the time
of payment of Deferred Stock under this
Agreement.
|
5.
|
A
“Special Separation Situation” is defined as a situation in which (a) a
Dow Company terminates your employment by employer action for a reason
that qualifies you for a severance benefit (which includes the Special
Stock Treatment described in this section 5) under a severance plan
sponsored by a Dow Company, and (i) you fulfill the requirements of the
severance plan in order to qualify for payment of the severance benefit,
and (ii) you and the Dow Company sign a Release that provides for the
Special Stock Treatment described in this section 5; or (b) a Dow Company
terminates your employment by employer action, and i) you do not qualify
for a severance benefit under a severance plan sponsored by the Dow
Company under the circumstances specified in paragraph 5a, and ii) the
reason for termination was not because of the violation of an employer
rule, or a law, regulation or other such government requirement, or
dishonesty or theft, or because you engaged in activity harmful to the
interests of, or in competition with, a Dow Company, and iii) you and the
Dow Company sign a Release that provides for the Special Stock Treatment
described in this section 5. If
your
|
6.
|
For
each Dow Common Stock dividend record date between ___________ and
___________, an account in your name will be credited with a sum of money
equal to the amount that you would have received in dividends if the
Shares Earned had been issued to you (the "Dividend Equivalents"). The
Dividend Equivalents associated with each share delivered to you pursuant
to Section 3 will be paid in cash to you as additional compensation on a
date between ___________ and ___________. Awardees regularly paid
compensation by a Dow Company in other than U.S. dollars will receive such
payment of Dividend Equivalents converted from U.S. dollars at the Dow
inter-company trading rate in effect at the time of
delivery.
|
7.
|
The
Company is under no obligation to grant you the right to receive any cash
payment under any law, federal, local, domestic or
foreign.
|
8.
|
Your
right to future issuance and delivery of Deferred Stock may not be sold,
pledged, assigned or otherwise transferred (except as hereinafter
provided) and any attempt to sell, pledge, assign or otherwise transfer
shall be void and your rights to Deferred Stock shall therefore be
forfeited. Your right to such future issuance and delivery shall, however,
be transferable by will or pursuant to the laws of descent and
distribution or you may make a written designation of a beneficiary on the
form prescribed by the Company, which beneficiary (if any) shall succeed
to your rights under this Agreement in the event of your
death.
|
9.
|
Upon
the occurrence of a Change of Control as defined in the Plan, your right
to receive the number of shares of Performance Shares credited to your
account under this Agreement shall not be forfeitable under any
circumstances, and your Performance Shares will generally continue to be
delivered based on the original deferral period schedule and Payment Date.
If you also experience an involuntary Separation from Service from Dow or
an affiliate thereof within two years following a Change of Control, and
prior to the Payment Date, the Company shall deliver the Performance
Shares credited to your account to you on the 30th day following such
Separation from Service. Shares credited to Awardees account
will be determined based on reported company performance prior to the date
of Separation from Service.
|
10.
|
If
at any time during the term of this Agreement you engage in any act of
Unfair Competition (as defined below), this Agreement shall terminate
effective on the date on which you enter into such act of Unfair
Competition, unless terminated sooner by operation of another term or
condition of this Agreement or the Plan. In addition, if at any time
within three years after issuance and delivery of this Deferred Stock you
engage in any act of Unfair Competition, you shall promptly pay to the
Company the Fair Market Value of Shares Earned and Dividend Equivalents
paid. The Compensation Committee shall, in its sole discretion, determine
when any act of Unfair Competition has occurred, and the determination of
the Compensation Committee shall be final and binding as to all parties.
For purposes of this Agreement, the term “Unfair Competition” shall mean
and include activity on your part that is in competition with a Dow
Company or is or may be harmful to the interests of a Dow Company,
including but not limited to conduct related to your employment for which
either criminal or civil penalties against you may be sought, or your
acceptance of employment with an employer that is in competition with a
Dow Company.
|
11.
|
In
the event that additional shares of Common Stock of the Company are issued
pursuant to a stock split or a stock dividend, the Board of Directors
shall make appropriate adjustments in the number and kind of Target Shares
credited to your account on the books of the Company as deemed
appropriate.
|
12.
|
Nothing
contained in this Agreement shall confer or be deemed to confer upon you
any right with respect to continuance of employment by a Dow Company, nor
interfere in any way with the right of a Dow Company to terminate your
employment at any time with or without assigning a reason
therefore.
|
13.
|
This
document shall constitute a Performance Shares Deferred Stock Agreement
between the Company and you, and this Agreement shall be deemed to have
been made on ___________. To the extent that federal laws do not otherwise
control, this Agreement shall be governed by the laws of the state of
Delaware and construed accordingly. Subject to earlier termination by
operation of another term or condition of this Agreement or the Plan, this
Agreement will expire when Shares Earned are delivered or when it is
determined by the Compensation Committee that the Company’s strategic
financial performance objectives have not been achieved, whichever date is
earlier. You may choose to reject this award by written notice delivered
to the Compensation Committee of the Company within ninety days of your
receipt of this instrument. Individuals who reject this Deferred Stock
will not receive additional cash or non-cash compensation in lieu of the
Deferred Stock.
|
1.
|
This
Agreement is in all respects subject to the provisions of the Plan, as the
Plan may be amended from time to time. The Plan is incorporated by
reference. In the event of any conflict between this Agreement and the
Plan, the provisions of the Plan shall govern and this Agreement shall be
deemed to be modified accordingly.
|
2.
|
The
deferral period of this Agreement shall be from ___________ until
___________. Issuance and delivery of the shares of Deferred Stock
credited to your account on the books of the Company hereunder shall be
deferred until ___________ and shall be subject to the conditions
described below. The shares will be released into your account at the end
of the deferral period. Prior to such issuance and delivery,
you shall have no rights as a stockholder with respect to the shares of
Deferred Stock credited to your account under this Agreement. In each year
prior to issuance and delivery, you (or your successors) shall make
arrangements satisfactory to the Compensation Committee for the payment of
any taxes required to be withheld in connection with your right to shares
of Deferred Stock under all applicable laws and regulations of any
governmental authority, whether federal, state or local and whether
domestic or foreign. The Company and its Subsidiaries or Affiliates
(collectively and individually a “Dow Company”) and their directors,
officers, employees, or agents shall not be liable for any delay in
issuance or receipt of any shares pursuant to this
Agreement.
|
3.
|
For
each Dow Common Stock dividend record date during the period while shares
of Deferred Stock remain credited to your account on the books of the
Company and before their issuance and delivery to you, the Company shall
pay to you as additional compensation a sum of money equal to the amount
which you would have received in dividends if the shares of Deferred Stock
credited to your account had been issued and delivered to you (the
“Dividend Equivalents”). Awardees regularly paid compensation by a Dow
Company in other than U.S. dollars will receive such payment of Dividend
Equivalents converted from U.S. dollars at the Dow inter-company trading
rate in effect at the time of delivery. Such Dividend Equivalents shall be
paid to you on the date the dividend was paid to shareholders of the
Company’s common stock.
|
4.
|
This
Agreement shall terminate and your rights under this Agreement shall be
forfeited if your employment with any Dow Company is terminated for any
reason other than death, disability, retirement, or Special Separation
Situation. In the event of your retirement, death or disability, your
current year’s Deferred Stock Grant will be prorated based on the period
of time worked during the year. If you take a leave of absence from a Dow
Company, for any reason, your award under this Agreement will be subject
to the leave of absence policy established by the Company for Plan
awards. For purposes of this Agreement, “retirement” is defined
in your home country retirement policy in effect at the inception of this
Agreement. You shall be considered to be disabled for the purposes of this
Agreement in the event you, by reason of any medically determinable
physical or mental impairment which can be expected to result in death or
which can be expected to last for a continuous period of not less than 12
months, are receiving income replacement benefits for a period of not less
than 3 months under an accident and health plan or arrangement covering
employees of the Company. Your death or disability shall not
accelerate the time of payment of Deferred Stock under this
Agreement.
|
5.
|
A
“Special Separation Situation” is defined as a situation in which (a) a
Dow Company terminates your employment by employer action for a reason
that qualifies you for a severance benefit (which includes the Special
Stock Treatment described in this section 5) under a severance plan
sponsored by a Dow Company, and (i) you fulfill the requirements of the
severance plan in order to qualify for payment of the severance benefit,
and (ii) you and the Dow Company sign a Release that provides for the
Special Stock Treatment described in this section 5; or (b) a Dow Company
terminates your employment by employer action, and i) you do not qualify
for a severance benefit under a severance plan sponsored by the Dow
Company under the circumstances specified in paragraph 5a, and ii) the
reason for termination was not because of the violation of an employer
rule, or a law, regulation or other such government requirement, or
dishonesty or theft, or because you engaged in activity harmful to the
interests of, or in competition with, a
Dow
|
|
Company,
and iii) you and the Dow Company sign a Release that provides for the
Special Stock Treatment described in this section 5. If your employment is
terminated under a Special Separation Situation, then your Award shall
receive Special Stock Treatment. Special Stock Treatment means that your
Award will be reduced to a number of shares proportionate to the total
period of time you were employed by the Dow Company during the deferral
period. This proportionally reduced amount shall be calculated by dividing
(x) the period of time between the grant date and the date of termination
of employment by (y) the deferral
period.
|
6.
|
The
Company is under no obligation to grant you the right to receive any cash
payment under any law, federal, local, domestic or
foreign.
|
7.
|
Your
right to future issuance and delivery of Deferred Stock may not be sold,
pledged, or otherwise transferred (except as hereinafter provided) and any
attempt to sell, pledge, assign or otherwise transfer shall be void and
your rights to Deferred Stock shall therefore be forfeited. Your right to
such future issuance and delivery shall, however, be transferable by will
or pursuant to the laws of descent and distribution or you may make a
written designation of a beneficiary on the form prescribed by the
Company, which beneficiary (if any) shall succeed to your rights under
this Agreement in the event of your
death.
|
8.
|
Upon
the occurrence of a Change of Control as defined in the Plan, your right
to receive the number of shares of Deferred Stock credited to your account
under this Agreement shall not be forfeitable under any circumstances, and
your Deferred Shares will generally continue to be delivered based on the
original deferral period schedule. If you also experience an involuntary
Separation from Service from Dow or an affiliate thereof within two years
following a Change of Control and prior to the Payment Date, the Company
shall deliver these shares to you on the 30th day following your
Separation from Service.
|
9.
|
If
at any time during the term of this Agreement you engage in any act of
Unfair Competition (as defined below), this Agreement shall terminate
effective on the date on which you enter into such act of Unfair
Competition, unless terminated sooner by operation of another term or
condition of this Agreement or the Plan. In addition, if at any time
within three years after issuance and delivery of this Deferred Stock you
engage in any act of Unfair Competition, you shall promptly pay to the
Company the Fair Market Value of Shares Earned and Dividend Equivalents
paid. The Compensation Committee shall, in its sole discretion, determine
when any act of Unfair Competition has occurred, and the determination of
the Compensation Committee shall be final and binding as to all parties.
For purposes of this Agreement, the term “Unfair Competition” shall mean
and include activity on your part that is in competition with a Dow
Company or is or may be harmful to the interests of a Dow Company,
including but not limited to conduct related to your employment for which
either criminal or civil penalties against you may be sought, or your
acceptance of employment with an employer that is in competition with a
Dow Company.
|
10.
|
In
the event that additional shares of Common Stock of the Company are issued
pursuant to a stock split or a stock dividend, the Board of Directors
shall make appropriate adjustments in the number and kind of Deferred
Stock credited to your account on the books of the Company as deemed
appropriate.
|
11.
|
Nothing
contained in this Agreement shall confer or be deemed to confer upon you
any right with respect to continuance of employment by a Dow Company, nor
interfere in any way with the right of a Dow Company to terminate your
employment at any time with or without assigning a reason
therefore.
|
12.
|
This
instrument shall constitute a Deferred Stock Agreement between the Company
and you, and this Agreement shall be deemed to have been made on
___________. To the extent that federal laws do not otherwise control,
this Agreement shall be governed by the laws of the state of Delaware and
construed accordingly. You may choose to reject this award by written
notice delivered to the Compensation Committee of the Company within
ninety days of your receipt of this instrument. Individuals who reject
this Deferred Stock will not receive additional cash or non-cash
compensation in lieu of the Deferred
Stock.
|
1.
|
This
Agreement is in all respects subject to the provisions of the Plan, as the
Plan may be amended from time to time. The Plan is incorporated by
reference. In the event of any conflict between this Agreement and the
Plan, as the Plan may be amended from time to time, the provisions of the
Plan shall govern and this Agreement shall be deemed to be modified
accordingly.
|
2.
|
Subject
to the vesting and exercise periods specified on the accompanying award
letter and the conditions described below, this Agreement grants you the
right to purchase the number of shares of Common Stock of the Company at
the option price specified on the letter attached to this Agreement (the
“Option”). Notice of the exercise of this Option in whole or in part shall
be made to Smith Barney via on-line trading or Customer Service. Such
notice of exercise shall be accompanied by payment in full for the shares
covered thereby. Payment shall be in United States dollars or, at the
discretion of the Compensation Committee, in Common Stock of the Company
valued at Fair Market Value or a combination of dollars and Common Stock
of the Company. Dollar payment shall be made by official bank check,
certified check, or the equivalent. The Stock Award Resource Center shall
have discretionary authority to accept a personal uncertified check or
bank transfer in lieu of the foregoing methods of payment. Prior to such
notice of exercise, and prior to the issuance and delivery of any shares,
you (or your successors) shall make arrangements satisfactory to the
Compensation Committee for the payment of any taxes required to be
withheld in connection with the exercise of this Option under all
applicable laws and regulations of any governmental authority, whether
federal, state or local and whether domestic or foreign. The Company and
its Subsidiaries and Affiliates (collectively and individually a “Dow
Company”) and their directors, officers, employees, or agents shall not be
liable for any delay in issuance or receipt of any shares pursuant to this
Agreement.
|
3.
|
This
Agreement shall terminate and your rights under this Agreement shall be
forfeited if your employment with any Dow Company is terminated for any
reason other than death, disability or retirement, or Special Separation
Situation. In the event of your death, disability, or retirement while
employed by a Dow Company, this Agreement shall, except as provided below,
terminate upon the earlier to occur of (a) five years after your death,
disability or retirement or (b) the original expiration date of this
Agreement as specified on the reverse side of this Agreement. In the event
of your retirement, death, or disability, your current year’s Stock Option
Grant will be prorated based on the time period worked during the year. If
you take a leave of absence from a Dow Company, for any reason, your award
under this Agreement will be subject to the leave of absence policy
established by the Compensation Committee for Plan awards. For
purposes of this Agreement, “retirement” is defined in your home country
retirement policy in effect at the inception of this Agreement. You shall
be considered to be disabled for the purposes of this Agreement in the
event you, by reason of any medically determinable physical or mental
impairment which can be expected to result in death or which can be
expected to last for a continuous period of not less than 12 months, are
receiving income replacement benefits for a period of not less than 3
months under an accident and health plan or arrangement covering employees
of the Company. Your death or disability shall not accelerate
the vesting period of Options under this
Agreement.
|
4.
|
If
(a) you exercise any portion of this Option prior to the expiration date
of this option, and (b) you leave the employment of a Dow Company within
one year after such exercise for any reason except death, disability or
retirement, then you shall pay to the Company any excess of the Fair
Market Value over the exercise price on the date of exercise. You may be
released from this obligation to pay the Company only if the Compensation
Committee (or its duly appointed agent or agents) determines in its or
their sole judgment that such action is in the best interests of a Dow
Company.
|
5.
|
A
“Special Separation Situation” is defined as a situation in which (a) a
Dow Company terminates your employment by employer action for a reason
that qualifies you for a severance benefit (which includes the Special
Stock Treatment described in this section 5) under a severance plan
sponsored by a Dow Company, and (i) you fulfill the requirements of the
severance plan in order to qualify for payment of the severance benefit,
and (ii) you and the Dow Company
sign
|
6.
|
The
Company is under no obligation to grant you the right to receive any cash
payment under any law, federal, local, domestic or
foreign.
|
7.
|
Your
right to exercise this Option may not be sold, pledged, or otherwise
transferred (except as hereinafter provided) and any attempts to sell,
pledge, assign or otherwise transfer shall be void and your rights to the
Option shall therefore be forfeited. Your right to exercise such Option
shall, however, be transferable by will or pursuant to the laws of descent
and distribution or you may make a written designation of a beneficiary on
the form prescribed by the Company, which beneficiary (if any) shall
succeed to your rights under this Agreement in the event of your
death.
|
8.
|
If
at any time during the term of this Agreement you engage in any act of
Unfair Competition (as defined below), this Agreement shall terminate
effective on the date on which you enter into such act of Unfair
Competition, unless terminated sooner by operation of another term or
condition of this Agreement or the Plan. In addition, if at any time
within three years after you exercise any portion of this Option you
engage in any act of Unfair Competition, you shall promptly pay to the
Company any excess of the Fair Market Value over the exercise price on the
date of exercise. The Compensation Committee shall, in its sole
discretion, determine when any act of Unfair Competition has occurred, and
the determination of the Compensation Committee shall be final and binding
as to all parties. For purposes of this Agreement, the term “Unfair
Competition” shall mean and include activity on your part that is in
competition with a Dow Company or is or may be harmful to the interests of
a Dow Company, including but not limited to conduct related to your
employment for which either criminal or civil penalties against you may be
sought, or your acceptance of employment with an employer that is in
competition with a Dow Company.
|
9.
|
In
the event that additional shares of Common Stock of the Company are issued
pursuant to a stock split or a stock dividend, the Board of Directors
shall make appropriate adjustments in the number and kind of Stock Options
credited to your account and the Option price recorded on the books of the
Company as deemed appropriate, provided that any adjustments to a Stock
Option shall be made in a manner that will not result in the grant of a
new Stock Option under Code Section
409A
|
10.
|
Nothing
contained in this Agreement shall confer or be deemed to confer upon you
any right with respect to continuance of employment by a Dow Company, nor
interfere in any way with the right of a Dow Company to terminate your
employment at any time with or without assigning a reason
therefore.
|
11.
|
This
instrument shall constitute a Non-Qualified Stock Option Agreement between
the Company and you, and this Agreement shall be deemed to have been made
on ___________. To the extent that federal laws do not otherwise control,
this Agreement shall be governed by the laws of the state of Delaware and
construed accordingly. Subject to earlier termination by operation of
another term or condition of this Agreement or the Plan, this Agreement
expires when all Options granted under this Agreement have been exercised
or on the expiration date outlined in the letter attached to this
Agreement, whichever date is earlier. You may choose to reject this award
by written notice delivered to the Compensation Committee of the Company
within ninety days of your receipt of this instrument. Individuals who
reject this Stock Option will not receive additional cash or non-cash
compensation in lieu of the Stock
Option.
|
12.
|
Upon
the occurrence of a Change of Control as defined in the Plan, your right
to receive the number of unvested Stock Options credited to your account
under this Agreement shall not be forfeitable under any circumstances. If
you also experience an involuntary Separation from Service from Dow or an
affiliate thereof within two years following a Change of Control, the
Company shall deliver these Stock Options to you on the 30th day following
such Separation from Service.
|
|
(a)
|
to
the spouse of such person, if any;
|
|
(b)
|
to
the children of such person, if any;
or
|
|
(c)
|
to
the deceased person’s estate.
|
Section
2.01 Administrator. "Administrator" means the
Retirement Board appointed under the Dow Employees’ Pension
Plan.
|
Section
2.02 Base Salary. “Base Salary” means the
annual base rate of pay from the Company at which a Participant is
employed (excluding Performance Awards, commissions, relocation expenses,
and other non-regular forms of compensation) before deductions under (A)
deferrals pursuant to Section 4.02 and (B) contributions made on his or
her behalf to any qualified plan maintained by any Company or to any
cafeteria plan under Code section 125 maintained by any
Company. "Base Salary" for a Cadre Employee means the annual
base rate of pay (excluding Performance Awards, commissions, relocation
expenses, and other non-regular forms of compensation) before the
deductions listed above payable to a Cadre Employee while the Cadre
Employee is on U.S. assignment.
|
Section
2.03 Base Salary Deferral. “Base Salary
Deferral” means the amount of a Participant’s Base Salary which the
Participant elects to have withheld on a pre-tax basis from his or her
Base Salary and credited to his or her Deferral Account pursuant to
Section 4.02.
|
Section
2.04 Beneficiary. "Beneficiary" means the
person, persons or entity designated by the Participant to receive any
benefits payable under the Plan pursuant to Article
VIII.
|
Section
2.05 Board. "Board" means the Board of
Directors of The Dow Chemical Company.
|
Section
2.06 Cadre Employee. “Cadre Employee” means an
employee who has been authorized by Dow Europe GmbH to participate in the
Cadre Pension Plan and who earns compensation while on assignment in the
U.S.
|
Section
2.07 Change of Control. For purposes of this
Plan, a “Change of Control” shall be deemed to have occurred on: (a) the
date that any one person, or more than one person acting as a group
acquires, ownership of stock of The Dow Chemical Company that, together
with stock held by such person or group, constitutes more than 50% of the
total fair market value or total voting power of the stock of The Dow
Chemical Company, (b) the date that a majority of the members of the Board
of Directors of The Dow Chemical Company is replaced during any 12-month
period by directors whose appointment or election is not endorsed by a
majority of the directors before the date of the appointment or election,
(c) the date that any one person, or more than one person acting as a
group, acquires (or has acquired during the 12-month period ending on the
date of the most recent acquisition by such person or persons) ownership
of stock of The Dow Chemical Company possessing 30% or more of the total
voting power of the stock of such corporation, (d) the date that any one
person, or more than one person acting as a group, acquires (or has
acquired during the 12-month period ending on the date of the most recent
acquisition by such person or persons) assets from The Dow Chemical
Company that has a total gross fair market value equal to or more than 40%
of the total gross fair market value of all of the assets of The Dow
Chemical Company immediately before such acquisition or acquisitions,
provided that the following asset transfers shall not result in a Change
of Control: (i) a transfer of assets to a
stockholder of The Dow Chemical Company in exchange for or with respect to
its stock, (ii) a transfer to a corporation, 50% or more of the
total value or voting power of which is owned, directly or indirectly, by
The Dow Chemical Company, (iii) a transfer to a person, or more than one
person acting as a group, that owns 50% or more of the stock of The Dow
Chemical Company, or (iv) a transfer to an entity, at least 50%
of the total value or voting power of which is owned, directly or
indirectly, by a person described in clause (iii). This
definition of “Change of Control” is intended to conform to the definition
of a “change in ownership or effective control of a corporation, or a
change in the ownership of a substantial portion of the assets of a
corporation” as defined under Code section 409A and any subsequent
authority issued pursuant thereto, and no corporate event shall be
considered a Change of Control unless it meets such
requirements.
|
Section
2.08 Code. "Code" means the Internal Revenue
Code of 1986, as amended.
|
Section
2.09 Common Stock. "Common Stock" means the
common stock of The Dow Chemical Company.
|
Section
2.10 Company. "Company" means The Dow Chemical
Company, its successors, any subsidiary or affiliated organizations
authorized by the Board or the Administrator to participate in the Plan
and any organization into which or with which The Dow Chemical Company may
merge or consolidate or to which all or substantially all of its assets
may be transferred.
|
Section
2.11 Deferral Account. "Deferral Account"
means the notional account established for record keeping purposes for
each Participant pursuant to Article VI.
|
Section
2.12 Deferred Amount. "Deferred Amount"
means the amount deferred pursuant to Section 4.02.
|
Section
2.13 Designee. “Designee” means The Dow
Chemical Company’s Global Compensation & Benefits Department to whom
the Administrator has delegated the authority to take action under the
Plan.
|
Section
2.14 Disabled. “Disabled” or "Disability"
means a Participant who, by reason of any medically determinable physical
or mental impairment which can be expected to result in death or can be
expected to last for a continuous period of not less than 12 months, is
receiving income replacement benefits for a period of not less than 3
months under the Company's ERISA welfare plan that provides long-term
disability payments. The Administrator, in its complete and
sole discretion, shall determine whether a Participant is
Disabled. The Administrator may require that the Participant
submit to an examination on an annual basis, at the expense of the Company
at which such Participant was employed, by a competent physician or
medical clinic selected by the Administrator to confirm the Participant is
Disabled. On the basis of such medical evidence, the
determination of the Administrator as to whether or not a condition of
Disability exists or continues shall be
conclusive.
|
Section
2.15 Discretionary Company
Contribution. "Discretionary Company Contribution" means an
amount credited to a Participant's Deferral Account pursuant to Section
7.09.
|
Section
2.16 Domestic Partner. A person who is a
member of a Domestic Partnership.
|
Section
2.17 Domestic Partnership. A partnership
of two people that meets the definition of “Domestic Partnership” as
defined in the Savings Plan.
|
Section
2.18 Eligible Compensation. "Eligible
Compensation" means any Base Salary, Performance Awards and any other
monies treated as eligible compensation by The Dow Chemical Company,
payable to a Participant to the extent the Participant is on the U.S.
payroll of the Company at the time the amount would have otherwise been
paid to the Participant. "Eligible Compensation" for a Cadre
Employee means any Base Salary, Performance Awards and any other monies
treated as eligible compensation by The Dow Chemical Company, payable to a
Cadre Employee while the Cadre Employee is on U.S.
assignment.
|
Section
2.19 Eligible Employee. “Eligible Employee”
means an employee of any Company who: (i) is a United States employee or
an expatriate who is paid from one of The Dow Chemical Company’s U.S.
entities, (ii) is a member of the functional specialist/functional leader
or global leadership job families, (iii) has a job level of 362 points or
higher, (iv) is eligible for participation in the Savings Plan,
(v) is designated by the Administrator as eligible to participate in the
Plan as of September 30 for deferral of Base Salary and Performance
Awards, and (vi) qualifies as a member of the “select group of management
or highly compensated employees” under ERISA. For purposes of
Section 7.09, Discretionary Company Contributions, only, “Eligible
Employee” means an employee who: (i) is a United States employee, (ii) has
terminated employment with a foreign affiliate of the Company and has
accepted employment with one of the Company’s U.S. entities, (iii) is
eligible for a signing bonus from one of the Company’s U.S. entities, (iv)
has a job level of 208 points or higher, (v) is eligible for participation
in the Savings Plan and (vi) qualifies as a member of the “select group of
management or highly compensated employees” under
ERISA.
|
Section
2.20 ERISA. "ERISA" means the Employee
Retirement Income Security Act of 1974, as amended.
|
Section
2.21 Executive Life Insurance. “Executive Life
Insurance” means a life insurance policy under TDCC Executive Split Dollar
Life Insurance Plan, or the UCC Executive Life Insurance
Plan.
|
Section
2.22 Fair Market Value. "Fair Market Value" of
a share of Common Stock means the closing price of The Dow Chemical
Company’s Common Stock on the New York Stock Exchange on the most recent
day on which the Common Stock was so traded that precedes the date the
Fair Market Value is to be determined. The definition of Fair Market Value
in this Section shall be exclusively used to determine the values of a
Participant’s interest in The Dow Chemical Company Stock Index Fund
(defined in Section 6.02(b)) for all relevant purposes under the
Plan.
|
Section
2.23 Form of Payment. "Form of Payment" means
payment in one lump sum or in substantially equal monthly, quarterly or
annual installments not to exceed 15 years.
|
Section
2.24 Hardship Withdrawal. “Hardship
Withdrawal” means the early payment of all or part of the balance in a
Deferral Account(s) in the event of an Unforeseeable
Emergency.
|
Section
2.25 Hypothetical Investment
Benchmark. “Hypothetical Investment Benchmark” shall mean the
phantom investment benchmarks which are used to measure the return
credited to a Participant’s Deferral Account.
|
Section
2.26 Key Employee. "Key Employee" means any
Eligible Employee or Cadre Employee who has a job level of 820 points or
higher as of his Separation from Service.
|
Section
2.27 Matching Contribution. “Matching
Contribution” means the amount of annual matching contribution that each
Company will make to the Plan.
|
Section2.28 Participant. "Participant"
means any individual who is eligible and makes an election to participate
in this Plan by filing a Participation Agreement as provided in Article
IV.
|
Section
2.29 Participation Agreement. "Participation
Agreement" means an agreement filed by a Participant in accordance with
Article IV.
|
Section
2.30 Performance Awards. “Performance
Awards” means the amount paid in cash to the Participant by any Company in
the form of annual incentive bonuses for a Plan
Year. "Performance Awards" for a Cadre Employee means the
annual incentive bonuses for a Plan Year payable to a Cadre Employee while
the Cadre Employee is on U.S. assignment.
|
Section
2.31 Performance Deferral. “Performance
Deferral” means the amount of a Participant’s Performance Award which the
Participant elects to have withheld on a pre-tax basis from his or her
Performance Award and credited to his or her account pursuant to Section
4.02.
|
Section
2.32 Phantom Share Units. “Phantom Share
Units” means units of deemed investment in shares of The Dow Chemical
Company Common Stock so determined under Section
6.02(b).
|
Section
2.33 Plan Year. "Plan Year" means a
twelve-month period beginning January 1 and ending the following December
31.
|
Section
2.34 Savings Plan. “Savings Plan” means The Dow Chemical
Company Employees’ Savings Plan as it currently exists and as it may
subsequently be amended.
|
Section
2.35 Section 16 Participant. “Section 16
Participant” means an officer or director of The Dow Chemical Company
required to report transactions in The Dow Chemical Company securities to
the Securities and Exchange Commission pursuant to Section 16(a) of the
Securities Exchange Act of 1934.
|
Section
2.36 Separation from Service. "Separation from
Service” or "Separates from Service" means a “separation from service”
within the meaning of Section 409A of the Code, except that in applying
Section 1563(a)(1), (2), and (3) of the Code for purposes of determining a
controlled group of corporations under Section 414(b) and (c) of the Code,
and in applying Treasury Regulation section 1.414(c)-2 for purposes of
determining trades or businesses that are under common control under
Section 414(c) of the Code, the language “at least 45 percent” is used
instead of “at least 80 percent” each place it appears.
|
Section
2.37 Unforeseeable Emergency. "Unforeseeable
Emergency" means severe financial hardship to the Participant resulting
from an illness or accident of the Participant, the Participant’s spouse,
or a dependent (as defined in Code section 152(a)) of the Participant,
loss of the Participant's property due to casualty, or other similar
extraordinary and unforeseeable circumstances arising as a result of
events beyond the control of the Participant as determined by the
Administrator. The amount of the distribution may not exceed
the amounts necessary to satisfy such emergency plus amounts necessary to
pay taxes reasonably anticipated as a result of the distribution, after
taking into account the extent to which such hardship is or may be
relieved through reimbursement or compensation by insurance or otherwise,
by liquidation of the Participant’s assets (to the extent the liquidation
of such assets would not itself cause severe financial hardship) or by
cessation of the Participant's deferrals under the
Plan.
|
Section
2.38 Valuation Date. "Valuation Date"
means the last day of each calendar month or such other date as the
Administrator in its sole discretion may
determine.
|
Section
4.02 Contents of Participation
Agreement.
|
(a) Eligible
Employees. Subject to Article VII, each Participation Agreement
shall set forth the amount of Eligible Compensation for the Plan Year to
which the Participation Agreement relates that is to be deferred under the
Plan (the "Deferred Amount"), expressed as either a dollar amount or a
percentage of the Base Salary and Performance Awards for such Plan Year;
provided, that the minimum Deferred Amount for any Plan Year shall not be
less than 5% (in 5% increments) of Base Salary and/or 5% (in 5%
increments) of any Performance Award and the maximum Deferred Amount for
any Plan Year shall not exceed 50% of Base Salary and 85% of any
Performance Award. In accordance with the provisions contained
in Article VII, each Participation Agreement shall also set forth a time
and Form of Payment of a Deferred Amount. Participation
Agreements are to be completed in a format specified by the
Administrator.
|
(b) Cadre
Employees. A Cadre Employee's Participation Agreement shall set
forth the amount of Base Salary for the Plan Year to which the
Participation Agreement relates that is to be deferred under the Plan (the
"Deferred Amount"), expressed as a whole percentage of the Base Salary for
such Plan Year; provided that the maximum Deferred Amount for any Plan
Year shall not exceed 15% of Base Salary. In addition, each
Participation Agreement shall, in accordance with the provisions contained
in Article VII, set forth a time and Form of Payment of a Deferred
Amount. Participation Agreements are to be completed in a
format specified by the Administrator.
|
|
Section
4.03 Modification or Revocation of Election by
Participant. A Participant may not change the amount of his or her
Deferred Amount during a Plan Year. A Participant’s
Participation Agreement may not be made, modified or revoked
retroactively.
|
Section
5.01 Elective Deferred Compensation. Except
for Section 16 Participants, the Deferred Amount of a Participant with
respect to each Plan Year of participation in the Plan shall be credited
to the Participant’s Deferral Account as and when such Deferred Amount
would otherwise have been paid to the Participant. For Section
16 Participants who elect to direct their Deferred Amount to the
Hypothetical Investment Benchmark of The Dow Chemical Company Stock Index
Fund only, the Deferred Amount of that Participant with respect to each
Plan Year of participation shall be credited to the Participant’s Deferral
Account in the Hypothetical Investment Benchmark of 125% of Ten Year
Treasury Notes as and when such Deferred Amount would otherwise have been
paid to the Participant; on a quarterly basis (on the last business day of
the months of March, June, September and December), such Deferred Amount
shall be reallocated to the Hypothetical Investment Benchmark of The Dow
Chemical Company Stock Index Fund. If a Participant is employed
at a Company other than The Dow Chemical Company, such Company shall pay
or transfer the Deferred Amounts for all such Company’s Participants to
The Dow Chemical Company as and when the Deferred Amounts are withheld
from a Participant’s Base Salary or Performance Award. Such
forwarded Deferred Amounts will be held as part of the general assets of
The Dow Chemical Company. The earnings credit under Section
6.02 based on a Participant’s investment selection among the Hypothetical
Investment Benchmarks specified in Appendix A hereto, as amended by the
Administrator from time to time, shall be borne by The Dow Chemical
Company. To the extent that any Company is required to withhold
any taxes or other amounts from the Deferred Amount pursuant to any state,
Federal or local law, such amounts shall be taken out of other
compensation eligible to be paid to the Participant that is not deferred
under this Plan.
|
Section
5.02 Vesting of Deferral Account. Except as
provided in Sections 7.09 and 7.10, a Participant shall be 100% vested in
his or her Deferral Account as of each Valuation Date.
|
Base
Pay:
|
You
will initially hire into Dow with a Swiss contract at Dow’s Horgen,
Switzerland location. Your annualized base pay salary will be
754,000 Swiss Francs per year. Within a reasonable time frame yet to be
determined following your hire, you will transfer into the US as a local
hire located in Midland, Michigan. Your initial salary will be
$580,000 per year, or $48,333 per month. Under our Salary
Management Process, your future increases will be based upon your
individual performance and Dow's overall annual salary
plan. Dow conducts a global compensation planning exercise in
February of each year. At that time, you will be eligible for
consideration for a salary increase. For calendar year 2006,
such an increase has been incorporated into the amount offered to
you.
|
Variable
Pay:
|
You
will also be eligible to participate in our annual variable pay program,
called the Performance Award Program. The Performance Award
Program is linked to a combination of company performance and
individual/team performance against business/functional goals, with a
possible range of awards equal to 0 to 200% of your target award
amount. When the company, your team, and you deliver excellent
results, Dow's Performance Award Program is designed to provide a
significant financial reward.
|
Long
Term Incentives:
|
You
will also be considered for participation in the annual Dow Long-Term
Incentive (LTI) Program based on management review and the terms of the
program. This program involves traditional stock options,
performance shares, and deferred stock issued under The Dow Chemical
Company 1988 Award and Option Plan (the 1988 A&O
Plan). Participation levels each year are decided by your
supervisor with Compensation Committee oversight. For calendar
year 2006, your award will consist of the following mix of stock options,
deferred stock, and performance
shares:
|
|
§
|
64,725
non-qualified Stock Option Shares,
|
|
§
|
7,861
Performance Shares,
|
|
§
|
and
7,861 Deferred Shares.
|
|
The
strike price of your non-qualified stock option grant will be calculated
based on the fair market value of Dow stock on your date of hire, which
will also be the date of grant. More
complete
terms and conditions, including the grant price and vesting periods of the
awards, will be outlined in the actual award agreements you will receive,
which, along with the terms of the A&O Plan, will control in the event
of a conflict with the terms of this offer
letter.
|
Cash
Bonus:
|
You
will receive a one-time, gross, lump sum cash bonus of $500,000 (less
applicable taxes), payable 90 days from your hire
date.
|
Additional
One-Time
|
|
Incentives:
|
You
will receive a one-time lump sum payment of $75,000 as a car
allowance. The position does not provide for a company
car.
|
Deferred
Stock:
|
Dow
will make a Deferred Stock grant to you in the amount of 12,000 shares of
Dow common stock, to be delivered on the sixtieth (60
th
)
day following the third anniversary of your actual 2006 date of hire into
Dow. A Deferred Stock Award means that, consistent with the
specified terms of the Award, the Company will deliver to you the
indicated number of Dow common stock shares on the sixtieth (60
th
)
day following the third anniversary date of your hire into
Dow. From the date of grant until the shares are actually
delivered to you, you will be eligible to receive a payment on those
shares equal to any Dow stock dividends that are declared. Any
such dividend equivalents (less applicable taxes) will be paid to you on a
quarterly basis through the normal payroll process. More
complete terms and conditions of this award will be outlined in the actual
agreement you will receive, which, along with the terms of the 1988
A&O Plan, will control in the event of a conflict with the terms of
this offer letter.
|
Vacation:
|
You
will receive 25 working days of vacation for the calendar year 2006,
prorated to your date of hire, as well as an additional 2 personal choice
days per year. You will enter the Dow vacation schedule at an
equivalent of 25 years of employment service credited for vacation
purposes. With each successive year of service, you will
acquire an additional year of employment service for purposes of vacation
benefit calculation.
|
Pension:
|
As
a Swiss employee, you will be eligible to join the Swiss Pension
Foundation defined benefit plan (Swiss Pension Plan). The Swiss
Pension Plan is funded jointly by the Company and employees, with the
employee contribution at 6% of pensionable pay. The maximum
pensionable pay designated by Swiss law is currently 774,000 CHF / year.
As a participant in the Swiss Pension Plan you will be offered the
opportunity to purchase years of service in the plan from the age of 25
immediately after re-hire. Please work with Martin Aschwanden, our
Switzerland H.R. Leader on the purchase of years of service into the Dow
Swiss Pension Plan.
|
Retiree
Medical
|
You
will be eligible for the retiree medical program available at that time to
retirees, in the country from which you retire which in your case is
Switzerland.
|
Severance:
|
While,
like all U.S. Dow employees, you have an at-will employment relationship
with Dow, you will, in the event of your involuntary separation from Dow,
and depending on the circumstances of your involuntary separation, be
eligible to receive any standard transition assistance benefits that are
otherwise available to employees at your job level under the terms and
conditions of any then applicable severance plan in which you are eligible
to participate.
|
Executive
Benefits:
|
In
addition to the full array of benefits available to all US-based salaried
employees, you will also be eligible to participate in several of Dow's
Executive Benefits Programs, including support for financial planning and
executive physical examinations.
|
Relocation:
|
Dow
will cover the shipment of your household goods from Europe to Midland and
will provide temporary housing to you and your family for up to 30
days. Upon acceptance of this offer,
Dow’s
Global Relocation Director, Traci Kellogg, will contact you to arrange
details.
|
Other
Benefits:
|
You
will be eligible to participate in a range of additional benefits
including health, life, dental and disability insurance, consistent with
your enrollment elections and the terms and conditions of those
programs. The details of these programs will be provided to you
in our standard benefits package
materials.
|
·
|
Providing
documentation of the proper authorization to work in the United States
and, if required, obtaining the appropriate U.S. export
license(s). Only U.S. citizens or nationals, U.S. Permanent
Residents, or aliens who are authorized to work in the United States can
be considered for employment with Dow. Upon acceptance of this offer,
Traci Kellogg, Global Relocation Director will be contacting you as to
arrange all the paperwork needed for your visa
permit.
|
·
|
Dow
determining, to its satisfaction, that your commencing employment with Dow
does not violate any confidentially and/or non-competition agreements you
may have entered into with your current or former
employers. Should any such agreements or restrictions exist,
you should forward them immediately to Gregory Freiwald via fax at
989-638-7073.
|
·
|
Signing
two (2) standard Dow Chemical Employee Agreement forms (patent and trade
secret) on your report-to-work date, a sample of which is enclosed for
your review. Among other things, this Agreement clarifies that
you will at all times have an at-will employment status with
Dow. Nothing in this offer letter constitutes or may be relied
upon as a contract of employment for any specified period or duration or
otherwise alters your status as an at-will employee of
Dow.
|
·
|
Passing
a screening for illegal and controlled substances (negative results)
during the first week of employment by Dow Health Services. You
may voluntarily authorize a screening prior to acceptance of this job
offer.
|
·
|
Verifying
your employment eligibility by completing an I-9 form with supportive
documentation on your report-to-work date. As required by law,
Dow employs only U.S. citizens and aliens authorized to work in the United
States.
|
For
the year ended December 31
|
||||||||||||||||||||
In
millions, except ratio (Unaudited)
|
2008
|
2007
|
2006
|
2005
|
2004
|
|||||||||||||||
Income
before Income Taxes and Minority Interests
|
$ | 1,321 | $ | 4,229 | $ | 4,972 | $ | 6,399 | $ | 3,796 | ||||||||||
Add
(deduct):
|
||||||||||||||||||||
Equity
in earnings of nonconsolidated affiliates
|
(787 | ) | (1,122 | ) | (959 | ) | (964 | ) | (923 | ) | ||||||||||
Distributed
income of earnings of nonconsolidated affiliates
|
836 | 774 | 616 | 495 | 370 | |||||||||||||||
Capitalized
interest
|
(97 | ) | (85 | ) | (73 | ) | (56 | ) | (48 | ) | ||||||||||
Amortization
of capitalized interest
|
84 | 79 | 70 | 70 | 65 | |||||||||||||||
Preferred
security dividends
|
(63 | ) | (81 | ) | (77 | ) | (65 | ) | (54 | ) | ||||||||||
Adjusted
earnings
|
$ | 1,294 | $ | 3,794 | $ | 4,549 | $ | 5,879 | $ | 3,206 | ||||||||||
Fixed
charges:
|
||||||||||||||||||||
Interest
expense and amortization of debt discount
|
$ | 648 | $ | 584 | $ | 616 | $ | 702 | $ | 747 | ||||||||||
Capitalized
interest
|
97 | 85 | 73 | 56 | 48 | |||||||||||||||
Preferred
security dividends
|
63 | 81 | 77 | 65 | 54 | |||||||||||||||
Rental
expense – interest component
|
120 | 124 | 131 | 133 | 135 | |||||||||||||||
Total
fixed charges
|
$ | 928 | $ | 874 | $ | 897 | $ | 956 | $ | 984 | ||||||||||
Earnings
available for the payment of fixed charges
|
$ | 2,222 | $ | 4,668 | $ | 5,446 | $ | 6,835 | $ | 4,190 | ||||||||||
Ratio
of earnings to fixed charges
|
2.4 | 5.3 | 6.1 | 7.2 | 4.3 |
Subsidiaries
of The Dow Chemical Company
|
|
||||||||||||||
At
December 31, 2008
|
|||||||||||||||
Location*
|
%
Ownership
|
||||||||||||||
This
list includes companies for which the effective ownership by The Dow
Chemical Company is 50 percent or more.
|
|||||||||||||||
The
Dow Chemical Company
|
Delaware
|
||||||||||||||
Americas
Styrenics LLC (1)
|
Delaware
|
50
|
|||||||||||||
Arabian
Chemical Company (Latex) Ltd. (1)
|
Saudi
Arabia
|
50
|
|||||||||||||
Arabian
Chemical Company (Polystyrene) Limited (1)
|
Saudi
Arabia
|
50
|
|||||||||||||
ARAKAWA
Europe GmbH
|
Germany
|
60
|
|||||||||||||
Buildscape,
LLC
|
Delaware
|
100
|
|||||||||||||
CanStates
Holdings Inc.
|
Oklahoma
|
100
|
|||||||||||||
ANGUS
Chemical Company
|
Delaware
|
100
|
|||||||||||||
CD
Polymers Inc.
|
Delaware
|
100
|
|||||||||||||
Centen
Ag Inc.
|
Delaware
|
100
|
|||||||||||||
Dow
AgroSciences LLC (9)
|
Delaware
|
39
|
|||||||||||||
DowBrands
Inc. (17)
|
Delaware
|
8
|
|||||||||||||
Mycogen
Corporation (16)
|
|
California
|
12
|
||||||||||||
Chemars
Inc.
|
Delaware
|
100
|
|||||||||||||
Chemars
III LLC
|
Delaware
|
100
|
|||||||||||||
Chemtech
II L.P. (8)
|
Delaware
|
22
|
|||||||||||||
DC
Partnership Management Inc.
|
Delaware
|
100
|
|||||||||||||
DowBrands
L.P. (6)
|
Delaware
|
42
|
|||||||||||||
DCOMCO,
Inc.
|
Delaware
|
100
|
|||||||||||||
Denmerco
Inc.
|
Delaware
|
100
|
|||||||||||||
Dexco
Polymers Operating Company LLC (1)
|
Texas
|
50
|
|||||||||||||
Dexco
Polymers L.P. (1) (23)
|
Texas
|
1
|
|||||||||||||
Diamond
Capital Management Inc.
|
Delaware
|
100
|
|||||||||||||
DML
Holding Inc. (36)
|
Delaware
|
89
|
|||||||||||||
DMM
Financial LLC
|
Delaware
|
100
|
|||||||||||||
MTD
Pipeline LLC (1)
|
Delaware
|
50
|
|||||||||||||
Dofinco,
Inc.
|
Delaware
|
100
|
|||||||||||||
Dow
Capital International LLC
|
Delaware
|
100
|
|||||||||||||
Dow
Chemical (Australia) Limited
|
Australia
|
100
|
|||||||||||||
Dow
Australia Superannuation Fund A Pty Limited
|
Australia
|
100
|
|||||||||||||
Polystyrene
Australia Pty Ltd (1)
|
Australia
|
50
|
|||||||||||||
Dow
Chemical (China) Investment Company Limited
|
China
|
100
|
|||||||||||||
Dow
Chemical (China) Company Limited
|
China
|
100
|
|||||||||||||
Dow
Chemical (Guangzhou) Company Limited
|
China
|
100
|
|||||||||||||
Dow
Chemical (Shanghai) Company Limited
|
China
|
100
|
|||||||||||||
Dow
Chemical (Zhangjiagang) Company Limited (13)
|
China
|
85
|
|||||||||||||
Dow
S/B Latex (Zhangjiagang) Co. Ltd. (12)
|
China
|
61
|
|||||||||||||
Guangdong
Zhongshan Amerchol Specialty Chemicals
|
China
|
90
|
|||||||||||||
SAL
Petrochemical (Zhangjiagang) Company Limited (15)
|
China
|
10
|
|||||||||||||
Zhejiang
Pacific Chemical Corporation
|
China
|
100
|
|||||||||||||
Dow
Chemical Delaware Corp.
|
Delaware
|
100
|
|||||||||||||
Chemtech
II L.P. (8)
|
Delaware
|
73
|
|||||||||||||
Chemtech
Portfolio Inc. (11)
|
Texas
|
33
|
|||||||||||||
Chemtech
Portfolio II Inc.
|
Michigan
|
100
|
|||||||||||||
Dow
Chemical (Hong Kong) Limited
|
Hong
Kong
|
100
|
|||||||||||||
Dow
Chemical International Ltd.
|
Delaware
|
100
|
|||||||||||||
Calvin
Capital LLC
|
Delaware
|
100
|
|||||||||||||
Dow
Chemical Thailand Ltd.
|
Thailand
|
100
|
|||||||||||||
Dow
International Holdings Company (27)
|
Delaware
|
1
|
|||||||||||||
Pacific
Plastics (Thailand) Limited (47)
|
Thailand
|
51
|
|||||||||||||
Petroquimica-Dow
S.A. (Petrodow)
|
Chile
|
100
|
|||||||||||||
Dow
Chemical Korea Limited (40)
|
Korea
|
86
|
Dow
Chemical (NZ) Limited
|
New
Zealand
|
100
|
||||||||||
Dow
Chemical Pacific Limited
|
Hong
Kong
|
100
|
||||||||||
Dow
Chemical Pacific (Singapore) Private Limited
|
Singapore
|
100
|
||||||||||
Dow
Chemical International Pvt. Ltd. (32)
|
India
|
99
|
||||||||||
Dow
Chemical (Malaysia) Sdn. Bhd.
|
Malaysia
|
100
|
||||||||||
Dow
Financial Holdings Singapore Pte Ltd.
|
Singapore
|
100
|
||||||||||
Dow
Chemical (Zhangjiagang) Company Limited (13)
|
China
|
15
|
||||||||||
Dow
S/B Latex (Zhangjiagang) Co. Ltd. (12)
|
China
|
39
|
||||||||||
SAL
Petrochemical (Zhangjiagang) Company Limited (15)
|
China
|
90
|
||||||||||
G.Z.
Holdings Pte. Ltd.
|
Singapore
|
100
|
||||||||||
PT
Dow Chemical Indonesia (18)
|
Indonesia
|
15
|
||||||||||
S.H.A.
Holdings Pte. Ltd.
|
Singapore
|
100
|
||||||||||
Dow
Chemical (Singapore) Private Limited
|
Singapore
|
100
|
||||||||||
Dow
Chemical International Pvt. Ltd. (32)
|
India
|
1
|
||||||||||
Dow
Chemical Taiwan Limited
|
Taiwan
|
100
|
||||||||||
Dow
Chemical Telecommunications Corp.
|
Delaware
|
100
|
||||||||||
Dow
Credit Corporation
|
Delaware
|
100
|
||||||||||
Dow
Customs & Trade Inc.
|
Delaware
|
100
|
||||||||||
Dow
Deutschland Inc.
|
Delaware/Germany
|
100
|
||||||||||
Dow
Chemical Inter-American Limited
|
Delaware
|
100
|
||||||||||
Dow
Quimica de Colombia S.A. (5)
|
Colombia
|
10
|
||||||||||
Dow
Deutschland Management Inc.
|
Delaware
|
100
|
||||||||||
Dow
Engineering Company
|
Delaware
|
100
|
||||||||||
Dow
Engineering, Inc.
|
Michigan
|
100
|
||||||||||
Dow
Environmental Inc.
|
Delaware
|
100
|
||||||||||
Dow
Financial Services Inc.
|
Delaware
|
100
|
||||||||||
Dow
Global Technologies Inc.
|
Delaware
|
100
|
||||||||||
Chemtech
Portfolio Inc. (11)
|
Texas
|
67
|
||||||||||
Dow
Petrochemicals Holding LLC (48)
|
Delaware
|
25
|
||||||||||
Daulat
Holdco LLC
|
Delaware
|
100
|
||||||||||
K-D
Petrochemicals C.V. (1) (55)
|
Netherlands
|
1
|
||||||||||
K-Dow
Petrochemicals GmbH (1)
|
Switzerland
|
50
|
||||||||||
K-D
Petrochemicals C.V. (1) (55)
|
Netherlands
|
47
|
||||||||||
Dow
Technology Investments LLC (43)
|
Delaware
|
50
|
||||||||||
Dow
Holdings LLC
|
Delaware
|
100
|
||||||||||
Dow
Corning Corporation (1)
|
Michigan
|
50
|
||||||||||
Dow
Hydrocarbons and Resources LLC
|
Delaware
|
100
|
||||||||||
Cayuse
Pipeline, Inc.
|
Texas
|
100
|
||||||||||
Dow
Intrastate Gas Company
|
Louisiana
|
100
|
||||||||||
Dow
Pipeline Company
|
Texas
|
100
|
||||||||||
K/D/S
Promix, LLC (1)
|
Texas
|
50
|
||||||||||
Midland
Pipeline Corp.
|
Delaware
|
100
|
||||||||||
Fort
Saskatchewan Ethylene Storage Corporation (1)
|
Canada
|
50
|
||||||||||
Fort
Saskatchewan Ethylene Storage Limited Partnership (1) (14)
|
Canada
|
1
|
||||||||||
DowBrands
L.P. (6)
|
Delaware
|
58
|
||||||||||
Dow
Internacional Mexicana S.A. de C.V.
|
Mexico
|
100
|
||||||||||
Dow
International B.V.
|
Netherlands
|
100
|
||||||||||
Dow
International Financial Services
|
Ireland
|
100
|
||||||||||
Dow
Capital Public Limited Company
|
Ireland
|
100
|
||||||||||
Dow
International Holdings Company (27)
|
Delaware
|
72
|
||||||||||
DC
Spectrum Holding C.V. (44)
|
Netherlands
|
99
|
||||||||||
Coöperatieve
DC Prisma Holding U.A. (45)
|
Netherlands
|
99
|
Dow
Dutch Holding B.V.
|
Netherlands
|
100
|
||||||||||
DC
Galaxy Holding C.V. (46)
|
Netherlands
|
1
|
||||||||||
Dow
Europe Finance I B.V.
|
Netherlands
|
100
|
||||||||||
Dow
International Holdings S.A.
|
Switzerland
|
100
|
||||||||||
DC
Galaxy Holding C.V. (46)
|
Netherlands
|
99
|
||||||||||
Dow
Europe Holding B.V.
|
Netherlands
|
100
|
||||||||||
BASF
DOW HPPO B.V. (1)
|
Netherlands
|
50
|
||||||||||
BASF
DOW HPPO Technology B.V. (1)
|
Netherlands
|
50
|
||||||||||
Control
Securities Finance (Consecfin) B.V.
|
Netherlands
|
100
|
||||||||||
DC
Finance Canada B.V.
|
Netherlands
|
100
|
||||||||||
Domaluna
B.V.
|
Netherlands
|
100
|
||||||||||
Dow
Austria Gesellschaft m.b.H
|
Austria
|
100
|
||||||||||
Dow
Belgium B.V.B.A.
|
Belgium
|
100
|
||||||||||
Dow
Benelux B.V.
|
Netherlands
|
100
|
||||||||||
Dow
Netwerk B.V.
|
Netherlands
|
100
|
||||||||||
Emergo
Finance C.V. (1)
|
Netherlands
|
50
|
||||||||||
Polyol
Belgium B.V.B.A. (10)
|
Belgium
|
99
|
||||||||||
Valuepark
Terneuzen Beheer B.V. (1)
|
Netherlands
|
50
|
||||||||||
Valuepark
Terneuzen C.V. (1) (31)
|
Netherlands
|
1
|
||||||||||
Dow
Beteiligungsgesellschaft mbH & Co. KG
|
Germany
|
100
|
||||||||||
Dow
Olefinverbund GmbH (50)
|
Germany
|
5
|
||||||||||
Dow
Chemical Company Limited
|
United
Kingdom
|
100
|
||||||||||
Autothane
Limited
|
United
Kingdom
|
100
|
||||||||||
Cromarty
Petroleum Company Limited (1)
|
United
Kingdom
|
50
|
||||||||||
Hyperlast
Limited
|
United
Kingdom
|
100
|
||||||||||
ALH
Rail Coatings Limited (1)
|
United
Kingdom
|
50
|
||||||||||
Hypertec
Print Services Limited
|
United
Kingdom
|
100
|
||||||||||
Xitrack
Limited (1)
|
United
Kingdom
|
50
|
||||||||||
Dow
Chemical Iberica S.L.
|
Spain
|
99
|
||||||||||
Terminal
de Atraque de Productos Petroquimicos AIE (1)
|
Spain
|
50
|
||||||||||
Transformadora
de Etileno A.I.E. (1)
|
Spain
|
50
|
||||||||||
Dow
Chemical Korea Limited (40)
|
Korea
|
14
|
||||||||||
Dow
Chemical OOO
|
Russia
|
100
|
||||||||||
Dow
Chemical Romania S.R.L.
|
Romania
|
100
|
||||||||||
Dow
Europe GmbH
|
Switzerland
|
100
|
||||||||||
Advanced
Design Concepts GmbH (1)
|
Germany
|
50
|
||||||||||
Dolpa
S.a.r.l.
|
Luxembourg
|
100
|
||||||||||
Dow-GACL
Solventure LTD (1)
|
India
|
50
|
||||||||||
Dow
Chemical IMEA GmbH
|
Switzerland
|
100
|
||||||||||
Dow
Contract Services FZE
|
Dubai
|
100
|
||||||||||
Dow
Egypt Services Limited (49)
|
Egypt
|
25
|
||||||||||
Dow
Mideast Systems S.A.E. (JSC) (2)
|
Egypt
|
1
|
||||||||||
Dow
France S.A.S.
|
France
|
100
|
||||||||||
UPPC
S.A.R.L. (54)
|
France
|
25
|
||||||||||
Dow
Hellas A.E.
|
Greece
|
100
|
||||||||||
Dow
Hungary Kft. (29)
|
Hungary
|
99
|
||||||||||
Dow
InterBranch B.V.
|
Netherlands
|
100
|
||||||||||
Dow
Danmark A/S
|
Denmark
|
100
|
||||||||||
Dow
Hungary Kft. (29)
|
Hungary
|
1
|
||||||||||
Dow
Mideast Systems S.A.E. (JSC) (2)
|
Egypt
|
1
|
||||||||||
Dow
Norge A/S
|
Norway
|
100
|
||||||||||
Dow
Saudi Arabia Company (41)
|
Saudi
Arabia
|
15
|
Dow
Turkiye Kimya Sanayi ve Ticaret Ltd Sti (3)
|
Turkey
|
1
|
||||||||||||
Dow
Zwijndrecht B.V.B.A. (24)
|
Belgium
|
1
|
||||||||||||
Santa
Vitoria Acucar e Alcool Ltda. (1)
|
Brazil
|
50
|
||||||||||||
Dow
Italia s.r.l.
|
Italy
|
100
|
||||||||||||
Dow
AgroSciences Italia s.r.l.
|
Italy
|
100
|
||||||||||||
Dow
Italia Divisione Commerciale s.r.l
|
Italy
|
100
|
||||||||||||
Dow
Mideast Systems S.A.E. (JSC) (2)
|
Egypt
|
98
|
||||||||||||
Dow
Egypt Services Limited (49)
|
Egypt
|
75
|
||||||||||||
Dow
Olefinverbund GmbH (50)
|
Germany
|
95
|
||||||||||||
ANGUS
Chemie GmbH
|
Germany
|
100
|
||||||||||||
Dow
Deutschland GmbH & Co OHG (35)
|
Germany
|
30
|
||||||||||||
Dow
Wolff Cellulosics GmbH & Co OHG (42)
|
Germany
|
50
|
||||||||||||
Dow
AgroSciences GmbH
|
Germany
|
100
|
||||||||||||
Dow
Automotive (Deutschland) GmbH
|
Germany
|
100
|
||||||||||||
Dow
Deutschland GmbH & Co OHG (35)
|
Germany
|
35
|
||||||||||||
Dow
Deutschland Anlagengesellschaft mbH
|
Germany
|
100
|
||||||||||||
Dow
Wolff Cellulosics GmbH
|
Germany
|
100
|
||||||||||||
Probis
GmbH
|
Germany
|
100
|
||||||||||||
UPPC
GmbH
|
Germany
|
100
|
||||||||||||
UPPC
Ltd.
|
United
Kingdom
|
100
|
||||||||||||
UPPC
S.A.R.L. (54)
|
France
|
75
|
||||||||||||
Dow
Pipeline Gesellschaft mbH & Co. KG
|
Germany
|
80
|
||||||||||||
Dow
Pipeline Verwaltungsgesellschaft mbH
|
Germany
|
80
|
||||||||||||
Haltermann
Products GmbH
|
Germany
|
100
|
||||||||||||
SAFECHEM
Europe GmbH
|
Germany
|
100
|
||||||||||||
Dow
Deutschland GmbH & Co OHG (35)
|
Germany
|
35
|
||||||||||||
Dow
Wolff Cellulosics GmbH & Co OHG (42)
|
Germany
|
50
|
||||||||||||
Dow
Plastics and Chemicals Holding B.V.
|
Netherlands
|
100
|
||||||||||||
K-D
Petrochemicals C.V. (1) (55)
|
Netherlands
|
1
|
||||||||||||
Dow
Polska Sp.z.o.o.
|
Poland
|
100
|
||||||||||||
Dow
Portugal - Produtos Quimicos, Unipessoal, Lda.
|
Portugal
|
100
|
||||||||||||
Dow
Real Estate Terneuzen B.V.
|
Netherlands
|
100
|
||||||||||||
Dow
Saudi Arabia Company (41)
|
Saudi
Arabia
|
85
|
||||||||||||
Dow
Southern Africa (Pty) Ltd
|
South
Africa
|
100
|
||||||||||||
Dow
Suomi OY
|
Finland
|
100
|
||||||||||||
Dow
Sverige AB
|
Sweden
|
100
|
||||||||||||
Dow
Turkiye Kimya Sanayi ve Ticaret Ltd Sti (3)
|
Turkey
|
99
|
||||||||||||
Dow
(Wilton) Limited
|
United
Kingdom
|
100
|
||||||||||||
Dow
Zwijndrecht B.V.B.A. (24)
|
Belgium
|
99
|
||||||||||||
Edulan
A/S
|
Denmark
|
100
|
||||||||||||
Edulan
UK Limited
|
United
Kingdom
|
100
|
||||||||||||
Haltermann
B.V.B.A.
|
Belgium
|
100
|
||||||||||||
HPPO
Holding & Finance C.V. (1)
|
Netherlands
|
50
|
||||||||||||
K-Dow
Petrochemicals EU B.V.
|
Netherlands
|
100
|
||||||||||||
K-Dow
Petrochemicals Belgium B.V.B.A.
|
Belgium
|
100
|
||||||||||||
K-Dow
Petrochemicals Iberica S.L.
|
Spain
|
100
|
||||||||||||
K-Dow
Petrochemicals Netherlands B.V.
|
Netherlands
|
100
|
||||||||||||
MEGlobal
B.V. (1)
|
Netherlands
|
50
|
||||||||||||
MTP
HPJV C.V. (1)
|
Netherlands
|
50
|
||||||||||||
MTP
HPJV Management B.V. (1)
|
Netherlands
|
50
|
||||||||||||
Oman
Petrochemical Industries Company LLC (1)
|
Oman
|
50
|
||||||||||||
Polyol
Belgium B.V.B.A. (10)
|
Belgium
|
1
|
RUS
Polyurethanes Holding B.V.
|
Netherlands
|
58
|
|||||||||||||
Dow
Izolan OOO (52)
|
Russia
|
100
|
|||||||||||||
Dow
Izolan Ukraine LLC (53)
|
Ukraine
|
100
|
|||||||||||||
UC
Investment B.V.
|
Netherlands
|
100
|
|||||||||||||
EQUATE
Marketing Company E.C. (1)
|
Bahrain
|
50
|
|||||||||||||
Rofan
Automation and Information Systems B.V.
|
Netherlands
|
100
|
|||||||||||||
Terneuzen
Partnership Services B.V.
|
Netherlands
|
100
|
|||||||||||||
Valuepark
Terneuzen C.V. (1) (31)
|
Netherlands
|
49
|
|||||||||||||
Dow
Netherlands Investments LLC
|
Delaware
|
100
|
|||||||||||||
Coöperatieve
DC Prisma Holding U.A. (45)
|
Netherlands
|
1
|
|||||||||||||
Dow
Netherlands Holdings LLC
|
Delaware
|
100
|
|||||||||||||
DC
Spectrum Holding C.V. (44)
|
Netherlands
|
1
|
|||||||||||||
DowBrands
Inc. (17)
|
Delaware
|
79
|
|||||||||||||
Dow
International Technology Corporation
|
Delaware
|
100
|
|||||||||||||
Dow
Kakoh Kabushiki Kaisha
|
Japan
|
65
|
|||||||||||||
Dow
Pacific Holdings B.V.
|
Netherlands
|
100
|
|||||||||||||
Dow
Petrochemicals Holding LLC (48)
|
Delaware
|
25
|
|||||||||||||
Dow
Quimica Argentina S.A. (25)
|
Argentina
|
87
|
|||||||||||||
Dow
Quimica Chilena S.A. (26)
|
Chile
|
89
|
|||||||||||||
Dow
Quimica de Colombia S.A. (5)
|
Colombia
|
90
|
|||||||||||||
Dow
Quimica Mexicana S.A. de C.V. (21)
|
Mexico
|
85
|
|||||||||||||
Dow
Roofing Systems LLC
|
Delaware
|
100
|
|||||||||||||
Dow
South Africa Holdings (Pty) Ltd.
|
South
Africa
|
100
|
|||||||||||||
Sentrachem
Limited
|
South
Africa
|
100
|
|||||||||||||
Cisvaal
(Proprietary) Limited
|
South
Africa
|
100
|
|||||||||||||
Minchem
International Inc.
|
South
Africa
|
100
|
|||||||||||||
South
African Polymer Holdings (PTY) Ltd.
|
South
Africa
|
100
|
|||||||||||||
Dow
Trading S.A.
|
Switzerland
|
100
|
|||||||||||||
Dow
Trent Limited
|
United
Kingdom
|
100
|
|||||||||||||
Dow
UK Limited
|
United
Kingdom
|
100
|
|||||||||||||
Haltermann
Limited
|
United
Kingdom
|
100
|
|||||||||||||
Ascot
Investments Limited
|
United
Kingdom
|
100
|
|||||||||||||
Ascot
Chemicals Limited
|
United
Kingdom
|
100
|
|||||||||||||
Haltermann
Pension Trustees Limited
|
United
Kingdom
|
100
|
|||||||||||||
Suter
Limited
|
United
Kingdom
|
100
|
|||||||||||||
Dow
Venezuela, C.A. (7)
|
Venezuela
|
36
|
|||||||||||||
Dow
Verwaltungsgesellschaft mbH
|
Germany
|
100
|
|||||||||||||
DSL
Holdings Inc.
|
Delaware
|
100
|
|||||||||||||
Dow
Reichhold Specialty Latex LLC (1)
|
Delaware
|
50
|
|||||||||||||
DW
Dexco Investment LLC
|
Delaware
|
100
|
|||||||||||||
Dexco
Polymers L.P. (1) (23)
|
Texas
|
49
|
|||||||||||||
Equipolymers
B.V. (1)
|
Netherlands
|
50
|
|||||||||||||
Essex
Chemical Corporation
|
New
Jersey
|
100
|
|||||||||||||
Essex
Specialty Products LLC
|
New
Jersey
|
100
|
|||||||||||||
American
Mortell Corporation
|
Texas
|
100
|
|||||||||||||
Mortell
Company
|
Delaware
|
100
|
|||||||||||||
Anabond
Essex India Private Limited (1)
|
India
|
50
|
|||||||||||||
Dow
International Holdings Company (27)
|
Delaware
|
8
|
|||||||||||||
Essex
de Hermosillo, S.A. DE C.V.
|
Mexico
|
100
|
|||||||||||||
GWN
Holding, Inc. (37)
|
Delaware
|
27
|
|||||||||||||
Wuhan
Essex Chemical Co., Ltd.
|
China
|
100
|
|||||||||||||
Fenex
Biopharmaceuticals Inc.
|
Delaware
|
100
|
FilmTec
Corporation
|
Delaware
|
100
|
|||||||||||||
OMEX
Overseas Holdings Inc.
|
Virgin
Islands
|
100
|
|||||||||||||
Zhejiang
OMEX Environmental Engineering Co., Ltd.
|
China
|
100
|
|||||||||||||
Flexible
Products Company
|
Georgia
|
100
|
|||||||||||||
Flexible
Products Company of Canada, Inc
|
Canada
|
100
|
|||||||||||||
Forbanco
Inc.
|
Delaware
|
100
|
|||||||||||||
General
Latex and Chemical Corporation
|
Massachusetts
|
100
|
|||||||||||||
GNS
Enterprises, LLC
|
Georgia
|
100
|
|||||||||||||
GNS
Technologies, LLC
|
Georgia
|
100
|
|||||||||||||
Great
Western Pipeline Company, Inc.
|
California
|
100
|
|||||||||||||
GWN
Holding, Inc. (37)
|
Delaware
|
66
|
|||||||||||||
Dow
Canada Holding LP
|
Canada
|
100
|
|||||||||||||
Daulat
Canada Holding LP (51)
|
Canada
|
50
|
|||||||||||||
Dow
Canada Holding B.V.
|
Netherlands
|
100
|
|||||||||||||
3229809
Nova Scotia Company
|
Canada
|
100
|
|||||||||||||
Dow
Investment Argentina S.A.
|
Argentina
|
100
|
|||||||||||||
PBBPolisur
S.A. (34)
|
Argentina
|
72
|
|||||||||||||
PBBPolisur
S.A. (34)
|
Argentina
|
28
|
|||||||||||||
Dow
Canadian Holding BV
|
Netherlands
|
100
|
|||||||||||||
Daulat
Canada Holding LP
|
Canada
|
50
|
|||||||||||||
K-D
Petrochemicals C.V. (1) (55)
|
Netherlands
|
1
|
|||||||||||||
K-Dow
Canada ULC
|
Canada
|
100
|
|||||||||||||
Dow
Chemical Finance Canada Inc.
|
Canada
|
100
|
|||||||||||||
Modeland
International Holdings Inc. (28)
|
Barbados
|
59
|
|||||||||||||
Dow
Brasil S.A.
|
Brazil
|
100
|
|||||||||||||
Branco
Dow Compostos de Engenharia S.A.
|
Brazil
|
100
|
|||||||||||||
Cambricos
de Uruguay S.A.
|
Uruguay
|
100
|
|||||||||||||
Dopec
Industria E Comercio Ltda.
|
Brazil
|
100
|
|||||||||||||
Dow
Especialidades Quimicas Ltda.
|
Brazil
|
100
|
|||||||||||||
Dow
Brasil Sudeste Industrial Ltda.
|
Brazil
|
100
|
|||||||||||||
Keytil
Sociedad Anonima
|
Uruguay
|
100
|
|||||||||||||
Fort
Saskatchewan Ethylene Storage Limited Partnership (1) (14)
|
Canada
|
49
|
|||||||||||||
H-D
Tech Inc. (1)
|
Canada
|
50
|
|||||||||||||
MEGlobal
Canada Inc (1)
|
Canada
|
50
|
|||||||||||||
Pétromont
and Company, Limited Partnership (1)
|
Canada
|
50
|
|||||||||||||
Pétromont
Inc. (1)
|
Canada
|
50
|
|||||||||||||
Ifco
Inc.
|
Delaware
|
100
|
|||||||||||||
Chemtech
II L.P. (8)
|
Delaware
|
5
|
|||||||||||||
Ion
Holdings LLC (20)
|
Delaware
|
60
|
|||||||||||||
Ion
Investments S.a.r.l.
|
Luxembourg
|
100
|
|||||||||||||
Tornado
Finance V.O.F.
|
Netherlands
|
60
|
|||||||||||||
Intarsia
Corporation
|
Delaware
|
99
|
|||||||||||||
Joliet
Marine Terminal Trust Estate (1)
|
Illinois
|
50
|
|||||||||||||
Liana
Limited
|
Delaware
|
100
|
|||||||||||||
Dorinco
Insurance (Ireland) Limited
|
Ireland
|
100
|
|||||||||||||
Dorinco
Reinsurance Company
|
Michigan
|
100
|
|||||||||||||
Dorintal
Reinsurance Limited
|
Bermuda
|
100
|
|||||||||||||
Timber
Insurance Limited
|
Bermuda
|
100
|
|||||||||||||
LG
DOW Polycarbonate Limited (1)
|
Korea
|
50
|
|||||||||||||
Pacific
Plastics (Thailand) Limited (47)
|
Thailand
|
49
|
|||||||||||||
Productos
Quimicos Peruanos S.A. (30)
|
Peru
|
91
|
|||||||||||||
PT
Dow Chemical Indonesia (18)
|
Indonesia
|
85
|
Ramses
Acquisition Corp.
|
Delaware
|
100
|
||||||||||||
Raven
Group Ltd.
|
Delaware
|
100
|
||||||||||||
RavenWorks
Ltd.
|
Delaware
|
100
|
||||||||||||
Rofan
Services Inc.
|
Delaware
|
100
|
||||||||||||
Dow
AgroSciences LLC (9)
|
Delaware
|
10
|
||||||||||||
DowBrands
Inc. (17)
|
Delaware
|
2
|
||||||||||||
Ion
Holdings LLC (20)
|
Delaware
|
40
|
||||||||||||
Mycogen
Corporation (16)
|
California
|
88
|
||||||||||||
Dow
AgroSciences LLC (9)
|
Delaware
|
51
|
||||||||||||
Alsan
Research (1)
|
Iowa
|
50
|
||||||||||||
Bayer
DAS (Private) Limited (1)
|
Pakistan
|
50
|
||||||||||||
DAS
Agricultural Investment Holding Company Ltd.
|
Mauritius
|
100
|
||||||||||||
Dow
AgroSciences India Pvt. Ltd. (33)
|
India
|
1
|
||||||||||||
Nantong
DAS Chemical Co., Ltd.
|
China
|
100
|
||||||||||||
DERe
Insurance Company
|
Vermont
|
100
|
||||||||||||
Dintec
Agrichemicals LLC (1)
|
Delaware
|
50
|
||||||||||||
Dow
AgroSciences Agricultural Products Limited
|
Mauritius
|
100
|
||||||||||||
Dow
AgroSciences India Pvt. Ltd. (33)
|
India
|
99
|
||||||||||||
Dow
AgroSciences B.V.
|
Netherlands
|
100
|
||||||||||||
Ambito
DAS S.A. (1)
|
Argentina
|
50
|
||||||||||||
ChacoDAS
S.A. (1)
|
Argentina
|
50
|
||||||||||||
DASER
AGRO S.A. (1)
|
Argentina
|
50
|
||||||||||||
Desab
S.A. (1)
|
Argentina
|
50
|
||||||||||||
Dintec
Agroquimica Produtos Quimicos, Lda.
|
Portugal
|
66
|
||||||||||||
Distribuidora
de Agroquimicos del Sureste de la Republica S.A. de C.V.
(1)
|
Mexico
|
50
|
||||||||||||
Dow
AgroSciences A.S.
|
Turkey
|
100
|
||||||||||||
Dow
AgroSciences Argentina S.A. (22)
|
Argentina
|
89
|
||||||||||||
Dow
AgroSciences Bolivia S.A. (38)
|
Bolivia
|
1
|
||||||||||||
Dow
AgroSciences Paraguay S.A. (39)
|
Paraguay
|
1
|
||||||||||||
Dow
AgroSciences Asia Sdn. Bhd.
|
Malaysia
|
100
|
||||||||||||
Dow
AgroSciences Australia Limited
|
Australia
|
100
|
||||||||||||
Dow
AgroSciences Bolivia S.A. (38)
|
Bolivia
|
98
|
||||||||||||
Dow
AgroSciences Canada Inc.
|
Canada
|
100
|
||||||||||||
Dow
AgroSciences Chile S.A.
|
Chile
|
100
|
||||||||||||
Dow
AgroSciences Costa Rica S.A.
|
Costa
Rica
|
100
|
||||||||||||
Dow
AgroSciences Danmark A/S
|
Denmark
|
100
|
||||||||||||
Dow
AgroSciences de Colombia S.A.
|
Colombia
|
100
|
||||||||||||
Dow
AgroSciences de Mexico S.A. de C.V.
|
Mexico
|
100
|
||||||||||||
Dow
AgroSciences Export S.A.S.
|
France
|
100
|
||||||||||||
Dow
AgroSciences Guatemala S.A.
|
Guatemala
|
100
|
||||||||||||
Dow
AgroSciences Iberica S.A.
|
Spain
|
100
|
||||||||||||
Dow
AgroSciences Industrial Ltda.
|
Brazil
|
100
|
||||||||||||
Agromen
Technolgia Ltda.
|
Brazil
|
100
|
||||||||||||
Dow
AgroSciences Limited
|
United
Kingdom
|
100
|
||||||||||||
Dow
AgroSciences (Malaysia) Sdn Bhd
|
Malaysia
|
100
|
||||||||||||
Dow
AgroSciences (NZ) Limited
|
New
Zealand
|
100
|
||||||||||||
Dow
AgroSciences Pacific Limited
|
Hong
Kong
|
100
|
||||||||||||
Dow
AgroSciences Paraguay S.A. (39)
|
Paraguay
|
99
|
||||||||||||
Dow
AgroSciences Bolivia S.A. (38)
|
Bolivia
|
1
|
||||||||||||
Dow
AgroSciences Polska Sp z.o.o.
|
Poland
|
100
|
||||||||||||
Dow
AgroSciences Hungary KFT (19)
|
Hungary
|
1
|
||||||||||||
Dow
AgroSciences S.A.S.
|
France
|
100
|
Dow
AgroSciences Distribution S.A.S.
|
France
|
100
|
|||||||||||||
Dow
AgroSciences s.r.o.
|
Czech
Republic
|
100
|
|||||||||||||
Dow
AgroSciences Sverige A/B
|
Sweden
|
100
|
|||||||||||||
Dow
AgroSciences Taiwan Ltd.
|
Taiwan
|
100
|
|||||||||||||
Dow
AgroSciences Technology GmbH
|
Switzerland
|
100
|
|||||||||||||
Dow
AgroSciences Switzerland S.A.
|
Switzerland
|
100
|
|||||||||||||
Dow
AgroSciences Hungary KFT (19)
|
Hungary
|
99
|
|||||||||||||
Dow
AgroSciences Uruguay S.A.
|
Uruguay
|
100
|
|||||||||||||
Dow
AgroSciences Vertriebsgesellschaft m.b.H.
|
Austria
|
100
|
|||||||||||||
Dow
Chemical Japan Limited
|
Japan
|
100
|
|||||||||||||
Dow
Venezuela, C.A. (7)
|
Venezuela
|
54
|
|||||||||||||
Fedea
S.A. (1)
|
Argentina
|
50
|
|||||||||||||
I.C.R.
- Intermedi Chimici Ravenna s.r.l. (1)
|
Italy
|
50
|
|||||||||||||
JV
Agro S.A. (1)
|
Argentina
|
50
|
|||||||||||||
P.T.
Dow AgroSciences Indonesia
|
Indonesia
|
95
|
|||||||||||||
Pentec
- Produtos Quimicos, Lda. (1)
|
Portugal
|
50
|
|||||||||||||
Rindes
y Cultivos - DAS S.A. (1)
|
Argentina
|
50
|
|||||||||||||
Terramar
JV S.A. (1)
|
Argentina
|
50
|
|||||||||||||
Ubajay-DAS
S.A. (1)
|
Argentina
|
50
|
|||||||||||||
Dow
AgroSciences Barbados Limited
|
Barbados
|
100
|
|||||||||||||
Dow
AgroSciences China Ltd.
|
Delaware
|
100
|
|||||||||||||
Dow
AgroSciences International Ltd.
|
Delaware
|
100
|
|||||||||||||
Dow
AgroSciences (Thailand) Limited
|
Thailand
|
100
|
|||||||||||||
Dow
AgroSciences Southern Africa (Proprietary) Limited
|
South
Africa
|
100
|
|||||||||||||
Sanachem
Zimbabwe (Pvt) Ltd.
|
Zimbabwe
|
100
|
|||||||||||||
DowBrands
Inc. (17)
|
Delaware
|
11
|
|||||||||||||
Mycogen
Crop Protection, Inc.
|
California
|
100
|
|||||||||||||
Mycogen
S.A. de C.V. (4)
|
Mexico
|
99
|
|||||||||||||
Mycogen
Plant Science, Inc.
|
Delaware
|
100
|
|||||||||||||
Agrigenetics,
Inc.
|
Delaware
|
100
|
|||||||||||||
Agrigenetics
Molokai LLC
|
Hawaii
|
100
|
|||||||||||||
Brodbeck
Seeds LLC
|
Delaware
|
100
|
|||||||||||||
Dairyland
Seed Co., Inc.
|
Wisconsin
|
100
|
|||||||||||||
Dow
AgroSciences Argentina S.A. (22)
|
Argentina
|
11
|
|||||||||||||
Duo
Maize B.V.
|
Netherlands
|
100
|
|||||||||||||
Mycogen
S.A. de C.V. (4)
|
Mexico
|
1
|
|||||||||||||
Mycogen
Seeds-Puerto Rico Corporation
|
Delaware
|
100
|
|||||||||||||
Renze
Seeds LLC
|
Delaware
|
100
|
|||||||||||||
Texas
Triumph Seed Co., Inc.
|
Texas
|
100
|
|||||||||||||
Monterey
Seed Company, Inc.
|
Texas
|
100
|
|||||||||||||
Phytogen
Seed Company, LLC
|
Delaware
|
54
|
|||||||||||||
Wenben
Inc.
|
Delaware
|
100
|
|||||||||||||
SD
Group Service Co., Ltd. (1)
|
Thailand
|
50
|
|||||||||||||
Sentrachem
US, Inc.
|
Delaware
|
100
|
|||||||||||||
Hampshire
Holdings, Inc.
|
Delaware
|
100
|
|||||||||||||
Hampshire
Chemical Corp.
|
Delaware
|
100
|
|||||||||||||
Siam
Polystyrene Company Limited (1)
|
Thailand
|
50
|
|||||||||||||
Siam
Styrene Monomer Co., Ltd. (1)
|
Thailand
|
50
|
|||||||||||||
Siam
Synthetic Latex Company Limited (1)
|
Thailand
|
50
|
|||||||||||||
Styron
Asia Limited
|
Hong
Kong
|
100
|
|||||||||||||
Sumitomo
Dow Limited. (1)
|
Japan
|
50
|
|||||||||||||
TCM
Technologies Inc.
|
Delaware
|
100
|
Texas
LNG Holdings LLC
|
Delaware
|
100
|
|||||||||
Union
Carbide Corporation
|
New
York
|
100
|
|||||||||
Amerchol
Corporation
|
Delaware
|
100
|
|||||||||
Benefit
Capital Management Corporation
|
Delaware
|
100
|
|||||||||
Calidria
Corporation
|
Delaware
|
100
|
|||||||||
Carbide
Chemical (Thailand) Limited
|
Thailand
|
100
|
|||||||||
Excellent
Quality (Thailand) Company Limited
|
Thailand
|
100
|
|||||||||
Catalysts,
Adsorbents & Process Systems, Inc.
|
Maryland
|
100
|
|||||||||
Chemicals
Marine Fleet, Inc.
|
Delaware
|
100
|
|||||||||
DML
Holding Inc. (36)
|
Delaware
|
11
|
|||||||||
Dow
International Holdings Company (27)
|
Delaware
|
19
|
|||||||||
Dow
Petrochemicals Holding LLC (48)
|
Delaware
|
25
|
|||||||||
Dow
Quimica Argentina S.A. (25)
|
Argentina
|
12
|
|||||||||
Dow
Quimica Mexicana S.A. de C.V. (21)
|
Mexico
|
15
|
|||||||||
Dow
Venezuela, C.A. (7)
|
Venezuela
|
10
|
|||||||||
Global
Industrial Corporation
|
New
York
|
100
|
|||||||||
GWN
Holding, Inc. (37)
|
Delaware
|
7
|
|||||||||
Industrias
Carlisil, S.A.
|
Mexico
|
100
|
|||||||||
K-Dow
Petrochemicals UC Sub C, Inc.
|
Delaware
|
100
|
|||||||||
Univation
Technologies, LLC (1)
|
Delaware
|
50
|
|||||||||
KTI
Chemicals, Inc.
|
Delaware
|
100
|
|||||||||
Modeland
International Holdings Inc. (28)
|
Barbados
|
41
|
|||||||||
Nippon
Unicar Company Limited (1)
|
Japan
|
50
|
|||||||||
OPTIMAL
Chemicals (Malaysia) Sdn. Bhd. (1)
|
Malaysia
|
50
|
|||||||||
P.T.
Union Carbide Indonesia
|
Indonesia
|
100
|
|||||||||
Seadrift
Pipeline Corporation
|
Delaware
|
100
|
|||||||||
Servicios
de Quimicos Agricolas, S. A.
|
Mexico
|
100
|
|||||||||
South
Charleston Sewage Treatment Company
|
West
Virginia
|
100
|
|||||||||
UC
Finco Inc.
|
Delaware
|
100
|
|||||||||
UCAR
Emulsion Systems International, Inc.
|
Delaware
|
100
|
|||||||||
UCAR
Emulsion Systems FZE
|
Dubai
|
100
|
|||||||||
UCAR
Interam Inc.
|
Delaware
|
100
|
|||||||||
UCAR
Louisiana Pipeline Company
|
Delaware
|
100
|
|||||||||
UCAR
Pipeline Incorporated
|
Delaware
|
100
|
|||||||||
UCMG
LLC
|
Delaware
|
100
|
|||||||||
OPTIMAL
Glycols (Malaysia) Sdn. Bhd. (1)
|
Malaysia
|
50
|
|||||||||
Umetco
Minerals Corporation
|
Delaware
|
100
|
|||||||||
Australia
and New Zealand Exploration Company
|
Delaware
|
100
|
|||||||||
Blue
Creek Coal Company, Inc.
|
Delaware
|
100
|
|||||||||
Predate
Properties (Pty) Ltd.
|
South
Africa
|
100
|
|||||||||
Umetco
Minerals Exploration Corporation
|
Delaware
|
100
|
|||||||||
Union
Carbide Asia Limited
|
Hong
Kong
|
100
|
|||||||||
Union
Carbide (Guangdong Zhongshan) Company Limited
|
China
|
75
|
|||||||||
Union
Carbide Asia Pacific, Inc.
|
Delaware
|
100
|
|||||||||
Union
Carbide Caribe LLC
|
Delaware
|
100
|
|||||||||
Union
Carbide Chemicals & Plastics Technology LLC
|
Delaware
|
100
|
|||||||||
Dow
Petrochemicals Holding LLC (48)
|
Delaware
|
25
|
|||||||||
Dow
Technology Investments LLC (43)
|
Delaware
|
50
|
|||||||||
Union
Carbide Comercial Nicaragua, S.A.
|
Nicaragua
|
100
|
|||||||||
Union
Carbide Customer Services Pte. Ltd.
|
Singapore
|
100
|
|||||||||
Union
Carbide Ethylene Oxide/Glycol Company
|
Delaware
|
100
|
|||||||||
Union
Carbide Inter-America, Inc. (Delaware)
|
Delaware
|
100
|
(1)
|
These
companies are 50%-owned, nonconsolidated affiliates of The Dow Chemical
Company and are accounted for on the equity basis. Separate financial
statements for these companies are not included in this Form 10-K. These
companies are not controlled, directly or indirectly, by The Dow Chemical
Company. Subsidiaries of these companies, if any, are not listed in this
Exhibit 21.
|
(2)
|
The
Dow Chemical Company effective ownership of Dow Mideast Systems S.A.E.
(JSC) is 100% of which Dow Europe Holding B.V. owns 99.96%, Dow Europe
GmbH owns 0.020% and Dow InterBranch B.V. owns 0.020%.
|
(3)
|
The
Dow Chemical Company effective ownership of Dow Turkiye Kimya Sanayi ve
Ticaret Ltd Sti is 100% of which Dow Europe Holding B.V. owns 99.9988% and
Dow InterBranch B.V. owns 0.0012%.
|
(4)
|
The
Dow Chemical Company effective ownership of Mycogen S.A. de C.V. is 100%
of which Mycogen Crop Protection, Inc. owns 99% and Agrigenetics, Inc.
owns 1%.
|
(5)
|
The
Dow Chemical Company effective ownership of Dow Quimica de Colombia S.A.
is 100% of which The Dow Chemical Company owns 90% and Dow Chemical
Inter-American Limited owns 10%.
|
(6)
|
The
Dow Chemical Company effective ownership of DowBrands L.P. is 100% of
which Dow Holdings LLC owns 58% and DC Partnership Management Inc. owns
42%.
|
(7)
|
The
Dow Chemical Company effective ownership of Dow Venezuela, C.A. is 100% of
which Dow AgroSciences B.V. owns 53.84%, The Dow Chemical Company owns
36.06% and Union Carbide Corporation owns 10.1%.
|
(8)
|
The
Dow Chemical Company effective ownership of Chemtech II L.P. is 100% of
which Dow Chemical Delaware Corp. owns 72.46%, The Dow Chemical Company
owns 22.39% and Ifco Inc. owns 5.15%.
|
(9)
|
The
Dow Chemical Company effective ownership of Dow AgroSciences LLC is 100%
of which Mycogen Corporation owns 51%, Centen Ag Inc. owns 38.91% and
Rofan Services Inc. owns 10.09%.
|
(10)
|
The
Dow Chemical Company effective ownership of Polyol Belgium B.V.B.A. is
100% of which Dow Benelux B.V. owns 99.5% and Dow Europe Holding B.V. owns
0.5%.
|
(11)
|
The
Dow Chemical Company effective ownership of Chemtech Portfolio Inc. is
100% of which Dow Global Technologies Inc. owns 66.82% and Chemtech II
L.P. owns 33.18% .
|
(12)
|
The
Dow Chemical Company effective ownership of Dow S/B Latex (Zhangjiagang)
Co. Ltd. is 100% of which Dow Chemical (China) Investment Company Limited
owns 61.16% and Dow Financial Holdings Singapore Pte Ltd. owns
38.84%.
|
(13)
|
The
Dow Chemical Company effective ownership of Dow Chemical (Zhangjiagang)
Company Limited is 100% of which Dow Chemical (China) Investment Company
Limited owns 85.36% and Dow Financial Holdings Singapore Pte Ltd. owns
14.64%.
|
(14)
|
The
Dow Chemical Company effective ownership of Fort Saskatchewan Ethylene
Storage Limited Partnership is 50% of which K-Dow Canada ULC owns 49.9%
and Fort Saskatchewan Ethylene Storage Corporation owns 0.2%. (Midland
Pipeline Corp. owns 50% of Fort Saskatchewan Ethylene Storage
Corporation.)
|
(15)
|
The
Dow Chemical Company effective ownership of SAL Petrochemical
(Zhangjiagang) Company Limited is 100% of which Dow Financial Holdings
Singapore Pte Ltd. owns 90% and Dow Chemical (China) Investment Company
Limited owns 10%.
|
(16)
|
The
Dow Chemical Company effective ownership of Mycogen Corporation is 100% of
which Rofan Services Inc. owns 88.11% and Centen Ag Inc. owns
11.89%.
|
(17)
|
The
Dow Chemical Company effective ownership of DowBrands Inc. is 100% of
which Dow International Holdings Company owns 79%, Mycogen Corporation
owns 11%, Centen Ag Inc. owns 8% and Rofan Services Inc. owns
2%.
|
(18)
|
The
Dow Chemical Company effective ownership of PT Dow Chemical Indonesia is
100% of which The Dow Chemical Company owns 84.5991% and Dow Chemical
Pacific (Singapore) Private Limited owns 15.4009%.
|
(19)
|
The
Dow Chemical Company effective ownership of Dow AgroSciences Hungary KFT
is 100% of which Dow AgroSciences Switzerland S.A. owns 99.97% and Dow
AgroSciences Polska Sp z.o.o. owns 0.03%.
|
(20)
|
The
Dow Chemical Company effective ownership of Ion Holdings LLC is 100% of
which The Dow Chemical Company owns 60% and Rofan Services Inc. owns
40%.
|
(21)
|
The
Dow Chemical Company effective ownership of Dow Quimica Mexicana S.A. de
C.V. is 100% of which The Dow Chemical Company owns 84.58% and Union
Carbide Corporation owns 15.42%.
|
(22)
|
The
Dow Chemical Company effective ownership of Dow AgroSciences Argentina
S.A. is 100% of which Dow AgroSciences B.V. owns 89.13% and Agrigenetics,
Inc. owns 10.87%.
|
(23)
|
The
Dow Chemical Company effective ownership of Dexco Polymers L.P. is 50% of
which DW Dexco Investment LLC owns 49.5% and Dexco Polymers Operating
Company LLC owns 1%. (The Dow Chemical Company owns 50% of Dexco Polymers
Operating Company LLC).
|
(24)
|
The
Dow Chemical Company effective ownership of Dow Zwijndrecht B.V.B.A. is
100% of which Dow Europe Holding B.V. owns 99.65% and Dow InterBranch B.V.
owns 0.35%.
|
(25)
|
The
Dow Chemical Company effective ownership of Dow Quimica Argentina S.A. is
100% of which The Dow Chemical Company owns 87.89%, Union Carbide
Corporation owns 11.99% and Union Carbide Pan America, Inc. owns
0.12%.
|
(26)
|
The
Dow Chemical Company effective ownership of Dow Quimica Chilena S.A. is
100% of which The Dow Chemical Company owns 89.81%, Union Carbide
Inter-America, Inc. (Delaware) owns 10.16% and Union Carbide Pan America,
Inc. owns 0.03%.
|
(27)
|
The
Dow Chemical Company effective ownership of Dow International Holdings
Company is 100% of which The Dow Chemical Company owns 72.0268%, Union
Carbide Corporation owns 19.1341%, Essex Specialty Products LLC owns
8.7988% and Dow Chemical International Ltd owns 0.0403%.
|
(28)
|
The
Dow Chemical Company effective ownership of Modeland International
Holdings Inc. is 100% of which Dow Chemical Finance Canada Inc. owns 59.1%
and Union Carbide Corporation owns 40.9%.
|
(29)
|
The
Dow Chemical Company effective ownership of Dow Hungary Kft. is 100% of
which Dow Europe Holding B.V. owns 99.98% and Dow InterBranch B.V. owns
0.02%.
|
(30)
|
The
Dow Chemical Company effective ownership of Productos Quimicos Peruanos
S.A. is 100% of which The Dow Chemical Company owns 91.21% and Union
Carbide Inter-America, Inc. (Delaware) owns 8.79%.
|
(31)
|
The
Dow Chemical Company effective ownership of Valuepark Terneuzen C.V. is
50% of which Terneuzen Partnership Services B.V. owns 49.82% and Valuepark
Terneuzen Beheer B.V. owns 0.36%. (Dow Benelux B.V. owns 50% of Valuepark
Terneuzen Beheer BV).
|
(32)
|
The
Dow Chemical Company effective ownership of Dow Chemical International
Pvt. Ltd. is 100% of which Dow Chemical Pacific (Singapore) Private
Limited owns 99.99% and Dow Chemical (Singapore) Private Limited owns
0.01%.
|
(33)
|
The
Dow Chemical Company effective ownership of Dow AgroSciences India Pvt.
Ltd. is 100% of which Dow AgroSciences Agricultural Products Limited owns
99.99% and DAS Agricultural Investment Holding Company Ltd. owns
0.01%.
|
(34)
|
The
Dow Chemical Company effective ownership of PBBPolisur S.A. is 100% of
which Dow Investment Argentina S.A. owns 72% and 3229809 Nova Scotia
Company owns 28%.
|
(35)
|
The
Dow Chemical Company effective ownership of Dow Deutschland GmbH & Co
OHG is 100% of which Dow Automotive (Deutschland) GmbH owns 35%, SAFECHEM
Europe GmbH owns 35% and ANGUS Chemie GmbH owns 30%.
|
(36)
|
The
Dow Chemical Company effective ownership of DML Holding Inc. is 100% of
which The Dow Chemical Company owns 88.84% and Union Carbide Corporation
owns 11.16%.
|
(37)
|
The
Dow Chemical Company effective ownership of GWN Holding, Inc. is 100% of
which The Dow Chemical Company owns 66.23%, Essex Specialty Products LLC
owns 26.93% and Union Carbide Corporation owns 6.84%.
|
(38)
|
The
Dow Chemical Company effective ownership of Dow AgroSciences Bolivia S.A.
is 100% of which Dow AgroSciences B.V. owns 99%, Dow AgroSciences
Argentina S.A. owns 0.5% and Dow AgroSciences Paraguay S.A. owns
0.5%.
|
(39)
|
The
Dow Chemical Company effective ownership of Dow AgroSciences Paraguay S.A.
is 100% of which Dow AgroSciences B.V. owns 99.99% and Dow AgroSciences
Argentina S.A. owns 0.01%.
|
(40)
|
The
Dow Chemical Company effective ownership of Dow Chemical Korea Limited is
100% of which The Dow Chemical Company owns 85.82% and Dow Europe Holding
B.V. owns 14.18%.
|
(41)
|
The
Dow Chemical Company effective ownership of Dow Saudi Arabia Company is
100% of which Dow Europe Holding B.V. owns 85% and Dow Interbranch B.V.
owns 15%.
|
(42)
|
The
Dow Chemical Company effective ownership of Dow Wolff Cellulosics GmbH
& Co OHG is 100% of which ANGUS Chemie GmbH owns 50% and SAFECHEM
Europe GmbH owns 50%. Dow Europe Holding B.V. acts as general partner with
0% capital participation.
|
(43)
|
The
Dow Chemical Company effective ownership of Dow Technology Investments LLC
is 100% of which Dow Global Technologies Inc. owns 50% and Union Carbide
Chemicals & Plastics Technology LLC owns 50%.
|
(44)
|
The
Dow Chemical Company effective ownership of DC Spectrum Holding C.V. is
100% of which Dow International Holdings Company owns 99.999% and Dow
Netherlands Holdings LLC owns 0.001%.
|
(45)
|
The
Dow Chemical Company effective ownership of Coöperatieve DC Prisma Holding
U.A. is 100% of which DC Spectrum Holding C.V. owns 99.999% and Dow
Netherlands Investments LLC owns .001%.
|
(46)
|
The
Dow Chemical Company effective ownership of DC Galaxy Holding C.V. is 100%
of which Dow International Holdings S.A. owns 99.928% and Dow Dutch
Holding B.V. owns 0.072%.
|
(47)
|
The
Dow Chemical Company effective ownership of Pacific Plastics (Thailand)
Limited is 100% of which Dow Chemical International Ltd. owns 51% and The
Dow Chemical Company owns 49%.
|
(48)
|
The
Dow Chemical Company effective ownership of Dow Petrochemicals Holding LLC
is 100% of which The Dow Chemical Company owns 25%, Dow Global
Technologies Inc. owns 25%, Union Carbide Corporation owns 25% and Union
Carbide Chemicals & Plastics Technology LLC owns 25%.
|
(49)
|
The
Dow Chemical Company effective ownership of Dow Egypt Services Limited is
100% of which Dow Mideast Systems S.A.E. (JSC) owns 75% and Dow Europe
GmbH owns 25%.
|
(50)
|
The
Dow Chemical Company effective ownership of Dow Olefinverbund GmbH is 100%
of which Dow Europe Holding B.V. owns 95% and Dow Beteiligungsgesellschaft
mbH & Co. KG owns 5%.
|
(51)
|
The
Dow Chemical Company effective ownership of Daulat Canada Holding LP is
100% of which Dow Canada Holding LP owns 50% and Dow Canadian Holding BV
owns 50%.
|
(52)
|
The
Dow Chemical Company effective ownership of Dow Izolan OOO is
58% via its ownership interest in RUS Polyurethanes Holding
B.V.
|
(53)
|
The
Dow Chemical Company effective ownership of Dow Izolan Ukraine LLC is 58%
via its ownership interest in RUS Polyurethanes Holding B.V.
|
(54)
|
The
Dow Chemical Company effective ownership of UPPC S.A.R.L. is 100% of which
UPPC GmbH owns 75% and Dow France S.A.S. owns 25%.
|
(55)
|
The
Dow Chemical Company effective ownership of K-D Petrochemicals C.V. is 50%
of which Daulat Holdco LLC owns .00058011%, Dow Plastics and Chemicals
Holding B.V. owns .00058011%, Daulat Canada Holding LP owns .00058011% and
K-Dow Petrochemicals GmbH owns 99.99651933% (Dow Petrochemicals Holding
LLC owns 50% of K-Dow Petrochemicals
GmbH.)
|
Form
S-3:
|
|
Nos.
|
333-101647
|
333-140859
|
|
Form
S-4:
|
|
No.
|
333-88443
|
Form
S-8:
|
|
Nos.
|
2-64560
|
33-21748
|
|
33-51453
|
|
33-52841
|
|
33-58205
|
|
33-61795
|
|
333-27381
|
|
333-40271
|
|
333-43730
|
|
333-49183
|
|
333-67414
|
|
333-88443
|
|
333-91027
|
|
333-103518
|
|
333-103519
|
|
333-105080
|
|
333-115185
|
|
333-122932
|
|
333-145015
|
|
333-155074
|
/s/
DELOITTE & TOUCHE LLP
|
Deloitte & Touche
LLP
Midland,
Michigan
February
17, 2009
|
Form
S-3:
|
|
Nos.
|
333-101647
|
333-140859
|
|
Form
S-4:
|
|
No.
|
333-88443
|
Form
S-8:
|
|
Nos.
|
2-64560
|
33-21748
|
|
33-51453
|
|
33-52841
|
|
33-58205
|
|
33-61795
|
|
333-27381
|
|
333-40271
|
|
333-43730
|
|
333-49183
|
|
333-67414
|
|
333-88443
|
|
333-91027
|
|
333-103518
|
|
333-103519
|
|
333-105080
|
|
333-115185
|
|
333-122932
|
|
333-145015
|
|
333-155074
|
/s/
B.
THOMAS FLORENCE
|
B.
Thomas Florence
President
Analysis,
Research & Planning Corporation
February 18,
2009
|
The Dow Chemical Company and Subsidiaries
|
EXHIBIT
31(a)
|
1.
|
I
have reviewed this annual report on Form 10-K of The Dow Chemical
Company;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
The
registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and
have:
|
|
a)
|
designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
b)
|
designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
|
c)
|
evaluated
the effectiveness of the registrant's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation;
and
|
|
d)
|
disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
The
registrant's other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to
the registrant's auditors and the audit committee of registrant's board of
directors (or persons performing the equivalent
function):
|
|
a)
|
all
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information;
and
|
|
b)
|
any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.
|
/s/
ANDREW N. LIVERIS
|
||
Andrew
N. Liveris
President,
Chief Executive Officer and
Chairman
of the Board
|
||
The
Dow Chemical Company and Subsidiaries
|
EXHIBIT
31(b)
|
1.
|
I
have reviewed this annual report on Form 10-K of The Dow Chemical
Company;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
The
registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and
have:
|
|
a)
|
designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
b)
|
designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
|
c)
|
evaluated
the effectiveness of the registrant's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation;
and
|
|
d)
|
disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
The
registrant's other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to
the registrant's auditors and the audit committee of registrant's board of
directors (or persons performing the equivalent
function):
|
|
a)
|
all
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information;
and
|
|
b)
|
any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.
|
/s/
GEOFFERY E. MERSZEI
|
||
Geoffery
E. Merszei
Executive
Vice President and Chief Financial Officer
|
||
The
Dow Chemical Company and Subsidiaries
|
EXHIBIT
32(a)
|
1.
|
the
Annual Report on Form 10-K of the Company for the year ended December 31,
2008 as filed with the Securities and Exchange Commission (the “Report”)
fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934;
and
|
2.
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
/s/
ANDREW N. LIVERIS
|
Andrew
N. Liveris
President,
Chief Executive Officer and
Chairman
of the Board
February
18,
2009
|
The
Dow Chemical Company and Subsidiaries
|
EXHIBIT
32(b)
|
1.
|
the
Annual Report on Form 10-K of the Company for the year ended December 31,
2008 as filed with the Securities and Exchange Commission (the “Report”)
fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934;
and
|
2.
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
/s/
GEOFFERY E. MERSZEI
|
Geoffery
E. Merszei
Executive
Vice President and Chief Financial Officer
February
18, 2009
|